Next Article in Journal
The Role of Steroidomics in the Diagnosis of Alzheimer’s Disease and Type 2 Diabetes Mellitus
Previous Article in Journal
Enhancing SARS-CoV-2 Surveillance through Regular Genomic Sequencing in Spain: The RELECOV Network
Previous Article in Special Issue
Drug-Induced Enterocolitis Syndrome in Children
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

The Role of Vitamins in the Pathogenesis of Asthma

by
Dominika Zajac
* and
Piotr Wojciechowski
Department of Respiration Physiology, Mossakowski Medical Research Institute, Polish Academy of Sciences, 02-106 Warszawa, Poland
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2023, 24(10), 8574; https://doi.org/10.3390/ijms24108574
Submission received: 28 February 2023 / Revised: 27 April 2023 / Accepted: 9 May 2023 / Published: 10 May 2023
(This article belongs to the Special Issue Molecular and Cellular Basis of Allergies and Allergic Asthma)

Abstract

:
Vitamins play a crucial role in the proper functioning of organisms. Disturbances of their levels, seen as deficiency or excess, enhance the development of various diseases, including those of the cardiovascular, immune, or respiratory systems. The present paper aims to summarize the role of vitamins in one of the most common diseases of the respiratory system, asthma. This narrative review describes the influence of vitamins on asthma and its main symptoms such as bronchial hyperreactivity, airway inflammation, oxidative stress, and airway remodeling, as well as the correlation between vitamin intake and levels and the risk of asthma in both pre- and postnatal life.

1. Introduction

Asthma is a heterogeneous inflammatory disease of the airways. Currently, about 300 million people worldwide suffer from this disease [1]. Its symptoms comprise tightness of the chest, wheezing, dyspnea, and cough, all of which are accompanied by reversible airway obstruction and persistent inflammation of the airways. At the local level, the asthma-related changes include disturbances in the balance of Th1/Th2 pro- and anti-inflammatory cytokines, an increased cellular influx into the bronchi, chronic oxidative stress, and airway hyperreactivity. Within time or in the case of poor control of the disease, remodeling of small airways may occur [2,3]. Uncontrolled asthma leads not only to impairments of every-day-life such as a decreased physical condition, chronic fatigue, sleep problems, and obesity, but also to dangerous complications including obstructive sleep apnea (OSA), respiratory failure, chronic obstructive pulmonary diseases (COPD), pneumonia, or the life-threatening status asthmaticus. There is no single well-defined cause of asthma, but rather a number of risk factors, among which allergies, environmental pollution and irritants, genetic factors, excessive hygienic measures in childhood, frequent respiratory infections in early life, prenatal exposure to certain medications, and obesity are the most important. Asthma exacerbations can be induced by many factors such as allergen or irritant exposure, the use of specific medication, increased physical activity, and cold or viral infections [4]. A healthy lifestyle with appropriate physical activity and a balanced diet covering the proper levels of micro-, macro-nutrients, and vitamins may improve the control of the disease and alleviate its symptoms. The role of micronutrients in asthma has recently been summarized by Zajac [5], and this paper, as a kind of continuation, aims to describe the role of vitamins and their deficiencies in the pathogenesis of asthma.
Reports on the role of vitamins in asthma can be divided into three main groups. The first one includes studies on the general nutritional habits seen as a healthy lifestyle, including the Mediterranean diet and an increased consumption of fruits and vegetables, fish, and unsaturated oils. These reports rely mostly on diet diaries, specially designed questionnaires, or other recordings of food intake during a certain period. On the basis of these data, the authors conclude on the vitamin levels taken by a subject. In some of them, supplements from other sources are taken into account.
The second group of analyses limits its data to certain groups of vitamins, such as antioxidant vitamins (A, C, and E) or group B vitamins. The data are based either on surveys with detailed questions on the subpopulation of compounds tested or on direct observations of the subjects supplementing the given vitamin(s).
The third type of research focuses on direct supplementation (or depletion—in animal studies) of the given vitamin to the subject.
A proper sum-up of the role of vitamins in asthma is challenging for several reasons, all of them due to the character of the published studies. Some studies have concentrated on general healthy lifestyles and proper nutrition and described the relationship between the given diet (Mediterranean diet or avoidance of processed foods, etc.) and asthma. Others, in turn, have rather described the importance of a class of vitamins (water vs. fat soluble, antioxidant vitamins, etc.) in the prevention, risk of development, or treatment of asthma. Further articles have dealt with the role of one chosen vitamin, its deficiency or excess in the pathogenesis of asthma, and the possibility of its supplementation in the treatment of the disease. This review is, to our knowledge, one of very few taking together the influence of all vitamins, and not only general nutrition or each vitamin alone, on asthma. Specifically, for the first time, we focus not on asthma as a disease, but on its features, such as impaired lung function, airway hyperreactivity, airway inflammation, chronic oxidative stress, mucus oversecretion, or airway remodeling, together with viral infections being the main trigger of its exacerbations. Another problem we address in the present review is the role of maternal vitamin intake in asthma development in children, mentioning also the importance of gut microbiota. In consequence, the present paper aims to summarize all these findings in order to clarify the influence of vitamins on asthma and its main manifestations. The articles were searched in Pubmed and Google Scholar using the following terms (“vitamin A”, “vitamin B1”, “vitamin B2”, “vitamin B3”, “vitamin B5”, “vitamin B6”, “vitamin B7”, “vitamin B9”, “vitamin B12”, “vitamin C”, “vitamin D”, “vitamin E”, “vitamin K”, “thiamine”, “riboflavin”, “niacin”, “nicotinamide”, “nicotinamide riboside”, “pantothenic acid”, “pyridoxine”, “pyridoxal 5′-phosphate”, “biotin”, “folic acid”, “folate”, “tetrahydrofolic acid”, “cobalamin”, “ascorbic acid”, “1,25-dihydroxyvitamin D”, “tocopherol”, and “tocotrienol”) and (“asthma”, “risk of asthma”, maternal risk of asthma”), (“airway hyperreactivity”, “lung function”, “oxidative stress”, “cellular influx”, “mucus”, and “airway remodeling”) within the years of 2000–2023. Older articles were taken under consideration only if they provided information that could not be found elsewhere in newer publications and was fundamental to the subject.

2. Healthy Lifestyle, Nutrition, and Asthma

In general, a diet rich in antioxidants and anti-oxidant vitamins (vit. A, C, and E) decreases oxidative stress and lowers the risk of inflammation. Interestingly, in various studies, no association between anti-oxidant vitamins and asthma could be found [6,7], most likely due to dissimilarities in the basic diets in different regions, the potential fortification of food or supplementation from different sources (herbal or natural medicines, OTC (over the counter), or prescribed drugs), and the possibility of non-controlled use of vitamin supplements. For example, different results of studies are obtained regarding the influence of vitamin E on the asthma outcomes in Europe and America, where different oils are used for every-day cooking. The amounts of different isoforms of vitamin E (of the pro-inflammatory gamma-Tocopherol (γTPh) and the anti-inflammatory alpha-Tocopherol (αTPh)) vary between these oils. Therefore, the regular intake of the vitamin E isoforms present in the respective oils may interfere with supplemented vitamin E (see below). Moreover, the overconsumption of highly vitamin-A- and D-containing food, such as cod liver, may increase the risk of adult-onset asthma [8].
Another concern about vitamins and their involvement in the pathogenesis of asthma is the problem of deficiencies, which can be related to malnutrition, lifestyle, or place of residence. Only in 2014, about a billion people, especially those with respiratory disorders, suffered from a vitamin D deficiency, making it a global problem that could, in fact, be easily eliminated [9]. The risk factors of developing both asthma and a vitamin D deficiency are shared and overlap, and include air pollution, smoking, the use of certain medications, a sedentary lifestyle with low or absent outdoor activity, metabolic disorders, and others [10,11,12,13,14,15]. Other cultural habits, including traditional or weather-dependent clothes covering the body to a smaller or higher degree, the types of activities undertaken during free time, and the consumption of processed food or beverages as additional meals or snacks may influence vitamin levels and facilitate the occurrence of their deficiencies.

3. General Characteristics of the Vitamins

3.1. Vitamin A and Carotenoids

Retinoic acid (RA), the main active form of vitamin A, is essential for pre- and postnatal development, eye sight, reproduction, and immune function [16]. It is stored and later activated in the liver from retinol. The retinoic acid pathway (retinoic acid and receptors) regulates more than 500 genes, including those involved in immunity [17].
Regarding asthma, vitamin A promotes the normal development of the lungs, the differentiation and growth of respiratory epithelial cells [18], and enhances the proliferation and survival of T cells [19,20,21]. Together with other carotenoids, vitamin A is a ROS (reactive oxygen species) scavenger and has, in consequence, antioxidant and immunomodulatory properties. As such, they have been shown to decrease ROS (including superoxide anion and hydrogen peroxide) levels and suppress pro-inflammatory cytokines (explained in detail below) [22].
The form of the administration of retinoids is important. A liposomal formulation of all-trans retinoic acid (ATRA) aggravates asthma outcomes and exacerbates allergic inflammatory responses in OVA mice, while other forms of dosage alleviate them [23]. The exact mechanisms underlying this phenomenon are not known. Similarly, Reifen et al. [24] described that the aerosol administration of vitamin A has, contrary to other ways, no influence on asthma outcomes in children. An excess of vitamin A increases the risk of a child developing asthma when the compound is administered in a water-based formulation instead of an oil-based one [25]. Once again, the reasons of such difference have not been established yet.
In the literature, not only is vitamin A taken under consideration, but also other carotenoids, such as carotenes or even lycopene, which, however, is not transformed into vitamin A. The general consumption of carotenoid-rich food leads to a lower risk of asthma [26], better asthma control, and lung function, probably due to the antioxidant properties of this class of compounds [27,28].

3.2. Vitamin B Group

The vitamins of the B family are a group of eight water-soluble vitamins that are involved in various metabolic processes, including the formation of red blood cells. Moreover, they are cofactors (or their direct precursors) of enzymes. Only some of them participate in the processes related to asthma. Up until now, there have been no reports about a possible link between this disease and vitamins B1, B2, B5, and B7. Later in the text, a vitamin of this group is only mentioned when research data about its levels, intake, or influence on a feature of asthma are available.
The term vitamin B3 covers three substances, niacin, nicotinamide, and nicotinamide riboside, which are all included in the structure of nicotinamide adenine dinucleotide (NAD) and its phosphorylated derivative, nicotinamide adenine dinucleotide phosphate (NADPH), key coenzymes involved in metabolism and energy production. Their role and the role of NADPH-dependent oxidase in inflammation, asthma, and other respiratory diseases have been summarized by Harijith [29] and Chang [30]. In summary, NADPH-dependent oxidases participate in the stimulation of mucus production, neutrophil recruitment, the induction of ciliary dysfunction, and airway smooth muscle hypercontractivity. The role of nicotinamide as a molecule itself in asthma is not known, even if its levels are higher in asthmatics.
Vitamin B6, pyridoxine, and its active form, pyridoxal 5′-phosphate, is a coenzyme of some crucial enzymes. The compound is involved in amino acid metabolism, the synthesis of neurotransmitters including dopamine and serotonin, glucose and lipid metabolism, and hemoglobin synthesis. It enhances magnesium absorption. Vitamin B6 affects cell-mediated immunity; its administration improves immune responses. The role of vitamin B6 in these processes has been presented by Ueland et al. [31].
Vitamin B9, including folic acid, folate, and related compounds such as tetrahydrofolic acid participate in metabolic processes at the cellular level and act as methyl donors, a group of substances transporting single-carbon groups between bioactive substances. They participate in the methylation of DNA, its synthesis, and modification. Folates are needed in the activation process of cobalamin (vitamin B12), which, in turn, transforms homocysteine into methionine; thus, they are essential in the folate–methionine cycle and for methyl transport in cells [32]. Folate deficiencies in prenatal life are related to neural tube malformations and congenital heart defects. To prevent such issues, food fortification with folates is recommended worldwide, together with folic acid supplementation prior to and during pregnancy [33].
Vitamin B12, cobalamin, and its derivatives are another group of methyl donors that participate in the methylation and transformation of homocysteine to methionine. They play roles in the formation of blood cells, DNA synthesis, the synthesis of myelin, and the correct functioning of the nervous system [32]. Although vitamin B12 can be seen as an immunomodulator [34], its direct role in respiratory diseases is not known [5].

3.3. Vitamin C

Vitamin C (ascorbic acid) is a water-soluble compound that plays a role in tissue repair, collagen production, the proper activity of various enzymes, and the absorption of certain nutrients and minerals such as iron. Vitamin C is known for its anti-oxidant and anti-inflammatory properties [35,36]. It is believed to alleviate the symptoms of viral airway infections such as the common cold [37]. Moreover, smoking-induced airway irritation and cough are reduced by vitamin C supplementation or a vitamin-C-rich diet [38]. High levels of vitamin C are observed in the lungs, lung macrophages, and type II cells [39]. However, the supplementation of vitamin C does not change its levels in the lining fluid of the respiratory tract [40].
The most important challenge in research on the function of vitamin C with animal studies is that rats and mice have the ability to synthesize vitamin C on their own; thus, they are not prone to developing a vitamin C deficiency [35,41]. Hence, the majority of studies are performed on guinea pigs that are not capable of synthesizing this vitamin [42]. The data on the protective role of vitamin C in the respiratory system may vary between species. In animal models of ozone-induced asthma, the levels of vitamin C after exposure to the stimulus may either increase or decrease, depending on whether the animal of choice is mouse or guinea pig, respectively [41].

3.4. Vitamin D

Recently, increasing attention has been paid to vitamin D, its deficiency, and its role in immunity. The latter has been widely described by Kerley et al. [43,44] and its involvement in immunity has been discussed in excellent reviews by Chirumbolo et al. [45], Mora et al. [17], Hewison [46,47], Bikle [48], and Colotta et al. [49]. Mathyssen et al. [50] summarized the findings about its metabolism. One of the most important properties of vitamin D in asthma is its ability to inhibit inflammation by regulating the proliferation, migration, and cytokine release from various immune cells including mast cells, neutrophils, and eosinophils. Vitamin D has been shown to induce a decrease in the production of pro-inflammatory cytokines including IL-1β, IL-6, and TNFα, and an increase in the secretion of the anti-inflammatory IL-10 [43,44,45,46,47,48,49,50].
There are several forms of vitamin D, with vitamin D3 (cholecalciferol) and D2 (ergocalciferol) being the most important in mammalian and human health.
Vitamin D receptors have been found throughout the respiratory system, including epithelial smooth muscle cells [51], where the vitamin is converted into its active form (1, 25-dihydroxyvitamin D) [52,53]. Vitamin D is produced by immune cells, including macrophages, T, and B cells [54,55,56]. It has been found to play a role in mast cells, as described by Liu et al. [57]. In a vitamin-D-deficient medium, murine mast cells release more markers of their activation, including TNFα and histamine, than in a vitamin-D-sufficient medium, with this process being reversed by vitamin D administration.
One of the difficulties of asthma treatment and control is poor responses to inhaled corticosteroids (ICS) [3,4]. The correct level of vitamin D is crucial, as vitamin D downregulates the genes responsible for steroid resistance and thus enhances steroid responsiveness [12], especially in severe asthma [58,59], which, in turn, enables better asthma control. Interestingly, in the case of a deficiency, the supplementation of vitamin D can restore the proper response to ICS [60,61], probably directly at the levels of lymphocytes and monocytes [60].
In addition, it is interesting that better protection by vitamin D is observed when the vitamin is administered in an oil-based formula rather than in a water-based one [25].

3.5. Vitamin E

At least eight different forms can be called ‘vitamin E’: four tocopherols (alpha, beta, gamma, and delta TPh) and four tocotrienols (alpha, beta, gamma, and delta TT), all slightly different in mode of action [62]. The most widely described and of the greatest clinical significance are alpha and gamma tocopherol (αTPh and γTPh). According to various studies, these two isoforms have opposite properties [63] and the lack of an exact notice about the isoform used in the respective study leads to inconclusive results on the influence of vitamin E on animal and human health and disease. Additionally, not only does the isoform influence the results [62], but so does the model (allergic vs. non-allergic asthma) and species (mice vs. rats) used [64]. Another problem related to inconclusive results is the solvent. Some oils contain high amounts of γTPh (such as soy bean, canola (rapeseed), peanuts, or sesame). Others, in turn, do not contain it or contain it in small amounts (e.g., sunflower, safflower, olive, or grape seed) [62]. Therefore, the results may vary because of the type of oil used in the examined population (North and South America vs. Asia vs. Europe). At the same time, a higher prevalence of asthma has been observed in regions where oils with a high γTPh content are consumed [62]. αTPh supplementation in a γTPh-rich oil can block its beneficial actions and thus has no positive effect on asthma [65]. What is important in the context of animal experimentation is that regular mouse chow does not contain γTPh [66]. Abdala-Valenzia et al. have published a detailed list of studies involving α and γTPh in lung diseases, including the isoform and species used [67]. Nevertheless, there are papers, summarized by Jiang et al. [68], that have discussed the beneficial effects of γTPh, which would be similar to those of αTPh. Since mammalians cannot convert the isoforms of vitamin E [67], there is no possibility of transforming αTPh to γTPh, even in a time of high demand.
Vitamin E deficiency occurs commonly in malnutrition or absorption diseases, as vitamin E is fat soluble [69]. Furthermore, disorders of transport proteins such as the αTPh transport protein lead to vitamin E deficiency, as shown in knock-out mice by Lim et al. [70].
Unlike other vitamins, plasma TPh levels correlate with lung levels [62]. However, a lower αTPh level is often observed in airway lining fluid but not in plasma together with vitamin C deficiency [67].
Another bioactive form of vitamin E is tocotrienols (TT), with γTT being the most bioactive form [71,72]. Its potency against asthma symptoms is comparable with that of prednisolone, a high-efficiency corticosteroid [73]. Furthermore, tocotrienols are stronger antioxidants than other isoforms of vitamin E [74].

3.6. Vitamin K

There is only a limited number of publications linking vitamin K and lung diseases. Nevertheless, vitamin K and its derivatives and analogues might be useful in asthma [75], as their administration has ameliorated the asthma outcomes in 90% of mild, 86% of moderate, and 72% of severe adult asthmatics after one year of treatment [76]. Vitamin K reduces inflammation via the inhibition of NLRP3 inflammasome [77]. Moreover, vitamin K analogues decrease the levels of pro-inflammatory cytokines released in vitro by stimulating PBMC cells in allergic and non-allergic subjects [78]. Animal studies have shown that dietary vitamin K supplementation decreased the inflammatory markers in lipopolysaccharide (LPS)-induced lung injury [79], which, together with the antioxidant properties of vitamin K [80], suggests a possible use of this class of compounds in other inflammatory states of the respiratory system.

4. Vitamins and the Risk of Asthma

A healthy lifestyle, a balanced diet with the proper consumption of vitamins, accompanied by moderate physical activity, decreases the risk of various diseases, including lung diseases such as asthma, and diminishes their risk factors such as obesity. Low vitamin levels can be related to decreased intake and absorption or increased demand. Lower levels usually lead to the impairment of homeostasis and thus to an increased risk of developing diseases, including asthma, allergy, and general inflammation [81]. Not only can a deficiency be a risk factor for diseases, but an overload or excessive intake can contribute to the development of pathologies, as antioxidant vitamins, under certain conditions, can act as antioxidants.
The most important is the question of if there is a well-defined diet that could reduce the risk of asthma, allergy, and other respiratory diseases. This diet or lifestyle should cover the entire needs of the organism towards micro- and macronutrient vitamins, proteins, fats, and carbohydrates in correct proportions. It seems that the Mediterranean diet, composed of a high intake of fruits, vegetables, cereals, and olive oil, with moderate quantities of white meat, fish, and dairy products, and a low intake of sugar and red meat, could be one of the best nutritional patterns. Some meta-analyses [82] have indicated its protective role against the development of childhood asthma, but, interestingly, not allergy. In others, however, no association between the adherence to this diet during pregnancy and childhood asthma could be found [83]. Nevertheless, as described below, the correct levels of vitamins may lower the risk of developing asthma.

4.1. Vitamin A

According to Lee et al. [84], vitamin A deficiency in children, accompanied by exposure to tobacco smoke, increases the risk of asthma. At the same time, Huang et al. [85] found a negative association between vitamin A intake and the risk of asthma in Taiwanese asthmatic adolescents, while Checkley et al. [86] observed that vitamin A supplementation in early life in regions with chronic vitamin A deficiencies was not associated with a lower asthma risk; Green and Fascetti [87] also observed vitamin A supplementation to be helpful in asthma. Articles on the relationship between asthma and vitamin A have recently been lately summarized and analyzed by Hu et al. [88], who state that, according to the existing studies, there is no relationship between the risk of asthma and serum vitamin A levels.

4.2. Vitamin B Family

There are no reports linking asthma and vitamins B1, B3, B5, and B7. Where riboflavin (vitamin B2) is concerned, its intake correlates with a lower risk of developing an allergy [89]. There have been some attempts to link vitamin B12 levels and the risk of asthma, but the papers describing this were withdrawn and no further studies have been published.
There are nearly no data on the relationship between pyridoxine (vitamin B6) intake and asthma. There has been an attempt to determine whether vitamin B6 supplementation could ameliorate steroid-dependent asthma, but it did not show any benefits of such treatment [90]. On the other hand, Collipp et al. described that B6 supplementation ameliorated asthma outcomes and decreased the use of bronchodilators, including steroids [91]. Newer reports are missing.
The relationship between folate (vitamin B9) intake and asthma is not well established. The consumption of folate-rich green vegetables is part of a healthy lifestyle and thus reduces the risk of asthma [92]. It seems that a higher folate consumption from different sources is a kind of protection in postnatal life against the disease [93].

4.3. Vitamin C

In general, the consumption of fruits, vegetables, and other foods containing high amounts of antioxidants, including antioxidant vitamins such as vitamin C, diminishes the risk of asthma, wheezing, and other respiratory disorders [94,95]. There is a strong correlation between vitamin C intake and its plasma levels [96]. Asthmatic patients generally have a lower intake of vitamin C than other subjects [97,98]. Therefore, vitamin C intake is negatively associated with the risks of asthma [85] and airway hyperresponsiveness [99], and, at the same time, positively with lung function [100,101]. However, the use of vitamin C as a therapeutic agent alone in asthma is not recommended [102], since, according to Troisi et al. [103], there is no direct protective effect of vitamin C supplementation.

4.4. Vitamin D

Vitamin D deficiency is a risk factor for developing asthma [104,105] and an increased susceptibility to allergic sensitization [106]. Simultaneously, vitamin D and its receptors are necessary for the development of an inflammatory response—vitamin-D-receptor-deficient mice do not develop experimental asthma [107,108].

4.5. Vitamin E

The isoforms of vitamin E seem to play essential roles in immunity, allergy, and asthma. An intake of αTPh-low and γTPh-high oils or supplements increases the risk of asthma and decreases lung function, whereas αTPh-high and γTPh-low oils or supplements have the opposite action. Moreover, γTPh levels, but not those of αTPh, are associated with allergic sensitization [109]. Supplementation with an αTPh-high γTPh-low composition decreased inflammatory markers and airway hyperreactivity (AHR) [110] and improved lung function parameters, such as forced expiratory volume in 1 s (FEV1), in well-controlled allergic asthmatics [111].
There are doubts about if vitamin E supplementation is beneficial towards asthma and the risk of developing the disease. On the one hand, Pearson et al. [112] could not find any advantages of this treatment, including its influence on asthma outcomes or ICS demand, and nor could Rubin et al. [113]. On the other hand, a low vitamin E intake aggravates the asthma severity in asthmatics [97,114] and further decreases their lung function [101]. A higher consumption of vitamin-E-containing supplements decreased the airway hyperresponsiveness to ozone and other irritants in asthmatic [115] and healthy [116,117] subjects and increased the lung function in patients suffering from exercise-induced asthma [118]. At the same time, according to Cook-Mills et al. [119] and Fogarty et al. [120], vitamin E supplementation seems to play a protective role in the development of asthma and allergy.

5. Maternal Intake of Vitamins and Asthma in the Offspring

In recent decades, the importance of prenatal factors in the health statuses of children has been emphasized. The period of fetal development seems to have a major impact on later life, and prenatal exposure to medications, pollutants, or oxidative stress may contribute to various metabolic, neurological, or respiratory disorders, including asthma [121]. Expecting mothers are highly encouraged to follow a healthy lifestyle, avoid medications without medical advice whenever possible, quit smoking, and take pregnancy-dedicated vitamin formulations, etc., in order to avoid the possible risks of mineral and vitamin deficiencies and ensure the correct development of their child. One of the compounds of such preventive supplementation is folic acid, which is applied to prevent neural tube malformations. However, as stated below, it is not without any further concerns regarding the development of lung diseases.

5.1. Vitamin A

It is not clear if maternal vitamin A supplementation influences the development of asthma in a child. Maslova et al. [122], Checkley et al. [86,123], and Stelmach et al. [124] could not find any relationship between maternal vitamin A supplementation and asthma in children at different age points (one to seven years old).
However, in a study by Parr et al. [125], based on questionnaires about food and supplement intake in Norwegian pregnant women, it has been found that an excess administration of vitamin A, of up to 2.5 times above the official recommendations of 10,000 IU per day [126], increased the risk of asthma in school children, probably due to the generally vitamin-rich diet in Western countries. The fact that a high vitamin A intake can increase the risk of asthma in a child was recently stated in the meta-analysis of Hu et al. [88].

5.2. Vitamin B Group

Miyake et al. [127] could not find any link between the maternal consumption of this vitamin and the risks of asthma, wheeze, or eczema in a child. As pyridoxine (vitamin B6) is supplied in nearly all formulations containing magnesium ions, in order to increase their availability, it is very difficult to establish a relationship between its maternal intake or deficiency and asthma in human studies.
The scarce data on the influence of maternal intake and prenatal exposure to folates on the risks for children remain contradictory. One of the reasons for these ambiguous results may be the source of folic acid in the diet of the mother. Folate can be delivered through a diet rich in vegetables, or through folate-fortified food (flour) and the supplements recommended for pregnant women. The other is the short duration of the studies, based on self-reported questionnaires without evaluating the real folate status of the patient. Another reason might be the time frame of the supplementation (whole pregnancy, first/second/third trimester, etc.), as well as the time of follow-up or the end-point of the study, and the age of the offspring at the time of diagnosis [128].
Some researchers have found that maternal folate intake increases the risk of developing asthma and other atopic diseases in a child [129,130,131,132,133,134]. Others, in turn, have shown that folate intake (from food and supplements) only in the late stages of pregnancy increases this risk [135], and only in atopic women [136]. In contrast, according to Veeranki et al. [137], folate supplementation from the first trimester increases this risk, while the introduction of supplementation afterward has no impact on asthma in a child. Other researchers have concluded the same, and could not find relationships between maternal vitamin B9 intake and asthma in a child around the world [138,139,140,141,142,143]. However, as summarized by Sharma and Litonjua [32] and Blatter et al. [139], methyl donors, including folate and vitamin B12, are only one of many prenatal risk factors contributing to the development of asthma or atopy in offspring.
There are no data about a link between B12 levels or the intake of a mother and asthma in a child. In human studies, only van der Valk et al. [144] has stated that there is no association between B12 cord blood levels at birth and asthma or eczema at the age of 6.

5.3. Vitamin C

In addition to the obvious relationship between the healthy lifestyle of a mother and the health of a newborn, maternal vitamin C supplementation normalizes smoking-related changes in DNA methylation and thus decreases the incidence of wheeze and asthma in children at any age, despite a smoking history of the mother [145,146], as has been shown inter alia in a long-term study for the same group of children at 3 and 12 months and 5 years [147,148,149]. Moreover, vitamin C supplementation improves the lung function of children [150]. It is not clear whether vitamin C can counteract the possible folate-related changes in DNA methylation.

5.4. Vitamin D

Similarly to other vitamins, especially anti-oxidant ones, the correct levels and appropriate intake of vitamin D promote the correct development of offspring. A low maternal intake of vitamin D increases the risk of wheeze and asthma but not of allergy (eczema or hay fever) at the various age points of a child [151,152,153,154,155,156,157], and a high vitamin D intake protects from these two diseases [125,153,155,158,159,160,161,162]. Furthermore, it strengthens the immune responses to stimuli [163]. In mice, a higher maternal vitamin D intake leads to increased IL-10 and decreased IL-3 releases from the airway epithelial cells of the offspring [164]. The protective role of vitamin D is related to its influence on early lung development, including alveolar development and surfactant production [165,166]. Therefore, vitamin D supplementation during the entire pregnancy improves a child’s lung function [167]. However, others have not found an association between maternal intake, umbilical cord blood levels, and the risk of asthma [167,168,169,170,171].

5.5. Vitamin E

Most researchers agree that vitamin E supplementation during pregnancy has a positive effect on the risks of asthma, wheeze [172], and the lung function of a child [173], whereas a vitamin E deficiency increases these risks [151,152,173,174,175,176]. However, Stelmach et al. [124], Greenough et al. [177], and Maslova et al. [122] could not find any association between cord blood levels or maternal intake and the risk of asthma in offspring. This may be related to the fact that an increased intake of γTPh-containing oils increases the risk of asthma [62], and further supplementation with αTPh or a mixture of vitamin E isoforms counteracts the negative influence of γTPh. This has been shown in mouse studies, where αTPh supplementation during gestation decreased and γTPh increased the susceptibility to asthma in the pups [178,179].

5.6. Vitamin K

Even if vitamin K is believed to play an anti-inflammatory role in asthma and other lung diseases (see above), Maslova et al. [122] found that increased maternal vitamin K intake was associated with an increased risk of asthma in a 7-year-old child. Still, this is the only paper dealing with this problem, and the subject needs further investigation.

5.7. Vitamins and the Gut Microbiota

Another important issue is the influence of the maternal intake of vitamins and other nutrients on a mother and child’s gut microbiota (described in detail by Gao et al. [180], Gray et al. [181], and Alsharairi [182]). Healthy maternal microbiota is one of the factors decreasing the risk of asthma [180,183], probably by the induction of Treg lymphocytes in the fetal lung. This, in turn, occurs through the proper production of short-chain fatty acids by bacteria [181]. Maternal nutrition and possibly bacterial supplementation seem to be crucial for the proper functioning of the gut flora. Although the role of vitamins in these processes is still under investigation, Padilha et al. [184] found positive correlations between vitamin C intake and the Staphylococcus levels in human milk. This is important, as allergic children have lower levels of these bacteria in their feces than healthy subjects [184].

6. Vitamins, Vitamin Levels and Asthma Features

6.1. Vitamin Levels in Asthma

Correct levels of vitamins are strongly related to the general well-being of patients, and chronic diseases can be both a cause and a consequence of deficiencies. Increased oxidative stress, as observed in asthma and other inflammatory diseases, leads to a drop in the concentration of antioxidant vitamins such as vitamin C or E. Lower levels of these vitamins due to insufficient supply or extensive demand may enhance oxidative stress and its consequences. Usually, asthma is accompanied by decreased levels of vitamins. However, even if links between vitamin levels and asthma and its symptoms are established, it is still doubtful which of them, asthma or the vitamin deficiencies, is the cause and which is the consequence. Another interesting but still unexplained problem is the lower intake of vitamins themselves or foods containing high quantities of vitamins by asthmatic patients, as has been observed for vitamin C (see below). The levels of vitamins in asthmatic patients, together with the relationship between maternal intake and the risk of a child developing asthma, are presented in Table 1.

6.2. Main Features of Asthma

6.2.1. Airway Hyperreactivity and Lung Function in Asthma

Airway hyperreactivity (AHR) is one of the key features of asthma. It is related to the extensive constriction of the bronchial tree in response to inhaled stimuli, leading to the narrowing of the airways, an increase in air flow resistance, and a reduced air flow, described often as decline in FEV1, thus leading to impaired lung function [185,186]. AHR is strongly related to airway inflammation, both acute and chronic character [187]. Acute airway inflammation, leading to a variable form of AHR, is usually reversed by inhaled glucocorticosteroids (ICS). Chronic airway inflammation, which results in the fixed form of AHR, is related to structural changes in the airways, the so-called airway remodeling (see below) [185,188]. The influence of vitamins on AHR is primarily related to the suppression of airway inflammation and the preclusion of early-stage structural changes in the airways (airway remodeling). Airway narrowing as a process leads to alterations in lung function, worsening over the course of asthma [186].
Decreased respiratory parameters occur in most patients with asthma [186] and are aggravated within the course of the disease [189]. However, this decline can be reduced in the course of proper asthma control with ICS and smoking cessation [190].

6.2.2. Oxidative Stress

One of the outcomes and, at the same time, causes of asthma is oxidative stress, which cannot be balanced with the natural defense mechanisms of organisms such as anti-oxidant enzymes, including superoxide dismutase (SOD) and glutathione peroxidase (GPx) [191]. Oxidative stress, especially if chronic, leads to the development of inflammation via the promotion of T cell differentiation towards Th2 phenotypes [192,193]. Therefore, the supplementation of anti-oxidant vitamins, such as vitamin C, may prevent the development of inflammation. Most vitamins share anti-oxidant and anti-inflammatory properties, and in some cases, it is difficult to distinguish them considering their overall beneficial actions against asthma. Riedl and Nel [194] have published a detailed description of the role of oxidative stress in asthma.

6.2.3. Airway Inflammation and Cellular Influx into the Airways

The key feature of asthma is chronic inflammation of the airways. Depending on the phenotype of the disease, it can be classified into allergic/nonallergic and eosinophilic/non-eosinophilic inflammation, etc. [2,195]. Not only is the abovementioned chronic oxidative stress one of the causes of airway inflammation in asthma, but so is an imbalance of the Th1/Th2 responses shifted towards the Th2 ones, leading to an increased production and release of pro-inflammatory cytokines and a reduction in anti-inflammatory cytokines by activated inflammatory cells [196]. Nevertheless, the immunological aspect of asthma is very complex and varies between the phenotypes of the disease [3].

6.2.4. Mucus Production and Structural Changes within the Airways (Airway Remodeling)

Another feature of asthma is the impairment of the bronchial epithelium, leading to mucus hyperproduction and hypersecretion and impaired mucociliary clearance [197,198], which, in turn, leads to a further decline in lung function and promotes chronic inflammation [199].
Structural changes in the bronchial tree (airway remodeling) are a complication of severe asthma. They lead to structural alterations in the airways and persistent limitations of air flow. There are at least three components leading to airway remodeling: first, disturbances at the level of the airway smooth muscles, second, disturbances of collagen deposition leading to fibrosis, and third, disturbances at the level of the airway epithelium. All these causes of remodeling have been discussed in reviews by Camoretti-Mercado and Lockey [200], Fang et al. [201], Papa et al. [202], and Boulet [203]. Disturbances in mucus production and secretion are reversible, whereas changes leading to airway remodeling seem to be permanent.

6.3. Vitamin A

6.3.1. Vitamin A Levels in Asthma

There is evidence about a link between vitamin A deficiency and asthma. According to Luo et al. [204], Al Senaidy [205], and other authors [97,114,206,207,208,209,210,211], asthmatics, independent of age, have a lower intake and levels of vitamin A and general carotenoids, even without showing any signs of deficiency. This has been confirmed in a broad meta-analysis by Hu et al. [88]. It appears that the levels and consumption of this group of substances are negatively correlated with the severity of asthma [207] and positively with lung function and quality of life [208,212,213,214,215,216,217]. As described by Gilliland et al. [101], poor lung function is associated with, among others, a low intake of antioxidant vitamins, including vitamin A. In Brazilian children, Ferreira et al. [218] showed lower retinol levels in asthmatic and asthmatic obese children, particularly with moderate and severe asthma. This is an important observation, as asthma and obesity share and are risk factors for each other [219].
In turn, Okuda et al. [132] in Japan and Schock [220] in Ireland could not find any association between asthma and serum carotenoid levels. Others have shown that an overdose of vitamin A and D due to an increased consumption of cod liver oil was associated with an increased incidence of adult-onset asthma [8]. The same has been observed by Laerum et al. [221]. On the other hand, Allen et al. [114] showed a negative association between vitamin A intake and asthma.
Interestingly, as studied by Misso et al. [98] and Rerksuppalhol [222], there was no difference in carotenoid intake nor levels between asthmatics and controls in Australia and Thailand, respectively.
Important in the context of the direct action of carotenoids in the airways is that their levels in sputum are lower than those in plasma, but the two values appear to be correlated [223].

6.3.2. Vitamin A, Lung Function, and Airway Hyperresponsiveness

As retinoic acid (RA), the active form of vitamin A, and its signaling pathways play a role in smooth muscle differentiation during airway formation, vitamin A deficiency during the prenatal period leads to pulmonary defects and structural changes in the airway smooth muscles (ASM) of mice [123,224,225,226], which can contribute to non-inflammatory airway hyperreactivity [227]. Importantly, these alterations in muscle structure can be reversed by vitamin A supplementation [123]. The prenatal lung is affected by disturbances of vitamin A levels. Retinoic acid (RA) signaling is crucial for the regulation of adult smooth muscles. RA-deficient smooth muscles are hypertrophic, hypercontractile, and pro-fibrobiotic via the increased activation of the transforming growth factor beta (TGFβ) signaling pathway. The inhibition of this signaling path prevents changes related to RA deficiency. A short pharmacological interruption of the RA signaling in adult mice leads to a decrease in airway function, an increase in airway smooth muscles (ASM) thickness, and collagen disposition, resulting in ASM hypertrophy and airway remodeling [228,229].
The role of retinoid X receptors (RXR) in asthma and immunity has been widely described by Fujii et al. [230], Denburg et al. [231], and Spiegl et al. [232]. In summary, the administration of a partial agonist of RXR during an OVA challenge in the OVA asthma model decreased nearly all the symptoms of the disease, including airway hyperreactivity, cellular influx into the airways, and the levels of pro-inflammatory cytokines in the BALF, together with goblet cell metaplasia. At the same time, the authors of these publications pointed out that the full RXR agonist may have numerous side effects. Kanagaratham et al. [233] performed similar studies, in which fenretinide, a vitamin A derivative, was administered to mice prior to an ovalbumin (OVA) sensitization and challenge. The compound abolished nearby all the features of asthma, including the AA/DHA ratio (the ratio of pro- (arachidonic) to anti-inflammatory (docosahexaenoic) fatty acids; a marker of the control of inflammation), oxidative stress (malondialdehyde (MDA) and nitrotyrosine levels), cellular influx into the airways, the levels of pro-inflammatory cytokines, and AHR, most of them to control levels (of healthy animals). This shows the potential of vitamin A and its derivatives in prevention and control. The same was observed by Sahamoto et al. [234] for an ATRA (all-trans retinoic acid) administration during OVA sensitization in mice, where a decrease in AHR, together with an alleviation of other asthma symptoms, could be observed. Dietary vitamin-A-deficient adult rats had a higher AHR [227], however, this was without a change in the airway wall thickness. The authors concluded that vitamin A may be essential in the regulation of airway hyperresponsiveness and, at the same time, in the maintenance of normal bronchial epithelium. Parallelly, Parr et al. [125] stated that an excess of vitamin A can accumulate in lungs, and, together with retinoid metabolites, cause asthma-like symptoms. This was confirmed by Schuster et al. [235], who found that extensive vitamin A intake increases the risk and severity of asthma in OVA mice, whereas a slight vitamin A deficiency decreases AHR. In terms of lung function, the serum levels of vitamin A and carotenoids are positively associated with parameters such as forced expiratory volume in 1 s (FEV1) or forced vital capacity (FVC) [236].

6.3.3. Vitamin A and Oxidative Stress

Vitamin A is accepted to be an antioxidant vitamin that reduces oxidative stress [22]. At the same time, it is still not clear whether vitamin A levels are correlated with those of oxidative stress markers in the airway. Bishopp et al. [237] could not find any relationship between vitamin A levels and exhaled nitric oxide (FeNO) and other oxidative stress markers among adults with uncontrolled asthma. At the cellular level, vitamin A seems to protect airway epithelium from oxidative stress-related injury [238,239]. In humans, a lycopene formulation in subjects with exercise-induced asthma improved lung function, probably through an antioxidant action [240]. Arora et al. [207] pointed out that decreased levels of vitamin A might be due to an increased use of this anti-oxidant during the chronic oxidative stress present in asthma. Wood and Gibson [241] found that asthmatics with airway hyperreactivity have lower beta-carotene levels and, at the same time, impaired (lower) plasma antioxidant potential.

6.3.4. Vitamin A, Inflammation and Cellular Influx into the Airways

Vitamin A modulates the immune system [17], mostly by the hampering of the allergy-related Th2 and pro-inflammatory Th17 pathways [19]. The administration of RA during OVA or a house dust mite (HDM) challenge in asthma and allergic rhinitis in mice decreased both inflammatory AHR and rhinitis symptoms by inhibiting Th2 / Th17 differentiation and Th2 responses [242,243,244]. According to Maruya [245], vitamin A deficiency lowers IgA levels. An interesting problem has been shown by Tian et al. [246]. Another inflammatory state, neonatal pneumonia, decreased vitamin A levels. Vitamin A supplementation in the post-infection period increased the levels of Th1 and decreased those of Th2 cytokines after OVA sensitization, together with reductions in cellular influx into the airways and airway hyperreactivity. This shows that a vitamin A supplementation after infection inhibits the progression of asthma. Additionally, as mentioned by Gozzi-Silva [81], the correct vitamin A levels may even protect against infections.
One of the forms of vitamin A, ATRA, also promotes anti-inflammatory responses. As stated by Wu et al. [244], it decreases Th2/Th17 differentiation and reduces the total cell, especially eosinophil, influx into the airways in pretreatment or during an OVA sensitization and challenge in mice. Similar results have been shown by Takamura et al. [247], Sakamoto et al. [234], and Fang et al. [248] in rats. In contrast, vitamin-A-deficient OVA-sensitized mice show signs of increased inflammation [229], mediated by an activation of the Th2 cytokines, and increased neutrophil and eosinophil influx into the airways [229]. This can be reversed by RA administration [249,250].
Another example can be lycopene, a carotenoid that is not transformed into vitamin A. The administration of it to mice during OVA sensitization abolishes most asthma features, including AHR, cellular influx into the airways, and levels of Th2 cytokines [251,252], which shows that lycopene supplementation can be protective against asthma.

6.3.5. Vitamin A, Mucus Production, and Airway Remodeling

It seems that vitamin A with its isoforms, as reported by Aggarwal et al. [253] for ATRA, plays an important role in the maintenance of the normal mucociliary phenotype. A supplementation with ATRA during OVA sensitization decreased goblet cell metaplasia and, as it is reversed by the administration of antagonists of retinoic acid receptors, is involved in the regulation of proper mucus production [253].
To date, there have been no reports on the influence of vitamin A on airway remodeling. Since the entire retinoic acid signaling pathway seems to be dysregulated [254] and the administration of ATRA inhibited the migration of airway smooth muscle cells in vitro [255], it is possible that vitamin A supplementation reduces the abnormal migration of airway smooth muscle cells within the bronchi of asthmatic subjects. Still, this needs to be investigated.

6.4. Vitamin B Group

6.4.1. Vitamin B Group Levels in Asthma

Both Husemoen [256] and Heinrich [257] failed to find any association between B2 intake and allergy or atopy. However, Comhair et al. [258] found higher levels of nicotinamide (vitamin B3) in the plasma of asthmatics, probably due to an increased consumption of NAD+ in the course of immunologic activation in asthma. A similar result was shown by Liu et al. [259], where asthmatics, especially those suffering from non-eosinophilic asthma, had higher levels of nicotinamide, which was positively correlated with the frequency of severe asthma exacerbation.
There are no differences between asthmatic and non-asthmatic subjects in pyridoxine (vitamin B6) levels. However, asthmatics had lower concentrations of its active, phosphorylated form, pyridoxal-5′-phosphate [260]. Furthermore, the use of theophylline, one of the drugs used in asthma treatment, decreased plasma vitamin B6 in the plasma [261].
Folate (vitamin B9) levels are lower in asthmatic children [262,263] and adults [264], regardless of diet. Lower folate levels lead to a higher prevalence of asthma and higher rate of severe exacerbations [262,265], together with a higher risk of atopy [266]. Cord blood folate levels did not have an association with asthma [144].
Until now, no correlations between B12 levels or intake and asthma outcomes have been found [36,256,265,267].

6.4.2. Vitamins of the B Group, Lung Function and Airway Hyperresponsiveness

There are no data about the vitamins of the B group and lung function or AHR in asthma. Only higher folate levels are associated with better lung function [268]. At the same time, a lower folate level has no impact on the lung function in asthmatic children [266,269].

6.4.3. Vitamins of the B Group and Oxidative Stress

There are no data on the influence of B vitamins on oxidative stress. Only Lin et al. [269] have pointed out that the beneficial effect of folate on asthma symptoms in postnatal life can be related to the antioxidant properties of the compound by reducing homocysteine levels.

6.4.4. Vitamins of the B Group, Inflammation and Cellular Influx into the Airways

There is only one report, dated fifty years ago, on the influence of nicotinamide (vitamin B3) on the features of asthma by Bekier et al. [270] in a guinea pig OVA model of asthma. Nicotinamide supplementation during sensitization decreased mast cell degranulation, the histamine release from these mast cells, and bronchial spasm.
Among the other vitamins of the B group, only folate is described in the context of asthma and the inflammation of the airways. There is no association between folate plasma levels and airway inflammation in both asthmatic and non-asthmatic children [262,265,267]. At the same time, as described in animal studies by Wu et al. [271], correct folate levels participate in maintaining Th cell balance, as folate-deficient mice showed impaired Th cell maturation. Furthermore, too high folate levels may increase the risk of sensitization, and thus airway inflammation, in postnatal life [272]. Iscan et al. [273] described in their study that prenatal folate supplementation in mice, followed by postnatal OVA sensitization, led to increased airway inflammation and higher allergic responses to OVA, an effect that was even more pronounced after a longer folate administration. Similar results have been observed by Hollingsworth et al. [274], who found that maternal supplementation with methyl donors, including folates, led to genetic changes in the offspring, resulting in increased airway inflammation and hyperreactivity, higher IgE levels, and airway remodeling. These changes were shown to be heritable, which leads to the conclusion that dietary factors can lead to a heritable risk of allergic diseases and a vulnerability to airway inflammations.

6.4.5. Vitamins of the B Group, Mucus Production, and Airway Remodeling

İscan et al. [273] described in their study that prenatal folate supplementation, followed by a postnatal OVA sensitization, led to increased airway inflammation and a higher allergic response to OVA, which may lead to structural changes in the airways. Furthermore, fibrosis and an increased proliferation of epithelial and subepithelial smooth muscles, together with fibrotic changes, have been observed. Yet, the role of any vitamin of this group or its deficiency in this asthma manifestation has to be investigated.

6.5. Vitamin C

6.5.1. Vitamin C Levels in Asthma

Not only does a low vitamin C intake occur in asthma, but first of all, a low plasma level of the vitamin is observed both in children [211,275] and adults [85,96,98], and is more pronounced in the severe form of the disease [275]. Moreover, low vitamin C levels are associated with an increased risk and prevalence of asthma [98,113,276]. At the same time, a low plasma vitamin C level is often associated with low levels of antioxidant enzymes, such as SOD and glutathione peroxidase (GPx) [211], and these levels decrease in the BALF shortly after exposure to irritants [277]. Nevertheless, in other studies [220,278,279], no relationship between vitamin C levels or intake and the incidence of asthma or lung function [97] has been found.

6.5.2. Vitamin C, Lung Function and Airway Hyperresponsiveness

As asthmatics have both lower vitamin C levels and intake, the supplementation of this vitamin may ameliorate the course of asthma by lowering the number of asthma attacks (exacerbations), the asthma symptom score, the ICS need [280], and decreasing respiratory symptoms such as sore throat or cough in exercise- and cold-induced asthma after stimulation [37,39]. Nonetheless, such supplementation has to be prolonged, since a short administration of the vitamin has no influence on the above mentioned outcomes [281].
One of the most important symptoms of asthma is airway hyperresponsiveness (AHR) to various stimuli. According to Soutar et al. [99], a deficiency in vitamin C leads to an increased AHR. Accordingly, vitamin C supplementation decreases AHR to methacholine, histamine, sulfur dioxide, or physical effort in various forms of asthma, including ozone- and exercise-related asthma [115,282]. This has also been shown for ozone-induced asthma in highly polluted big cities around the world, where vitamin C supplementation alone, or in combination with other antioxidant (pro)vitamins, such as beta-carotene and vitamin E, decreased AHR, as summarized by Fogarty [120]. These findings have also been shown in animal models, both in mice and in guinea pigs, where vitamin C supplementation, both general and during OVA sensitization, strongly reduced AHR [283].
Additionally, lung function is positively affected by vitamin C supplementation. Although Nadi et al. [284] could not find any influence of single or chronic vitamin C supplementation on the respiratory parameters in asthmatics, Ochs-Balcom et al. [214] have shown an increase in lung function in asthmatic subjects. So did acute and chronic vitamin C supplementation in exercise-induced asthma where it lowers the drop in respiratory parameters after physical effort [282,285,286].

6.5.3. Vitamin C and Oxidative Stress

The only known mechanism of the action of vitamin C in oxidative stress in asthma is the ability to scavenge the free radicals that are produced in response to oxidative stress, but also released during uncontrolled physical activity in exercise-induced asthma. Thus, this decreases the levels of oxidative stress markers [39,287].

6.5.4. Vitamin C, Inflammation, and Cellular Influx into the Airways

Like many other antioxidant substances, vitamin C also plays a role in immune defense and has anti-inflammatory properties. Vitamin C deficiency down-regulates the proper immune response to inflammatory stimuli and its supplementation up-regulates it, as mentioned above for common airway inflammation and infections.
Supplementation with vitamin C reduces inflammatory markers in the general population. It lowers CRP levels [288] and thereby reduces the severity of pneumonia [289]. It also increases white blood cell counts in adult asthmatics [284]. Simultaneously, vitamin C deficiency increases necrotic lung cell damage and prostaglandin levels after an in vitro H2O2 treatment and therefore inflammation in guinea pigs. Animal studies have shown that vitamin C supplementation reduces anti-OVA antibodies and IL-4 levels in an OVA rat model of asthma, along with a decrease in the markers of oxidative stress, such as MDA [39].
In OVA mice, i.p., the administration of vitamin C decreased airway cell influx during a sensitization and challenge [283]. Megadoses of vitamin C strongly inhibited the Th2 responses [290], eosinophilia, and neutrophilia in OVA mice and guinea pigs, respectively [35]. As a result, vitamin C was shown to modulate the Th1/Th2 responses towards Th1 [35] and thus act as an anti-inflammatory agent.

6.5.5. Vitamin C, Mucus Production, and Airway Remodeling

It is not known whether vitamin C directly influences mucus production. Only one study has described the influence of vitamin C on airway remodeling. As reported by Kianian et al. [291], both administrations of vitamin C alone and in co-administration with vitamin D during an allergen sensitization and challenge decreases goblet cell hyperplasia and subepithelial fibrosis. However, vitamin C may play a role in the collagen deposition, as vitamin C is a cofactor of collagen production. Therefore, low vitamin C levels could lead to impairments in collagen formation and structure.

6.6. Vitamin D

6.6.1. Vitamin D Levels in Asthma

Vitamin D levels correlate with the lung function in asthmatic [292,293,294] and healthy subjects [13,295]. Lower vitamin D levels are associated with chronic lung diseases [10] and an increased susceptibility to infections [208]. In this context, asthmatic patients show lower levels of vitamin D than healthy subjects, independent of age [12,208,292,293,296,297,298,299,299,300,301,302,303], and a more serious vitamin D deficiency correlates with asthma severity [208,302,304,305], lower asthma control, and ICS responsiveness [14,61,302,304,306,307,308,309,310]. Lower vitamin D levels increase the number of exacerbations of the disease [14,306,311,312], the risk of developing asthma and atopy [104,105], and the progression of the disease [313]. At the same time, asthmatic vitamin-D-deficient patients have higher ICS needs [58,308,310,314]. Vitamin D supplementation in subjects deficient in vitamin D decreases the numbers of asthma exacerbations and general asthma symptoms [315,316]. Moreover, it reduces the risk of developing wheeze in preterm children [317]. At the cellular level, a low vitamin D level aggravates inflammation via the promotion of M1 macrophage polarization. A supplementation of vitamin D restores the correct balance by promoting M2 macrophage polarization, leading to a kind of prevention of inflammation-related damage [318].
Contrary to the above mentioned papers, some researchers could not find any differences in the vitamin D levels between asthmatics and healthy controls [319,320] or associations between the levels of this vitamin and asthma [320,321,322,323]. Once again, this might be due to differences in the dietary habits, place of residence, age, and sun exposure of the analyzed populations.

6.6.2. Vitamin D, Lung Function and Airway Hyperresponsiveness

Vitamin D administration has a positive effect on lung function and lung mechanics [13,15,295,324]. This vitamin is essential for the correct lung development and surfactant production in rats [160], but also in humans [325]. Vitamin D deficiency is associated with worse lung function [13,14,15], a higher risk of developing lung diseases, and a faster progression of these diseases [326,327]. Vitamin D supplementation improves lung function [310,328,329] and reduces the number of exacerbations [50,60,328,330,331], leading to better asthma control [50,332,333], a lower ICS need [331,333,334], and a higher quality of life, pronounced by decreased absences from school and work and increased activities of daily life [208,335]. Better outcomes of this vitamin D supplementation are observed in the pediatric population [60]. What highlights the importance of vitamin D in respiratory diseases is the observation that its level falls strongly during an asthma exacerbation [336]; thus, a vitamin D deficiency leads to an increase in AHR [309].
All these findings have been confirmed in animal studies. In vitamin-D-deficient OVA mice, vitamin D supplementation decreased AHR and IgE levels [337,338,339]. Furthermore, the transfer of vitamin-D-treated T cells to OVA mice prevented AHR and airway inflammation [340].

6.6.3. Vitamin D and Oxidative Stress

Vitamin D is an anti-oxidant and promotes the antioxidant activity of other substances [341]. In the case of vitamin D deficiency, increases in oxidative stress and inflammation are observed [342]. Additionally, vitamin D protects mice from oxidative stress-related injury [343]. Adam-Bonci et al. [344] recently presented a very interesting study that not only summarized the latest findings on vitamin D in oxidative stress, but also showed the influence of short- and long-term vitamin D supplementations on the asthma symptoms in the serum, BALF, and lungs of OVA mice. Both treatments decreased the markers of oxidative stress, such as the oxidative stress index, total oxidative status, and lipid peroxidation, and increased the total antioxidant response. Additionally, vitamin D enhanced the activity of the enzymes involved in glutathione (GSH) production. Another observation was made by Lan et al. [341], where a vitamin D deficiency in human asthmatics increased ROS release and DNA damage, which, in turn, was reversed by vitamin supplementation.

6.6.4. Vitamin D, Inflammation, and Cellular Influx into the Airways

Vitamin D has anti-inflammatory properties. It enhances Treg activity [60,345,346], downregulates pro-inflammatory cytokines [154,347,348,349,350,351], and up-regulates anti-inflammatory cytokines [61,347,350,351,352], both in vitro and in vivo. Furthermore, it decreases mast cell activation and histamine release [57,353]. Vitamin D is an immunomodulator [328] and its administration improves allergen immunotherapy [81,354]. As it has been observed, vitamin D shows antiviral actions in children [355,356,357,358,359] and its proper levels may protect against infections, one of the risk factors for asthma exacerbations [159,356,359,360] (see below).
In animal studies, vitamin-D-deficient asthmatic mice had increased eosinophilia, which was reversed by vitamin D [361]. OVA mice supplemented with vitamin D during sensitization and an allergen challenge had fewer symptoms of airway inflammation [343,362]. It seems that vitamin D stabilizes the balance between the Th1 and Th2 responses [363]. As was shown by Liu et al. [57], both healthy and OVA-sensitized mice on a vitamin-D-deficient diet had higher histamine and TNFα levels in their serum compared to animals receiving vitamin-D-sufficient or supplemented chow. This points out that vitamin D downregulates the mast cell activation increased in allergic sensitization.
The anti-inflammatory effects of vitamin D are based on three main inhibitory mechanisms: first, NFKB signaling; second, p38 MARK phosphorylation; and third, the activity of immune cells [364,365,366].

6.6.5. Vitamin D, Mucus Production, and Airway Remodeling

There are only a few papers dealing with the problem of vitamin D and mucus. Lai et al. [362], Wang et al. [343], and Feng et al. [367] showed the relief of mucus disturbances in OVA mice with decreased goblet cell hyperplasia and mucus hypersecretion after vitamin D supplementation, suggesting that vitamin D may be a promising add-on therapy in asthma.
Vitamin D affects airway remodeling by decreasing smooth muscle proliferation [368,369]. Furthermore, it reduces the mass of ASM, epithelial collagen deposition, and goblet cell hyperplasia [362,368], all of which are increased in vitamin D deficiency [304]. It also downregulates the expression of the enzymes involved in airway remodeling [370,371,372,373]. In animal models, vitamin-D-deficient mice showed more pronounced airway remodeling, which was partially reversed by vitamin D supplementation [361]. At the same time, vitamin-D-supplemented OVA mice presented a reduced subepithelial collagen deposition [343,362]. Vitamin D receptors seem to be necessary for the maintenance of proper collagen synthesis, as vitamin D receptor knock-out animals had a higher collagen disposition than control subjects [374].

6.7. Vitamin E

6.7.1. Vitamin E Levels in Asthma

Inconsistent observations about the levels of vitamin E and its isoforms and asthma are most likely due to the study region, the dietary and culinary habits of the population, and the form of supplementation, as described above. Most researchers state that lower levels or intake of αTPh are observed in asthmatics, independent of age and the severity of the disease [62,98,114,120,209,209,237,375,376,377], and can be corrected by supplementation [209]. At the same time, no differences in the levels of vitamin E among minor and adult populations [378], nor an association between vitamin E level and asthma risk [113,132,220,379] have been found. However, vitamin E levels and intake correlate with the lung function in stable [101,236,380,381] but not uncontrolled asthmatics [237]. On the contrary, de Luis et al. [97] could not find any relationship between vitamin E levels and lung function (measured as FEV1) in asthmatic and healthy subjects. At the same time, low vitamin E levels were correlated with markers of oxidative stress and inflammation, such as MDA or FeNO [209]. Once again, most studies miss the information about the composition of vitamin E.

6.7.2. Vitamin E, Lung Function and Airway Hyperresponsiveness

In accordance with the theory of a beneficial action of αTPh and a detrimental one of γTPh, αTPh shows a positive correlation with lung function, whereas γTPh shows a negative one, both in asthmatic and non-asthmatic patients [62]. An αTPh administration decreased the AHR of atopic asthmatics and improved lung function in exercise-induced asthma [110,118]. In animal studies, both in OVA mice and rats, an αTPh and general vitamin E administration prior to various allergen challenges, including carbon and aluminum oxide nanotubes, decreased AHR [382,383,384]. Interestingly, this was observed also for γTPh during ozone exposure in OVA allergic animals [385]. At the same time, OVA mice on a vitamin-E-deficient diet showed more pronounced AHR [386].

6.7.3. Vitamin E and Oxidative Stress

Both αTPh and γTPh have antioxidant properties [387,388]. As described by Patel et al. [389], αTPh acts only on ROS, whereas γTPh is active against both reactive oxygen and nitrogen species (ROS and RNS). Additionally, γTT decreases in an HDM mouse model of asthma ROS levels [73], but also, similarly to αTPh, induces the expression of the antioxidant enzymes SOD and GPx [73,390].
Vitamin E, independently of the isoform, decreases oxidative stress via at least two independent pathways. First, it directly scavenges free radicals and second, it increases the expression of NRF2 (Nuclear factor erythroid 2-related factor 2), a transcription factor regulating anti-oxidant and detoxifying enzymes [73]. A higher expression of NRF2 decreases oxidative-stress-induced lung injury [391], whereas a lower one leads to increased oxidative stress and inflammation and has been found in macrophages from asthmatic patients [392]. Similar results have been obtained in animal experiments [393] on OVA mice, where vitamin E supplementation restored the otherwise decreased NRF2 levels and thus partially reversed the symptoms of asthma.
In another asthma model related to oxidative stress, namely toluene-diisocyanate-induced (TDI), mice and rats exposed to oxidized graphene, single-walled carbon nanotubes, nano aluminum oxide, or other highly pro-oxidative substances, vitamin E administration decreased ROS [382,383,394,395].
Some researchers have pointed out that an antioxidant action of αTPh is not always observed. Okamoto et al. [384] found that αTPh administered prior to and during OVA sensitization had no influence on oxidative stress, even if it decreased other asthma symptoms.
Nevertheless, tocopherols can be ROS donors when they cannot be reduced by vitamin C during increased peroxidation processes [67]. This has been observed in patients exposed to high doses of vitamin E, when increased pro-oxidant activity was measured [396].
Vitamin E, together with vitamin A, C, and D, directly influences not only the oxidant–antioxidant balance and oxidative stress, but also the inflammation induced by oxidative stress, as described below.

6.7.4. Vitamin E, Inflammation, and Cellular Influx into the Airways

The antagonistic effects of αTPh and γTPh on allergies and allergic inflammation have been described in detail [62,63,67,71,397,398]. γTPh seems to be a strong pro-inflammatory agent, about five–ten times stronger than the anti-inflammatory αTPh [62,71]. However, at physiological concentrations, γTPh does not directly modulate the expression of pro-inflammatory cytokines, but rather influences the regulation of endothelial cell signaling in leukocyte recruitment [66].
All the isoforms of vitamin E have immunomodulatory and anti-inflammatory properties [399,400] by inhibiting the release of pro-inflammatory cytokines, such as interleukin (IL)-1, IL-6, or tumor necrosis factor α (TNFα) [399,400]. A deficiency in vitamin E increases the levels of inflammatory markers, as reported by Talani et al. [386], where OVA mice on a diet deficient in vitamin E had elevated levels of F2-isoprostanes.
The anti-inflammatory action of αTPh has been proven in various studies, mainly in OVA mice and rats prior to and/or during an OVA sensitization and challenge. In all of these studies, αTPh reduced cellular influx into the airways, eosinophilia, and decreased the levels of pro-inflammatory cytokines such as IL-1, 4, 5, and 13, along with decreasing the levels of the IgE and NO metabolites in the lungs [383,384,401,402,403,404]. In healthy (non-asthmatic) mice, vitamin E supplementation decreased pro-inflammatory TNFα and increased the levels of the anti-inflammatory interferon γ (INFγ). These observations have been confirmed for the stimulated peripheral blood mononuclear cells (PBMC) from healthy humans [405]. Parallelly, αTPh and its metabolites decreased the activity of arachidonate 5-lipoxygenase (5-LOX) [406], leading to lower levels of pro-inflammatory leukotrienes. This is even more interesting, as vitamin E deficiency increases the expression and activity of 5-LOX [407].
The opposite effect of αTPh and γTPh has been described by Berdnikovs et al. [66] in an OVA mice model of asthma. αTPh decreased both cellular influx into the airways, airway inflammation, and AHR, whereas γTPh increased these parameters. The action of αTPh was antagonized by γTPh. Even if the two isoforms act contradictorily, the supplementation of a mixture of αTPh and γTPh, or even γTPh alone, can be useful in neutrophilic lung inflammation, including asthma, as according to several authors [385,401,408,409,410], as this type of inflammation is blocked by both tocopherols.
However, there are reports on a beneficial effect of γTPh. According to Suchankova et al. [411], αTPh supplementation in OVA rats had no major effect on asthma outcomes, whereas γTPh administration alleviated the majority of the symptoms of asthma, such as airway inflammation and mucus overproduction. This could be due to the solvent (soy oil), which contains large amounts of γTPh [62]. The same has been described by Wagner et al. [385], where oral γTPh supplementation decreased the inflammatory cell influx in OVA rats.
Another form of vitamin E, γTT, also shows anti-inflammatory properties. It decreased the inflammation regarded as increased AHR and pro-inflammatory cytokine levels in an HDM mouse model of asthma [73]. In vitro, it significantly decreased the levels of IL-1β, TNFα, IL-8, and NFκB [412,413]. It appears to be one of the most important pathways for the anti-inflammatory action of vitamin E in all its isoforms, occurring mainly via the inhibition of the NFκB pathway [414].
The administration of vitamin E before and after an OVA sensitization and challenge decreases not only oxidative stress and its consequences, including the development of airway inflammation (eosinophilia and the levels of pro-inflammatory cytokine levels such as IL-4, 5, and 13), but also AHR in OVA mice [384,403,415], especially in the presence of oxidative stress enhancers such as oxidized graphene, where vitamin E administration decreases Th2 responses [395].
Not only are the levels of the vitamin or a supplementation with one of its forms important, but so are the transport mechanisms within the body. Tocopherol transport proteins seem to be essential for the correct development of immune response to allergens. As presented by Lim et al. [70], tocopherol transport proteins in knock-out mice, when sensitized with OVA, had lower IgE levels and lower IL-5 and TNFα expression than sensitized wild mates. Consequently, vitamin E deficiency impairs immunity.

6.7.5. Vitamin E, Mucus Production, and Airway Remodeling

Both α and γTPh supplementation, before and during a sensitization and allergen challenge in OVA mice and rats, decreased mucus production and goblet cell hyperplasia [383,384,385,395,402,403]. Furthermore, they restored the mitochondrial ultrastructure at the level of the bronchial epithelium [403]. At the same time, γTT, in an HDM mouse model of asthma, decreased epithelial cell hypertrophy and mucus production [73]. Hence, vitamin E seems to prevent or slow down the development of airway remodeling and altered mucus production.
A short summary of the influence of these vitamins on the main manifestations of asthma is presented in Table 2.

7. Vitamins and Asthma Exacerbations

The management of asthma control and prevention of its potentially dangerous exacerbations relies mostly on proper medication measurements and an avoidance of its triggers. The latter include, but are not limited to, viral and bacterial infections, allergens, drugs, or pollutants [4,416]. Decreased responses to allergens can result from immunotherapy and antiallergic treatments. Exposure to pollutants can rarely be totally avoided and, as most of them (ozone, particulate matters, and nitrogen and sulfur oxides, etc.) are pro-oxidants and thus pro-inflammatory, their influence on asthma exacerbations can be partially limited by an administration of anti-oxidant vitamins, which has been described above. In the case of drug-induced asthma, especially aspirin-induced asthma, therapeutics from other groups have to be used. Probably the most important cause of asthma exacerbations are viral infections [417], which can be partially avoided by vaccinations, if available. Most virus-induced asthma attacks are related to respiratory syncytial virus (RSV) and rhinovirus (RV) infections [418], and the exact mechanisms involved in the pathogenesis of this type of asthma are described in detail by Hansbro et al. [419] and Hershenson [420]. Other viral pathogens that promote asthma exacerbations are influenza viruses [421], but, surprisingly, not COVID-19, as ICS administered in regular asthma treatment seem to protect against the disease and asthmatic patients are less prone to COVID-19 [422,423,424,425].
A healthy lifestyle, including the appropriate consumption of fruits and vegetables, promotes the proper immune responses to pathogens and reduces the risk of asthma exacerbations [426]. The exact role of vitamins in immunity has been widely described in previous parts of the paper and a detailed description of their role in the protection against viral infections exceeds the scope of the present review. Nevertheless, vitamin deficiencies lead to an increased sensitivity to pollutants and allergens and a higher susceptibility to respiratory infections, while proper vitamin levels contribute to resistance to them. There are only a few reports directly linking vitamin deficiencies and virus-induced asthma exacerbations; thus, only findings on the role of vitamins in respiratory infections are herein presented in summary.
It is doubtful if vitamin A supplementation has any influence on respiratory tract infections (RTI). In meta-analyses, no [427] or only slight [428] effects on outcomes and the incidence of RTIs, including RSV, could be shown. For the B group, Vlieg-Boerstra [428] did not find any influence of folate or vitamin B12 supplementation on the incidence of RTIs; studies on other B vitamins are lacking. Despite the common beliefs about the beneficial action of vitamin C towards viral infections, there is little evidence that its administration would prevent an RTI [429]. According to Hemilä et al. [430] and Keya et al. [431], vitamin C administration does not prevent or reduce the number of RTIs, however, it may reduce the duration of the disease, especially in prone subjects. In contrast, a vitamin D supplementation, especially a regular one, reduces the incidence of acute RTIs [417,432,433,434,435,436,437]. Vitamin D deficiency at birth increases the risk of severe RTIs, including RSV, in infants [438,439]. Low levels of this vitamin throughout life are generally associated with a higher incidence of infections [440], which can be corrected by its supplementation [441]. Interestingly, only for vitamin D have studies been performed directly on asthmatic subjects. They have shown that, in this group of patients, vitamin D supplementation decreases the number of RTIs [442] and asthma exacerbations [315]. Where vitamin E is concerned, data are scare and contradictory. Some researchers have described that vitamin E supplementation decreases the incidence of common cold [433] or some RTIs [434]; others do not support these findings [428].
In short, it seems that only vitamin D supplementation decreases the risk of developing respiratory tract infections, which are a major trigger of asthma exacerbations. In fact, only single studies linking vitamin deficiencies or intake with the frequency of viral infections have involved asthmatic patients.

8. Summary

A healthy lifestyle and balanced diet with an appropriate amount of vegetables and fruits, which provide adequate levels of vitamins, can reduce the risk or severity of asthma. Asthmatic patients are deficient in almost all vitamins and a supplementation of any kind may ameliorate their state, primarily by reducing oxidative stress and inflammation, thus improving the symptoms of asthma and overall health. Thus it might be a good add-on therapy to the respective medications. This seems to be more important, as asthmatic patients tend to already have a lower intake of vitamins and vitamin-rich food than healthy subjects. Only in the case of vitamin E should attention be paid to a supplementation of the anti-inflammatory isoform (αTocopherol). Furthermore, the correct intake of vitamins from natural or pharmacological sources during pregnancy decreases the risk of developing asthma and wheeze in a child. Nevertheless, attention has to be paid to the correct doses of the respective vitamins. According to the latest recommendations from health authorities, too high a supplementation may even increase the risk of allergy or asthma in a child, as is seen in the cases of vitamin B9 (folate) and vitamin K. Moreover, a dietary background including every-day cooking habits may influence the outcomes of vitamin supplementation via food fortification (vitamins of the B group), the natural content of the isoforms of a vitamin in oils (vitamin E), or a high consumption of vitamin-rich food (vitamin A and D in cold-water fish).
There are many factors that lead to asthma induction. Although the general risk factors for asthma are known, their detailed mechanisms and, in the context of this paper, the role of vitamins, are still under investigation. Prolonged exposure to pollutants (irritants, environmental, or air pollution) may lead to chronic inflammation, either by a direct irritation of the airways or by exposure to chronic oxidative stress. Moreover, mucus overproduction and consequent goblet cell hyperplasia and airway remodeling may occur. At this stage, epigenetic changes may come to light. Another risk factor are metabolic diseases including obesity and immunological disorders such as allergies of different origins. Additionally, prenatal exposure to certain medications and frequent respiratory infections can contribute to the development of asthma. It is quite impossible to avoid all these risk factors, however, as described above, the correct levels of vitamins may delay the onset of the disease or at least diminish its risk. In this context, low levels of the antioxidant vitamins C and A increase oxidative stress by lowering the antioxidant potential of the cells. Too high folate or cobalamin levels in prenatal life can lead to changes in DNA methylation, which, when natural repair mechanisms are impaired, can be chronic and irreversible, especially under vitamin C and D deficiencies. Too low vitamin D levels, but at the same time, chronic overdoses of vitamin A, may lead to an increased susceptibility to allergic sensitization and thus to higher responses to allergens. Additionally, vitamin D deficiency is predisposed not only to metabolic disorders, another risk factor for the development and progression of asthma, but also to respiratory tract infections, one of the triggers of asthma exacerbations. They are presented in Figure 1.
Another important problem of asthma is its control (presented in Figure 2). Well-controlled asthma leads to a reduction in or suppression of its exacerbations, a lower need for inhaled glucocorticosteroids (ICS), a better quality of life, and better all-day activity. Low levels of vitamin D and folate increase the numbers of respiratory tract infections, asthma exacerbations, and allergy symptoms. Vitamin D deficiency lowers the ICS responsiveness and thus increases their need. In contrast, correct vitamin D levels lower these factors and reduce allergy symptoms and oxidative stress, and thus inflammation. Similarly, vitamin C, in adequate quantities, prevents ROS production and oxidative stress. Together, the correct levels of vitamins facilitate asthma control and reduce the risk of its induction.
The beneficial action of vitamin supplementation in asthma is mainly based on the influences of these vitamins on oxidative stress and inflammation. All the vitamins, other than the vitamins of the B group and vitamin K, decrease oxidative stress, either directly by free radical scavenging or indirectly by the promotion of antioxidant enzymes. Vitamins of the B group, others than vitamin B9 which at too high or too low levels may act pro-inflammatory, have no influence on inflammation. Vitamins A, C, D, and K suppress inflammation just as vitamin E does, as long as the beneficial anti-inflammatory effect of α-tocopherol predominates the pro-inflammatory activity of the γ isoform. The same applies to airway hyperreactivity as a consequence of inflammation. Interestingly, only vitamin D and E hamper airway remodeling and only the latter has some impact on mucus overproduction. Regular vitamin D supplementation reduces the number of respiratory infections, one of the most common causes of asthma exacerbation. Taken together, although vitamin A, C, D, and E have been well described in respiratory diseases, including asthma, the role of the vitamins of the B group still needs to be investigated, together with the mysterious vitamin K, which can be a new player in the field of respiratory disorders. A short summary of the findings is presented in Figure 3.
This is a narrative review, summarizing the most important research articles and pointing out the excellent reviews of other authors, without any detailed analyses of the findings or meta-analyses for each vitamin or all the vitamins together. These would be far beyond the scope of a single article. Therefore, the aim of the present paper was to mark the influence of vitamins on asthma features, together with the impact of their deficiencies on pathophysiology of the disease. More details on this broad subject can be found in the cited papers. Nevertheless, as underlined above, the final conclusions should be drawn with caution, as the intake and levels of vitamins or micronutrients strongly depend on the patient’s lifestyle, place of residence, or dietary and cultural habits. The estimations of vitamin intake may also differ depending on the type of study (diary-based, direct supplementation, and animal vs human studies, etc.). Thus, the obtained results may vary between the studied groups or populations. Other limitations of the presented papers include, in some cases, a lack of information about other data such as age, definition of asthma (including or excluding wheeze), smoking habits, the general health of the patients (comorbidities, obesity, or allergies), or level of indoor/outdoor activity. Animal studies may have less limitations, apart from a small number of subjects.
Another problem that is beyond the scope of this review is the genetic background of asthma. Epigenetic marks may influence gene expression and can be further modified by environmental factors. This opens up a new research field in the pathophysiology of various diseases, including asthma. Some aspects, including DNA methylation and histone modification, have been recently described by Sharma et al. [443].
Nevertheless, asthma is a very complex disease and many factors may lead to its induction, development, and progression. One of these factors is nutrients, including vitamins, whose role in the pathogenesis of asthma has been described in the present paper.

Author Contributions

Conceptualization, D.Z. and P.W.; methodology, D.Z. and P.W.; formal analysis, D.Z. and P.W.; investigation, D.Z. and P.W.; resources, D.Z. and P.W.; data curation, D.Z. and P.W.; writing—original draft preparation, D.Z. and P.W.; writing—review and editing, D.Z. and P.W.; supervision, D.Z.; project administration, D.Z. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Data Availability Statement

Not applicable.

Acknowledgments

The authors would like to thank Katarzyna Kaczynska for the critical reading and remarks on the manuscript.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. 2022. Available online: www.ginasthma.org (accessed on 10 January 2023).
  2. Gans, M.D.; Gavrilova, T. Understanding the Immunology of Asthma: Pathophysiology, Biomarkers, and Treatments for Asthma Endotypes. Paediatr. Respir. Rev. 2020, 36, 118–127. [Google Scholar] [CrossRef] [PubMed]
  3. Papi, A.; Brightling, C.; Pedersen, S.E.; Reddel, H.K. Asthma. Lancet 2018, 391, 783–800. [Google Scholar] [CrossRef] [PubMed]
  4. Castillo, J.R.; Peters, S.P.; Busse, W.W. Asthma Exacerbations: Pathogenesis, Prevention, and Treatment. J. Allergy Clin. Immunol. Pract. 2017, 5, 918–927. [Google Scholar] [CrossRef] [PubMed]
  5. Zajac, D. Mineral Micronutrients in Asthma. Nutrients 2021, 13, 4001. [Google Scholar] [CrossRef] [PubMed]
  6. Gao, J.; Gao, X.; Li, W.; Zhu, Y.; Thompson, P.J. Observational Studies on the Effect of Dietary Antioxidants on Asthma: A Meta-Analysis. Respirology 2008, 13, 528–536. [Google Scholar] [CrossRef]
  7. Lee, S.-Y.; Kim, B.-S.; Kwon, S.-O.; Oh, S.-Y.; Shin, H.L.; Jung, Y.-H.; Lee, E.; Yang, S.-I.; Kim, H.Y.; Seo, J.-H.; et al. Modification of Additive Effect between Vitamins and ETS on Childhood Asthma Risk According to GSTP1 Polymorphism: A Cross -Sectional Study. BMC Pulm. Med. 2015, 15, 125. [Google Scholar] [CrossRef]
  8. Mai, X.-M.; Langhammer, A.; Chen, Y.; Camargo, C.A. Cod Liver Oil Intake and Incidence of Asthma in Norwegian Adults—The HUNT Study. Thorax 2013, 68, 25–30. [Google Scholar] [CrossRef]
  9. Palacios, C.; Gonzalez, L. Is Vitamin D Deficiency a Major Global Public Health Problem? J. Steroid Biochem. Mol. Biol. 2014, 144, 138–145. [Google Scholar] [CrossRef]
  10. Hejazi, M.; Modarresi-Ghazani, F.; Entezari-Maleki, T. A Review of Vitamin D Effects on Common Respiratory Diseases: Asthma, Chronic Obstructive Pulmonary Disease, and Tuberculosis. J. Res. Pharm. Pract. 2016, 5, 7. [Google Scholar] [CrossRef]
  11. Holick, M.F. The Vitamin D Deficiency Pandemic: Approaches for Diagnosis, Treatment and Prevention. Rev. Endocr. Metab. Disord. 2017, 18, 153–165. [Google Scholar] [CrossRef]
  12. Paul, G.; Brehm, J.M.; Alcorn, J.F.; Holguín, F.; Aujla, S.J.; Celedón, J.C. Vitamin D and Asthma. Am. J. Respir. Crit. Care Med. 2012, 185, 124–132. [Google Scholar] [CrossRef] [PubMed]
  13. Black, P.N.; Scragg, R. Relationship between Serum 25-Hydroxyvitamin d and Pulmonary Function in the Third National Health and Nutrition Examination Survey. Chest 2005, 128, 3792–3798. [Google Scholar] [CrossRef] [PubMed]
  14. Brehm, J.M.; Celedón, J.C.; Soto-Quiros, M.E.; Avila, L.; Hunninghake, G.M.; Forno, E.; Laskey, D.; Sylvia, J.S.; Hollis, B.W.; Weiss, S.T.; et al. Serum Vitamin D Levels and Markers of Severity of Childhood Asthma in Costa Rica. Am. J. Respir. Crit. Care Med. 2009, 179, 765–771. [Google Scholar] [CrossRef] [PubMed]
  15. Zosky, G.R.; Berry, L.J.; Elliot, J.G.; James, A.L.; Gorman, S.; Hart, P.H. Vitamin D Deficiency Causes Deficits in Lung Function and Alters Lung Structure. Am. J. Respir. Crit. Care Med. 2011, 183, 1336–1343. [Google Scholar] [CrossRef] [PubMed]
  16. Larange, A.; Cheroutre, H. Retinoic Acid and Retinoic Acid Receptors as Pleiotropic Modulators of the Immune System. Annu. Rev. Immunol. 2016, 34, 369–394. [Google Scholar] [CrossRef]
  17. Mora, J.R.; Iwata, M.; von Andrian, U.H. Vitamin Effects on the Immune System: Vitamins A and D Take Centre Stage. Nat. Rev. Immunol. 2008, 8, 685–698. [Google Scholar] [CrossRef] [PubMed]
  18. Shoseyov, D.; Bibi, H.; Biesalski, H.; Reifen, R. Repeated Allergen Challenge in Rats Increases Vitamin A Consumption. Chest 2002, 122, 1407–1411. [Google Scholar] [CrossRef]
  19. Benson, M.J.; Pino-Lagos, K.; Rosemblatt, M.; Noelle, R.J. All-Trans Retinoic Acid Mediates Enhanced T Reg Cell Growth, Differentiation, and Gut Homing in the Face of High Levels of Co-Stimulation. J. Exp. Med. 2007, 204, 1765–1774. [Google Scholar] [CrossRef]
  20. Engedal, N. Survival of Activated Human T Lymphocytes Is Promoted by Retinoic Acid via Induction of IL-2. Int. Immunol. 2004, 16, 443–453. [Google Scholar] [CrossRef]
  21. Sun, C.-M.; Hall, J.A.; Blank, R.B.; Bouladoux, N.; Oukka, M.; Mora, J.R.; Belkaid, Y. Small Intestine Lamina Propria Dendritic Cells Promote de Novo Generation of Foxp3 T Reg Cells via Retinoic Acid. J. Exp. Med. 2007, 204, 1775–1785. [Google Scholar] [CrossRef]
  22. Milani, A.; Basirnejad, M.; Shahbazi, S.; Bolhassani, A. Carotenoids: Biochemistry, Pharmacology and Treatment: Carotenoids: Pharmacology and Treatment. Br. J. Pharmacol. 2017, 174, 1290–1324. [Google Scholar] [CrossRef] [PubMed]
  23. Maret, M.; Ruffie, C.; Periquet, B.; Campo, A.-M.; Menevret, M.; Phelep, A.; Dziewiszek, K.; Druilhe, A.; Pretolani, M. Liposomal Retinoic Acids Modulate Asthma Manifestations in Mice. J. Nutr. 2007, 137, 2730–2736. [Google Scholar] [CrossRef] [PubMed]
  24. Reifen, R.; Berkovich, Z.; Mandelberg, A. Vitamin A Supplementation via Aerosol Spray in Asthmatic Children. Pediatr. Allergy Immunol. 2015, 26, 578–579. [Google Scholar] [CrossRef] [PubMed]
  25. Kull, I.; Bergstrom, A.; Melen, E.; Lilja, G.; Vanhage, M.; Pershagen, G.; Wickman, M. Early-Life Supplementation of Vitamins A and D, in Water-Soluble Form or in Peanut Oil, and Allergic Diseases during Childhood. J. Allergy Clin. Immunol. 2006, 118, 1299–1304. [Google Scholar] [CrossRef]
  26. Romieu, I.; Varraso, R.; Avenel, V.; Leynaert, B.; Kauffmann, F.; Clavel-Chapelon, F. Fruit and Vegetable Intakes and Asthma in the E3N Study. Thorax 2006, 61, 209–215. [Google Scholar] [CrossRef]
  27. Wood, L.G.; Garg, M.L.; Smart, J.M.; Scott, H.A.; Barker, D.; Gibson, P.G. Manipulating Antioxidant Intake in Asthma: A Randomized Controlled Trial. Am. J. Clin. Nutr. 2012, 96, 534–543. [Google Scholar] [CrossRef]
  28. Wood, L.G.; Garg, M.L.; Powell, H.; Gibson, P.G. Lycopene-Rich Treatments Modify Noneosinophilic Airway Inflammation in Asthma: Proof of Concept. Free Radic. Res. 2008, 42, 94–102. [Google Scholar] [CrossRef]
  29. Harijith, A.; Natarajan, V.; Fu, P. The Role of Nicotinamide Adenine Dinucleotide Phosphate Oxidases in Lung Architecture Remodeling. Antioxidants 2017, 6, 104. [Google Scholar] [CrossRef]
  30. Chang, S.; Linderholm, A.; Franzi, L.; Kenyon, N.; Grasberger, H.; Harper, R. Dual Oxidase Regulates Neutrophil Recruitment in Allergic Airways. Free Radic. Biol. Med. 2013, 65, 38–46. [Google Scholar] [CrossRef]
  31. Ueland, P.M.; McCann, A.; Midttun, Ø.; Ulvik, A. Inflammation, Vitamin B6 and Related Pathways. Mol. Asp. Med. 2017, 53, 10–27. [Google Scholar] [CrossRef]
  32. Sharma, S.; Litonjua, A. Asthma, Allergy, and Responses to Methyl Donor Supplements and Nutrients. J. Allergy Clin. Immunol. 2014, 133, 1246–1254. [Google Scholar] [CrossRef]
  33. Rautiainen, S.; Manson, J.E.; Lichtenstein, A.H.; Sesso, H.D. Dietary Supplements and Disease Prevention—A Global Overview. Nat. Rev. Endocrinol. 2016, 12, 407–420. [Google Scholar] [CrossRef] [PubMed]
  34. Tamura, J.; Kubota, K.; Murakami, H.; Sawamura, M.; Matsushima, T.; Tamura, T.; Saitoh, T.; Kurabayshi, H.; Naruse, T. Immunomodulation by Vitamin B12: Augmentation of CD8+ T Lymphocytes and Natural Killer (NK) Cell Activity in Vitamin B12-Deficient Patients by Methyl-B12 Treatment. Clin. Exp. Immunol. 1999, 116, 28–32. [Google Scholar] [CrossRef] [PubMed]
  35. Chang, H.-H.; Chen, C.-S.; Lin, J.-Y. High Dose Vitamin C Supplementation Increases the Th1/Th2 Cytokine Secretion Ratio, but Decreases Eosinophilic Infiltration in Bronchoalveolar Lavage Fluid of Ovalbumin-Sensitized and Challenged Mice. J. Agric. Food Chem. 2009, 57, 10471–10476. [Google Scholar] [CrossRef] [PubMed]
  36. Han, Y.-Y.; Blatter, J.; Brehm, J.M.; Forno, E.; Litonjua, A.A.; Celedón, J.C. Diet and Asthma: Vitamins and Methyl Donors. Lancet Respir. Med. 2013, 1, 813–822. [Google Scholar] [CrossRef]
  37. Hemilä, H. Vitamin C and Common Cold-Induced Asthma: A Systematic Review and Statistical Analysis. Allergy Asthma Clin. Immunol. 2013, 9, 46. [Google Scholar] [CrossRef] [PubMed]
  38. Omenaas, E.; Fluge, Ø.; Buist, A.S.; Vollmer, W.M.; Gulsvik, A. Dietary Vitamin C Intake Is Inversely Related to Cough and Wheeze in Young Smokers. Respir. Med. 2003, 97, 134–142. [Google Scholar] [CrossRef] [PubMed]
  39. Hemilä, H. The Effect of Vitamin C on Bronchoconstriction and Respiratory Symptoms Caused by Exercise: A Review and Statistical Analysis. Allergy Asthma Clin. Immunol. 2014, 10, 58. [Google Scholar] [CrossRef]
  40. Hernandez, M.; Zhou, H.; Zhou, B.; Robinette, C.; Crissman, K.; Hatch, G.; Alexis, N.E.; Peden, D. Combination Treatment with High-Dose Vitamin C and Alpha-Tocopherol Does Not Enhance Respiratory-Tract Lining Fluid Vitamin C Levels in Asthmatics. Inhal. Toxicol. 2009, 21, 173–181. [Google Scholar] [CrossRef]
  41. Wiester, M.J.; Winsett, D.W.; Richards, J.H.; Jackson, M.C.; Crissman, K.M.; Costa, D.L. Ozone Adaptation in Mice and Its Association with Ascorbic Acid in the Lung. Inhal. Toxicol. 2000, 12, 577–590. [Google Scholar] [CrossRef]
  42. Hornung, T.C.; Biesalski, H.-K. Glut-1 Explains the Evolutionary Advantage of the Loss of Endogenous Vitamin C-Synthesis. Evol. Med. Public Health 2019, 2019, 221–231. [Google Scholar] [CrossRef]
  43. Kerley, C.P.; Elnazir, B.; Faul, J.; Cormican, L. Vitamin D as an Adjunctive Therapy in Asthma. Part 1: A Review of Potential Mechanisms. Pulm. Pharmacol. Ther. 2015, 32, 60–74. [Google Scholar] [CrossRef] [PubMed]
  44. Kerley, C.P.; Elnazir, B.; Faul, J.; Cormican, L. Vitamin D as an Adjunctive Therapy in Asthma. Part 2: A Review of Human Studies. Pulm. Pharmacol. Ther. 2015, 32, 75–92. [Google Scholar] [CrossRef] [PubMed]
  45. Chirumbolo, S.; Bjørklund, G.; Sboarina, A.; Vella, A. The Role of Vitamin D in the Immune System as a Pro-Survival Molecule. Clin. Ther. 2017, 39, 894–916. [Google Scholar] [CrossRef] [PubMed]
  46. Hewison, M. Vitamin D and Immune Function: An Overview. Proc. Nutr. Soc. 2012, 71, 50–61. [Google Scholar] [CrossRef]
  47. Hewison, M. Vitamin D and Innate and Adaptive Immunity. In Vitamins & Hormones; Elsevier: Amsterdam, The Netherlands, 2011; Volume 86, pp. 23–62. [Google Scholar]
  48. Bikle, D.D. Vitamin D Regulation of Immune Function. In Vitamins & Hormones; Elsevier: Amsterdam, The Netherlands, 2011; Volume 86, pp. 1–21. [Google Scholar]
  49. Colotta, F.; Jansson, B.; Bonelli, F. Modulation of Inflammatory and Immune Responses by Vitamin D. J. Autoimmun. 2017, 85, 78–97. [Google Scholar] [CrossRef]
  50. Mathyssen, C.; Gayan-Ramirez, G.; Bouillon, R.; Janssens, W. Vitamin D Supplementation in Respiratory Diseases: Evidence from Randomized Controlled Trials. Pol. Arch. Intern. Med. 2017, 127, 775–784. [Google Scholar] [CrossRef]
  51. Bossé, Y.; Maghni, K.; Hudson, T.J. 1α,25-Dihydroxy-Vitamin D 3 Stimulation of Bronchial Smooth Muscle Cells Induces Autocrine, Contractility, and Remodeling Processes. Physiol. Genom. 2007, 29, 161–168. [Google Scholar] [CrossRef]
  52. Hansdottir, S.; Monick, M.M.; Hinde, S.L.; Lovan, N.; Look, D.C.; Hunninghake, G.W. Respiratory Epithelial Cells Convert Inactive Vitamin D to Its Active Form: Potential Effects on Host Defense. J. Immunol. 2008, 181, 7090–7099. [Google Scholar] [CrossRef]
  53. Herr, C.; Greulich, T.; Koczulla, R.A.; Meyer, S.; Zakharkina, T.; Branscheidt, M.; Eschmann, R.; Bals, R. The Role of Vitamin D in Pulmonary Disease: COPD, Asthma, Infection, and Cancer. Respir. Res. 2011, 12, 31. [Google Scholar] [CrossRef]
  54. Adorini, L. Tolerogenic Dendritic Cells Induced by Vitamin D Receptor Ligands Enhance Regulatory T Cells Inhibiting Autoimmune Diabetes. Ann. N. Y. Acad. Sci. 2003, 987, 258–261. [Google Scholar] [CrossRef] [PubMed]
  55. Hansdottir, S.; Monick, M.M. Vitamin D Effects on Lung Immunity and Respiratory Diseases. In Vitamins & Hormones; Elsevier: Amsterdam, The Netherlands, 2011; Volume 86, pp. 217–237. ISBN 978-0-12-386960-9. [Google Scholar]
  56. Yawn, J.; Lawrence, L.A.; Carroll, W.W.; Mulligan, J.K. Vitamin D for the Treatment of Respiratory Diseases: Is It the End or Just the Beginning? J. Steroid Biochem. Mol. Biol. 2015, 148, 326–337. [Google Scholar] [CrossRef] [PubMed]
  57. Liu, Z.-Q.; Li, X.-X.; Qiu, S.-Q.; Yu, Y.; Li, M.-G.; Yang, L.-T.; Li, L.-J.; Wang, S.; Zheng, P.-Y.; Liu, Z.-G.; et al. Vitamin D Contributes to Mast Cell Stabilization. Allergy 2017, 72, 1184–1192. [Google Scholar] [CrossRef] [PubMed]
  58. Goleva, E.; Searing, D.A.; Jackson, L.P.; Richers, B.N.; Leung, D.Y.M. Steroid Requirements and Immune Associations with Vitamin D Are Stronger in Children than Adults with Asthma. J. Allergy Clin. Immunol. 2012, 129, 1243–1251. [Google Scholar] [CrossRef]
  59. Zhang, Y.; Leung, D.Y.M.; Goleva, E. Anti-Inflammatory and Corticosteroid-Enhancing Actions of Vitamin D in Monocytes of Patients with Steroid-Resistant and Those with Steroid-Sensitive Asthma. J. Allergy Clin. Immunol. 2014, 133, 1744–1752.e1. [Google Scholar] [CrossRef]
  60. Pfeffer, P.E.; Hawrylowicz, C.M. Vitamin D in Asthma. Chest 2018, 153, 1229–1239. [Google Scholar] [CrossRef]
  61. Xystrakis, E.; Kusumakar, S.; Boswell, S.; Peek, E.; Urry, Z.; Richards, D.F.; Adikibi, T.; Pridgeon, C.; Dallman, M.; Loke, T.-K.; et al. Reversing the Defective Induction of IL-10–Secreting Regulatory T Cells in Glucocorticoid-Resistant Asthma Patients. J. Clin. Investig. 2006, 116, 146–155. [Google Scholar] [CrossRef]
  62. Cook-Mills, J.M.; Averill, S.H.; Lajiness, J.D. Asthma, Allergy and Vitamin E: Current and Future Perspectives. Free Radic. Biol. Med. 2022, 179, 388–402. [Google Scholar] [CrossRef]
  63. McCary, C.A.; Abdala-Valencia, H.; Berdnikovs, S.; Cook-Mills, J.M. Supplemental and Highly Elevated Tocopherol Doses Differentially Regulate Allergic Inflammation: Reversibility of α-Tocopherol and γ-Tocopherol’s Effects. J. Immunol. 2011, 186, 3674–3685. [Google Scholar] [CrossRef]
  64. Wagner, J.G.; Harkema, J.R.; Jiang, Q.; Hernandez, M.; Peden, D.B. Two Faces of Vitamin E in the Lung. Am. J. Respir. Crit. Care Med. 2014, 190, 841–842. [Google Scholar] [CrossRef]
  65. Abdala-Valencia, H.; Berdnikovs, S.; Cook-Mills, J.M. Vitamin E Isoforms Differentially Regulate Intercellular Adhesion Molecule-1 Activation of PKCα in Human Microvascular Endothelial Cells. PLoS ONE 2012, 7, e41054. [Google Scholar] [CrossRef] [PubMed]
  66. Berdnikovs, S.; Abdala-Valencia, H.; McCary, C.; Somand, M.; Cole, R.; Garcia, A.; Bryce, P.; Cook-Mills, J.M. Isoforms of Vitamin E Have Opposing Immunoregulatory Functions during Inflammation by Regulating Leukocyte Recruitment. J. Immunol. 2009, 182, 4395–4405. [Google Scholar] [CrossRef] [PubMed]
  67. Abdala-Valencia, H.; Berdnikovs, S.; Cook-Mills, J.M. Vitamin E Isoforms as Modulators of Lung Inflammation. Nutrients 2013, 5, 4347–4363. [Google Scholar] [CrossRef] [PubMed]
  68. Jiang, Q.; Im, S.; Wagner, J.G.; Hernandez, M.L.; Peden, D.B. Gamma-Tocopherol, a Major Form of Vitamin E in Diets: Insights into Antioxidant and Anti-Inflammatory Effects, Mechanisms, and Roles in Disease Management. Free Radic. Biol. Med. 2022, 178, 347–359. [Google Scholar] [CrossRef]
  69. Azzi, A. Many Tocopherols, One Vitamin E. Mol. Asp. Med. 2018, 61, 92–103. [Google Scholar] [CrossRef]
  70. Lim, Y.; Vasu, V.T.; Valacchi, G.; Leonard, S.; Hnin Aung, H.; Schock, B.C.; Kenyon, N.J.; Li, C.-S.; Traber, M.G.; Cross, C.E. Severe Vitamin E Deficiency Modulates Airway Allergic Inflammatory Responses in the Murine Asthma Model. Free Radic. Res. 2008, 42, 387–396. [Google Scholar] [CrossRef]
  71. Cook-Mills, J.M.; McCary, C.A. Isoforms of Vitamin E Differentially Regulate Inflammation. Endocr. Metab. Immune Disord. Drug Targets 2010, 10, 348–366. [Google Scholar] [CrossRef]
  72. Sen, C.K.; Khanna, S.; Roy, S. Tocotrienols in Health and Disease: The Other Half of the Natural Vitamin E Family. Mol. Asp. Med. 2007, 28, 692–728. [Google Scholar] [CrossRef]
  73. Peh, H.Y.; Ho, W.E.; Cheng, C.; Chan, T.K.; Seow, A.C.G.; Lim, A.Y.H.; Fong, C.W.; Seng, K.Y.; Ong, C.N.; Wong, W.S.F. Vitamin E Isoform γ-Tocotrienol Downregulates House Dust Mite–Induced Asthma. J. Immunol. 2015, 195, 437–444. [Google Scholar] [CrossRef]
  74. Ahn, K.S.; Sethi, G.; Krishnan, K.; Aggarwal, B.B. γ-Tocotrienol Inhibits Nuclear Factor-ΚB Signaling Pathway through Inhibition of Receptor-Interacting Protein and TAK1 Leading to Suppression of Antiapoptotic Gene Products and Potentiation of Apoptosis. J. Biol. Chem. 2007, 282, 809–820. [Google Scholar] [CrossRef]
  75. Xiao, H.; Chen, J.; Duan, L.; Li, S. Role of Emerging Vitamin K-dependent Proteins: Growth Arrest-specific Protein 6, Gla-rich Protein and Periostin (Review). Int. J. Mol. Med. 2021, 47, 2. [Google Scholar] [CrossRef] [PubMed]
  76. Kimur, I.; Tanizaki, Y.; Sato, S.; Saito, K.; Takahashi, K. Menaquinone (Vitamin K2) Therapy for Bronchial Asthma. II. Clinical Effect of Menaquinone on Bronchial Asthma. Acta Med. Okayama 1975, 29, 127–135. [Google Scholar] [PubMed]
  77. Zheng, X.; Hou, Y.; He, H.; Chen, Y.; Zhou, R.; Wang, X.; Gong, T.; Jiang, W. Synthetic Vitamin K Analogs Inhibit Inflammation by Targeting the NLRP3 Inflammasome. Cell. Mol. Immunol. 2021, 18, 2422–2430. [Google Scholar] [CrossRef] [PubMed]
  78. Kohli, V.; Sharma, D.; Sandur, S.K.; Suryavanshi, S.; Sainis, K.B. Immune Responses to Novel Allergens and Modulation of Inflammation by Vitamin K3 Analogue: A ROS Dependent Mechanism. Int. Immunopharmacol. 2011, 11, 233–243. [Google Scholar] [CrossRef]
  79. Ohsaki, Y.; Shirakawa, H.; Hiwatashi, K.; Furukawa, Y.; Mizutani, T.; Komai, M. Vitamin K Suppresses Lipopolysaccharide-Induced Inflammation in the Rat. Biosci. Biotechnol. Biochem. 2006, 70, 926–932. [Google Scholar] [CrossRef]
  80. Checker, R.; Sharma, D.; Sandur, S.K.; Khan, N.M.; Patwardhan, R.S.; Kohli, V.; Sainis, K.B. Vitamin K3 Suppressed Inflammatory and Immune Responses in a Redox-Dependent Manner. Free Radic. Res. 2011, 45, 975–985. [Google Scholar] [CrossRef]
  81. Gozzi-Silva, S.C.; Teixeira, F.M.E.; Duarte, A.J.d.S.; Sato, M.N.; Oliveira, L.d.M. Immunomodulatory Role of Nutrients: How Can Pulmonary Dysfunctions Improve? Front. Nutr. 2021, 8, 674258. [Google Scholar] [CrossRef]
  82. Koumpagioti, D.; Boutopoulou, B.; Moriki, D.; Priftis, K.N.; Douros, K. Does Adherence to the Mediterranean Diet Have a Protective Effect against Asthma and Allergies in Children? A Systematic Review. Nutrients 2022, 14, 1618. [Google Scholar] [CrossRef]
  83. Zhang, Y.; Lin, J.; Fu, W.; Liu, S.; Gong, C.; Dai, J. Mediterranean Diet during Pregnancy and Childhood for Asthma in Children: A Systematic Review and Meta-Analysis of Observational Studies. Pediatr. Pulmonol. 2019, 54, 949–961. [Google Scholar] [CrossRef]
  84. Lee, Y.-L.; Lee, Y.-C.; Guo, Y.L. Associations of Glutathione S-Transferase P1, M1, and Environmental Tobacco Smoke with Wheezing Illness in School Children. Allergy 2007, 62, 641–647. [Google Scholar] [CrossRef]
  85. Huang, S.-L.; Pan, W.-H. Dietary Fats and Asthma in Teenagers: Analyses of the First Nutrition and Health Survey in Taiwan (NAHSIT): Dietary Fats and Asthma in Teenagers. Clin. Exp. Allergy 2001, 31, 1875–1880. [Google Scholar] [CrossRef] [PubMed]
  86. Checkley, W.; West, K.P.; Wise, R.A.; Wu, L.; LeClerq, S.C.; Khatry, S.; Katz, J.; Christian, P.; Tielsch, J.M.; Sommer, A. Supplementation with Vitamin A Early in Life and Subsequent Risk of Asthma. Eur. Respir. J. 2011, 38, 1310–1319. [Google Scholar] [CrossRef] [PubMed]
  87. Green, A.S.; Fascetti, A.J. Meeting the Vitamin A Requirement: The Efficacy and Importance of β-Carotene in Animal Species. Sci. World J. 2016, 2016, 7393620. [Google Scholar] [CrossRef] [PubMed]
  88. Hu, J.; Sang, J.; Hao, F.; Liu, L. Association between Vitamin A and Asthma: A Meta-Analysis with Trial Sequential Analysis. Front. Pharmacol. 2023, 14, 1100002. [Google Scholar] [CrossRef]
  89. Quyen, D.T.; Irei, A.V.; Sato, Y.; Ota, F.; Fujimaki, Y.; Sakai, T.; Kunii, D.; Khan, N.C.; Yamamoto, S. Nutritional Factors, Parasite Infection and Allergy in Rural and Suburban Vietnamese School Children. J. Med. Investig. JMI 2004, 51, 171–177. [Google Scholar] [CrossRef]
  90. Sur, S.; Camara, M.; Buchmeier, A.; Morgan, S.; Nelson, H.S. Double-Blind Trial of Pyridoxine (Vitamin B6) in the Treatment of Steroid-Dependent Asthma. Ann. Allergy 1993, 70, 147–152. [Google Scholar]
  91. Collipp, P.J.; Goldzier, S.; Weiss, N.; Soleymani, Y.; Snyder, R. Pyridoxine Treatment of Childhood Bronchial Asthma. Ann. Allergy 1975, 35, 93–97. [Google Scholar]
  92. Seyedrezazadeh, E.; Pour Moghaddam, M.; Ansarin, K.; Reza Vafa, M.; Sharma, S.; Kolahdooz, F. Fruit and Vegetable Intake and Risk of Wheezing and Asthma: A Systematic Review and Meta-Analysis. Nutr. Rev. 2014, 72, 411–428. [Google Scholar] [CrossRef]
  93. Matsui, E.C.; Matsui, W. Higher Serum Folate Levels Are Associated with a Lower Risk of Atopy and Wheeze. J. Allergy Clin. Immunol. 2009, 123, 1253–1259.e2. [Google Scholar] [CrossRef]
  94. Chatzi, L.; Apostolaki, G.; Bibakis, I.; Skypala, I.; Bibaki-Liakou, V.; Tzanakis, N.; Kogevinas, M.; Cullinan, P. Protective Effect of Fruits, Vegetables and the Mediterranean Diet on Asthma and Allergies among Children in Crete. Thorax 2007, 62, 677–683. [Google Scholar] [CrossRef]
  95. Hosseini, B.; Berthon, B.S.; Wark, P.; Wood, L.G. Effects of Fruit and Vegetable Consumption on Risk of Asthma, Wheezing and Immune Responses: A Systematic Review and Meta-Analysis. Nutrients 2017, 9, 341. [Google Scholar] [CrossRef] [PubMed]
  96. Shidfar, F.; Baghai, N.; Keshavarz, A.; Ameri, A.; Shidfar, S. Comparison of Plasma and Leukocyte Vitamin C Status between Asthmatic and Healthy Subjects. East. Mediterr. Health J. 2005, 11, 87–95. [Google Scholar] [PubMed]
  97. de Luis, D.A.; Armentia, A.; Aller, R.; Asensio, A.; Sedano, E.; Izaola, O.; Cuellar, L. Dietary Intake in Patients with Asthma: A Case Control Study. Nutrition 2005, 21, 320–324. [Google Scholar] [CrossRef]
  98. Misso, N.L.A.; Brooks-Wildhaber, J.; Ray, S.; Vally, H.; Thompson, P.J. Plasma Concentrations of Dietary and Nondietary Antioxidants Are Low in Severe Asthma. Eur. Respir. J. 2005, 26, 257–264. [Google Scholar] [CrossRef] [PubMed]
  99. Soutar, A.; Seaton, A.; Brown, K. Bronchial Reactivity and Dietary Antioxidants. Thorax 1997, 52, 166–170. [Google Scholar] [CrossRef]
  100. Devereux, G.; Seaton, A. Diet as a Risk Factor for Atopy and Asthma. J. Allergy Clin. Immunol. 2005, 115, 1109–1117. [Google Scholar] [CrossRef] [PubMed]
  101. Gilliland, F.D.; Berhane, K.T.; Li, Y.-F.; Gauderman, W.J.; McConnell, R.; Peters, J. Children’s Lung Function and Antioxidant Vitamin, Fruit, Juice, and Vegetable Intake. Am. J. Epidemiol. 2003, 158, 576–584. [Google Scholar] [CrossRef] [PubMed]
  102. Milan, S.J.; Hart, A.; Wilkinson, M. Vitamin C for Asthma and Exercise-Induced Bronchoconstriction. Cochrane Database Syst. Rev. 2013, 2018, CD010391. [Google Scholar] [CrossRef]
  103. Troisi, R.J.; Willett, W.C.; Weiss, S.T.; Trichopoulos, D.; Rosner, B.; Speizer, F.E. A Prospective Study of Diet and Adult-Onset Asthma. Am. J. Respir. Crit. Care Med. 1995, 151, 1401–1408. [Google Scholar] [CrossRef]
  104. Hollams, E.M.; Hart, P.H.; Holt, B.J.; Serralha, M.; Parsons, F.; de Klerk, N.H.; Zhang, G.; Sly, P.D.; Holt, P.G. Vitamin D and Atopy and Asthma Phenotypes in Children: A Longitudinal Cohort Study. Eur. Respir. J. 2011, 38, 1320–1327. [Google Scholar] [CrossRef]
  105. Sikorska-Szaflik, H.; Sozańska, B. The Role of Vitamin D in Respiratory Allergies Prevention. Why the Effect Is so Difficult to Disentangle? Nutrients 2020, 12, 1801. [Google Scholar] [CrossRef] [PubMed]
  106. Hollams, E.M.; Teo, S.M.; Kusel, M.; Holt, B.J.; Holt, K.E.; Inouye, M.; De Klerk, N.H.; Zhang, G.; Sly, P.D.; Hart, P.H.; et al. Vitamin D over the First Decade and Susceptibility to Childhood Allergy and Asthma. J. Allergy Clin. Immunol. 2017, 139, 472–481.e9. [Google Scholar] [CrossRef] [PubMed]
  107. Wittke, A.; Chang, A.; Froicu, M.; Harandi, O.F.; Weaver, V.; August, A.; Paulson, R.F.; Cantorna, M.T. Vitamin D Receptor Expression by the Lung Micro-Environment Is Required for Maximal Induction of Lung Inflammation. Arch. Biochem. Biophys. 2007, 460, 306–313. [Google Scholar] [CrossRef] [PubMed]
  108. Wittke, A.; Weaver, V.; Mahon, B.D.; August, A.; Cantorna, M.T. Vitamin D Receptor-Deficient Mice Fail to Develop Experimental Allergic Asthma. J. Immunol. 2004, 173, 3432–3436. [Google Scholar] [CrossRef]
  109. Kompauer, I.; Heinrich, J.; Wolfram, G.; Linseisen, J. Association of Carotenoids, Tocopherols and Vitamin C in Plasma with Allergic Rhinitis and Allergic Sensitisation in Adults. Public Health Nutr. 2006, 9, 472–479. [Google Scholar] [CrossRef]
  110. Hoskins, A.; Roberts, J.L.; Milne, G.; Choi, L.; Dworski, R. Natural-Source d-α-Tocopheryl Acetate Inhibits Oxidant Stress and Modulates Atopic Asthma in Humans in Vivo. Allergy 2012, 67, 676–682. [Google Scholar] [CrossRef]
  111. Ghaffari, J.; Hossaini, R.F.; Khalilian, A.; Nahanmoghadam, N.; Salehifar, E.; Rafatpanah, H. Vitamin E Supplementation, Lung Functions and Clinical Manifestations in Children with Moderate Asthma: A Randomized Double Blind Placebo- Controlled Trial. Iran. J. Allergy Asthma Immunol. 2014, 13, 98–103. [Google Scholar]
  112. Pearson, P.J.K.; Lewis, S.A.; Britton, J.; Fogarty, A. Vitamin E Supplements in Asthma: A Parallel Group Randomised Placebo Controlled Trial. Thorax 2004, 59, 652–656. [Google Scholar] [CrossRef]
  113. Rubin, R.N.; Navon, L.; Cassano, P.A. Relationship of Serum Antioxidants to Asthma Prevalence in Youth. Am. J. Respir. Crit. Care Med. 2004, 169, 393–398. [Google Scholar] [CrossRef]
  114. Allen, S.; Britton, J.R.; Leonardi-Bee, J.A. Association between Antioxidant Vitamins and Asthma Outcome Measures: Systematic Review and Meta-Analysis. Thorax 2009, 64, 610–619. [Google Scholar] [CrossRef]
  115. Trenca, C.A.; Koenig, J.Q.; Williams, P.V. Dietary Antioxidants and Ozone-Induced Bronchial Hyperresponsiveness in Adults with Asthma. Arch. Environ. Health Int. J. 2001, 56, 242–249. [Google Scholar] [CrossRef] [PubMed]
  116. Grievink, L.; Zijlstra, A.G.; Ke, X.; Brunekreef, B. Double-Blind Intervention Trial on Modulation of Ozone Effects on Pulmonary Function by Antioxidant Supplements. Am. J. Epidemiol. 1999, 149, 306–314. [Google Scholar] [CrossRef]
  117. Romieu, I.; Meneses, F.; Ramirez, M.; Ruiz, S.; Padilla, R.P.; Sienra, J.J.; Gerber, M.; Grievink, L.; Dekker, R.; Walda, I.; et al. Antioxidant Supplementation and Respiratory Functions among Workers Exposed to High Levels of Ozone. Am. J. Respir. Crit. Care Med. 1998, 158, 226–232. [Google Scholar] [CrossRef] [PubMed]
  118. Kurti, S.P.; Murphy, J.D.; Ferguson, C.S.; Brown, K.R.; Smith, J.R.; Harms, C.A. Improved Lung Function Following Dietary Antioxidant Supplementation in Exercise-Induced Asthmatics. Respir. Physiol. Neurobiol. 2016, 220, 95–101. [Google Scholar] [CrossRef] [PubMed]
  119. Cook-Mills, J.M.; Abdala-Valencia, H.; Hartert, T. Two Faces of Vitamin E in the Lung. Am. J. Respir. Crit. Care Med. 2013, 188, 279–284. [Google Scholar] [CrossRef] [PubMed]
  120. Fogarty, A.; Lewis, S.; Weiss, S.; Britton, J. Dietary Vitamin E, IgE Concentrations, and Atopy. Lancet 2000, 356, 1573–1574. [Google Scholar] [CrossRef]
  121. Beasley, R.; Semprini, A.; Mitchell, E.A. Risk Factors for Asthma: Is Prevention Possible? Lancet 2015, 386, 1075–1085. [Google Scholar] [CrossRef]
  122. Maslova, E.; Hansen, S.; Strøm, M.; Halldorsson, T.I.; Olsen, S.F. Maternal Intake of Vitamins A, E and K in Pregnancy and Child Allergic Disease: A Longitudinal Study from the Danish National Birth Cohort. Br. J. Nutr. 2014, 111, 1096–1108. [Google Scholar] [CrossRef]
  123. Checkley, W.; West, K.P.; Wise, R.A.; Baldwin, M.R.; Wu, L.; LeClerq, S.C.; Christian, P.; Katz, J.; Tielsch, J.M.; Khatry, S.; et al. Maternal Vitamin A Supplementation and Lung Function in Offspring. N. Engl. J. Med. 2010, 362, 1784–1794. [Google Scholar] [CrossRef]
  124. Stelmach, I.; Grzelewski, T.; Bobrowska-Korzeniowska, M.; Kopka, M.; Majak, P.; Jerzynska, J.; Stelmach, W.; Polańska, K.; Sobala, W.; Gromadzińska, J.; et al. The Role of Zinc, Copper, Plasma Glutathione Peroxidase Enzyme, and Vitamins in the Development of Allergic Diseases in Early Childhood: The Polish Mother and Child Cohort Study. Allergy Asthma Proc. 2014, 35, 227–232. [Google Scholar] [CrossRef]
  125. Parr, C.L.; Magnus, M.C.; Karlstad, Ø.; Holvik, K.; Lund-Blix, N.A.; Haugen, M.; Page, C.M.; Nafstad, P.; Ueland, P.M.; London, S.J.; et al. Vitamin A and D Intake in Pregnancy, Infant Supplementation, and Asthma Development: The Norwegian Mother and Child Cohort. Am. J. Clin. Nutr. 2018, 107, 789–798. [Google Scholar] [CrossRef] [PubMed]
  126. McGuire, S. WHO Guideline: Vitamin A Supplementation in Pregnant Women. Geneva: WHO, 2011; WHO Guideline: Vitamin A Supplementation in Postpartum Women. Geneva: WHO, 2011. Adv. Nutr. 2012, 3, 215–216. [Google Scholar] [CrossRef] [PubMed]
  127. Miyake, Y.; Sasaki, S.; Tanaka, K.; Hirota, Y. Maternal B Vitamin Intake during Pregnancy and Wheeze and Eczema in Japanese Infants Aged 16–24 Months: The Osaka Maternal and Child Health Study: B Vitamin Intake and Wheeze and Eczema. Pediatr. Allergy Immunol. 2011, 22, 69–74. [Google Scholar] [CrossRef] [PubMed]
  128. Brown, S.B.; Reeves, K.W.; Bertone-Johnson, E.R. Maternal Folate Exposure in Pregnancy and Childhood Asthma and Allergy: A Systematic Review. Nutr. Rev. 2014, 72, 55–64. [Google Scholar] [CrossRef] [PubMed]
  129. Haberg, S.E.; London, S.J.; Stigum, H.; Nafstad, P.; Nystad, W. Folic Acid Supplements in Pregnancy and Early Childhood Respiratory Health. Arch. Dis. Child. 2009, 94, 180–184. [Google Scholar] [CrossRef]
  130. Håberg, S.E.; London, S.J.; Nafstad, P.; Nilsen, R.M.; Ueland, P.M.; Vollset, S.E.; Nystad, W. Maternal Folate Levels in Pregnancy and Asthma in Children at Age 3 Years. J. Allergy Clin. Immunol. 2011, 127, 262–264.e1. [Google Scholar] [CrossRef]
  131. Kiefte-de Jong, J.C.; Timmermans, S.; Jaddoe, V.W.V.; Hofman, A.; Tiemeier, H.; Steegers, E.A.; de Jongste, J.C.; Moll, H.A. High Circulating Folate and Vitamin B-12 Concentrations in Women During Pregnancy Are Associated with Increased Prevalence of Atopic Dermatitis in Their Offspring. J. Nutr. 2012, 142, 731–738. [Google Scholar] [CrossRef]
  132. Okuda, M.; Bando, N.; Terao, J.; Sasaki, S.; Sugiyama, S.; Kunitsugu, I.; Hobara, T. Association of Serum Carotenoids and Tocopherols with Atopic Diseases in Japanese Children and Adolescents: Serum Antioxidant and Atopy in Young Japanese. Pediatr. Allergy Immunol. 2010, 21, e705–e710. [Google Scholar] [CrossRef]
  133. Wang, T.; Zhang, H.-P.; Zhang, X.; Liang, Z.-A.; Ji, Y.-L.; Wang, G. Is Folate Status a Risk Factor for Asthma or Other Allergic Diseases? Allergy Asthma Immunol. Res. 2015, 7, 538. [Google Scholar] [CrossRef]
  134. Yang, L.; Jiang, L.; Bi, M.; Jia, X.; Wang, Y.; He, C.; Yao, Y.; Wang, J.; Wang, Z. High Dose of Maternal Folic Acid Supplementation Is Associated to Infant Asthma. Food Chem. Toxicol. 2015, 75, 88–93. [Google Scholar] [CrossRef]
  135. Whitrow, M.J.; Moore, V.M.; Rumbold, A.R.; Davies, M.J. Effect of Supplemental Folic Acid in Pregnancy on Childhood Asthma: A Prospective Birth Cohort Study. Am. J. Epidemiol. 2009, 170, 1486–1493. [Google Scholar] [CrossRef] [PubMed]
  136. Alfonso, V.H.; Bandoli, G.; von Ehrenstein, O.; Ritz, B. Early Folic Acid Supplement Initiation and Risk of Adverse Early Childhood Respiratory Health: A Population-Based Study. Matern. Child Health J. 2018, 22, 111–119. [Google Scholar] [CrossRef] [PubMed]
  137. Veeranki, S.P.; Gebretsadik, T.; Mitchel, E.F.; Tylavsky, F.A.; Hartert, T.V.; Cooper, W.O.; Dupont, W.D.; Dorris, S.L.; Hartman, T.J.; Carroll, K.N. Maternal Folic Acid Supplementation During Pregnancy and Early Childhood Asthma. Epidemiology 2015, 26, 934–941. [Google Scholar] [CrossRef] [PubMed]
  138. Bekkers, M.B.M.; Elstgeest, L.E.M.; Scholtens, S.; Haveman-Nies, A.; de Jongste, J.C.; Kerkhof, M.; Koppelman, G.H.; Gehring, U.; Smit, H.A.; Wijga, A.H. Maternal Use of Folic Acid Supplements during Pregnancy, and Childhood Respiratory Health and Atopy. Eur. Respir. J. 2012, 39, 1468–1474. [Google Scholar] [CrossRef] [PubMed]
  139. Blatter, J.; Han, Y.-Y.; Forno, E.; Brehm, J.; Bodnar, L.; Celedón, J.C. Folate and Asthma. Am. J. Respir. Crit. Care Med. 2013, 188, 12–17. [Google Scholar] [CrossRef]
  140. Granell, R.; Heron, J.; Lewis, S.; Davey Smith, G.; Sterne, J.A.C.; Henderson, J. The Association between Mother and Child MTHFR C677T Polymorphisms, Dietary Folate Intake and Childhood Atopy in a Population-Based, Longitudinal Birth Cohort. Clin. Exp. Allergy 2008, 38, 320–328. [Google Scholar] [CrossRef]
  141. Liu, J.; Li, Z.; Ye, R.; Liu, J.; Ren, A. Periconceptional Folic Acid Supplementation and Risk of Parent-Reported Asthma in Children at 4–6 Years of Age. ERJ Open Res. 2020, 6, 00250–02019. [Google Scholar] [CrossRef]
  142. Magdelijns, F.J.H.; Mommers, M.; Penders, J.; Smits, L.; Thijs, C. Folic Acid Use in Pregnancy and the Development of Atopy, Asthma, and Lung Function in Childhood. Pediatrics 2011, 128, e135–e144. [Google Scholar] [CrossRef]
  143. Martinussen, M.P.; Risnes, K.R.; Jacobsen, G.W.; Bracken, M.B. Folic Acid Supplementation in Early Pregnancy and Asthma in Children Aged 6 Years. Am. J. Obstet. Gynecol. 2012, 206, 72.e1–72.e7. [Google Scholar] [CrossRef]
  144. van der Valk, R.J.P.; Kiefte-de Jong, J.C.; Sonnenschein-van der Voort, A.M.M.; Duijts, L.; Hafkamp-de Groen, E.; Moll, H.A.; Tiemeier, H.; Steegers, E.A.P.; Hofman, A.; Jaddoe, V.W.V.; et al. Neonatal Folate, Homocysteine, Vitamin B12 Levels and Methylenetetrahydrofolate Reductase Variants in Childhood Asthma and Eczema. Allergy 2013, 68, 788–795. [Google Scholar] [CrossRef]
  145. Shorey-Kendrick, L.E.; McEvoy, C.T.; Ferguson, B.; Burchard, J.; Park, B.S.; Gao, L.; Vuylsteke, B.H.; Milner, K.F.; Morris, C.D.; Spindel, E.R. Vitamin C Prevents Offspring DNA Methylation Changes Associated with Maternal Smoking in Pregnancy. Am. J. Respir. Crit. Care Med. 2017, 196, 745–755. [Google Scholar] [CrossRef]
  146. Yieh, L.; McEvoy, C.T.; Hoffman, S.W.; Caughey, A.B.; MacDonald, K.D.; Dukhovny, D. Cost Effectiveness of Vitamin c Supplementation for Pregnant Smokers to Improve Offspring Lung Function at Birth and Reduce Childhood Wheeze/Asthma. J. Perinatol. 2018, 38, 820–827. [Google Scholar] [CrossRef] [PubMed]
  147. McEvoy, C.T.; Shorey-Kendrick, L.E.; Milner, K.; Schilling, D.; Tiller, C.; Vuylsteke, B.; Scherman, A.; Jackson, K.; Haas, D.M.; Harris, J.; et al. Oral Vitamin C (500 Mg/d) to Pregnant Smokers Improves Infant Airway Function at 3 Months (VCSIP). A Randomized Trial. Am. J. Respir. Crit. Care Med. 2019, 199, 1139–1147. [Google Scholar] [CrossRef] [PubMed]
  148. McEvoy, C.T.; Shorey-Kendrick, L.E.; Milner, K.; Schilling, D.; Tiller, C.; Vuylsteke, B.; Scherman, A.; Jackson, K.; Haas, D.M.; Harris, J.; et al. Vitamin C to Pregnant Smokers Persistently Improves Infant Airway Function to 12 Months of Age: A Randomised Trial. Eur. Respir. J. 2020, 56, 1902208. [Google Scholar] [CrossRef]
  149. McEvoy, C.T.; Shorey-Kendrick, L.E.; Milner, K.; Harris, J.; Vuylsteke, B.; Cunningham, M.; Tiller, C.; Stewart, J.; Schilling, D.; Brownsberger, J.; et al. Effect of Vitamin C Supplementation for Pregnant Smokers on Offspring Airway Function and Wheeze at Age 5 Years: Follow-up of a Randomized Clinical Trial. JAMA Pediatr. 2023, 177, 16–24. [Google Scholar] [CrossRef] [PubMed]
  150. McEvoy, C.T.; Milner, K.F.; Scherman, A.J.; Schilling, D.G.; Tiller, C.J.; Vuylsteke, B.; Shorey-Kendrick, L.E.; Spindel, E.R.; Schuff, R.; Mitchell, J.; et al. Vitamin C to Decrease the Effects of Smoking in Pregnancy on Infant Lung Function (VCSIP): Rationale, Design, and Methods of a Randomized, Controlled Trial of Vitamin C Supplementation in Pregnancy for the Primary Prevention of Effects of in Utero Tobacco Smoke Exposure on Infant Lung Function and Respiratory Health. Contemp. Clin. Trials 2017, 58, 66–77. [Google Scholar] [CrossRef]
  151. Allan, K.M.; Prabhu, N.; Craig, L.C.A.; McNeill, G.; Kirby, B.; McLay, J.; Helms, P.J.; Ayres, J.G.; Seaton, A.; Turner, S.W.; et al. Maternal Vitamin D and E Intakes during Pregnancy Are Associated with Asthma in Children. Eur. Respir. J. 2015, 45, 1027–1036. [Google Scholar] [CrossRef]
  152. Devereux, G. Maternal Diet during Pregnancy: An Emerging Risk Factor for Childhood Asthma. Expert Rev. Clin. Immunol. 2008, 4, 663–668. [Google Scholar] [CrossRef]
  153. Devereux, G.; Litonjua, A.A.; Turner, S.W.; Craig, L.C.A.; McNeill, G.; Martindale, S.; Helms, P.J.; Seaton, A.; Weiss, S.T. Maternal Vitamin D Intake during Pregnancy and Early Childhood Wheezing. Am. J. Clin. Nutr. 2007, 85, 853–859. [Google Scholar] [CrossRef]
  154. Drozdenko, G.; Heine, G.; Worm, M. Oral Vitamin D Increases the Frequencies of CD38 + Human B Cells and Ameliorates IL-17-Producing T Cells. Exp. Dermatol. 2014, 23, 107–112. [Google Scholar] [CrossRef]
  155. Erkkola, M.; Kaila, M.; Nwaru, B.I.; Kronberg-Kippilä, C.; Ahonen, S.; Nevalainen, J.; Veijola, R.; Pekkanen, J.; Ilonen, J.; Simell, O.; et al. Maternal Vitamin D Intake during Pregnancy Is Inversely Associated with Asthma and Allergic Rhinitis in 5-Year-Old Children. Clin. Exp. Allergy 2009, 39, 875–882. [Google Scholar] [CrossRef] [PubMed]
  156. Hollis, B.W.; Wagner, C.L. Vitamin D Supplementation during Pregnancy: Improvements in Birth Outcomes and Complications through Direct Genomic Alteration. Mol. Cell. Endocrinol. 2017, 453, 113–130. [Google Scholar] [CrossRef]
  157. Zosky, G.R.; Hart, P.H.; Whitehouse, A.J.O.; Kusel, M.M.; Ang, W.; Foong, R.E.; Chen, L.; Holt, P.G.; Sly, P.D.; Hall, G.L. Vitamin D Deficiency at 16 to 20 Weeks’ Gestation Is Associated with Impaired Lung Function and Asthma at 6 Years of Age. Ann. Am. Thorac. Soc. 2014, 11, 571–577. [Google Scholar] [CrossRef] [PubMed]
  158. Beckhaus, A.A.; Garcia-Marcos, L.; Forno, E.; Pacheco-Gonzalez, R.M.; Celedón, J.C.; Castro-Rodriguez, J.A. Maternal Nutrition during Pregnancy and Risk of Asthma, Wheeze, and Atopic Diseases during Childhood: A Systematic Review and Meta-Analysis. Allergy 2015, 70, 1588–1604. [Google Scholar] [CrossRef] [PubMed]
  159. Camargo, C.A.; Rifas-Shiman, S.L.; Litonjua, A.A.; Rich-Edwards, J.W.; Weiss, S.T.; Gold, D.R.; Kleinman, K.; Gillman, M.W. Maternal Intake of Vitamin D during Pregnancy and Risk of Recurrent Wheeze in Children at 3 y of Age. Am. J. Clin. Nutr. 2007, 85, 788–795. [Google Scholar] [CrossRef]
  160. Litonjua, A.A. Fat-Soluble Vitamins and Atopic Disease: What Is the Evidence? Proc. Nutr. Soc. 2012, 71, 67–74. [Google Scholar] [CrossRef]
  161. Litonjua, A.A.; Weiss, S.T. Is Vitamin D Deficiency to Blame for the Asthma Epidemic? J. Allergy Clin. Immunol. 2007, 120, 1031–1035. [Google Scholar] [CrossRef]
  162. Wolsk, H.M.; Harshfield, B.J.; Laranjo, N.; Carey, V.J.; O’Connor, G.; Sandel, M.; Strunk, R.C.; Bacharier, L.B.; Zeiger, R.S.; Schatz, M.; et al. Vitamin D Supplementation in Pregnancy, Prenatal 25(OH)D Levels, Race, and Subsequent Asthma or Recurrent Wheeze in Offspring: Secondary Analyses from the Vitamin D Antenatal Asthma Reduction Trial. J. Allergy Clin. Immunol. 2017, 140, 1423–1429.e5. [Google Scholar] [CrossRef]
  163. Akhtar, E.; Mily, A.; Haq, A.; Al-Mahmud, A.; El-Arifeen, S.; Hel Baqui, A.; Roth, D.E.; Raqib, R. Prenatal High-Dose Vitamin D3 Supplementation Has Balanced Effects on Cord Blood Th1 and Th2 Responses. Nutr. J. 2016, 15, 75. [Google Scholar] [CrossRef]
  164. Miller, D.R.; Turner, S.W.; Spiteri-Cornish, D.; Scaife, A.R.; Danielian, P.J.; Devereux, G.S.; Walsh, G.M. Maternal Vitamin D and E Intakes during Early Pregnancy Are Associated with Airway Epithelial Cell Responses in Neonates. Clin. Exp. Allergy 2015, 45, 920–927. [Google Scholar] [CrossRef]
  165. Foong, R.E.; Bosco, A.; Jones, A.C.; Gout, A.; Gorman, S.; Hart, P.H.; Zosky, G.R. The Effects of In Utero Vitamin D Deficiency on Airway Smooth Muscle Mass and Lung Function. Am. J. Respir. Cell Mol. Biol. 2015, 53, 664–675. [Google Scholar] [CrossRef] [PubMed]
  166. Lykkedegn, S.; Sorensen, G.L.; Beck-Nielsen, S.S.; Christesen, H.T. The Impact of Vitamin D on Fetal and Neonatal Lung Maturation. A Systematic Review. Am. J. Physiol.-Lung Cell. Mol. Physiol. 2015, 308, L587–L602. [Google Scholar] [CrossRef] [PubMed]
  167. Chawes, B.L.; Bønnelykke, K.; Stokholm, J.; Vissing, N.H.; Bjarnadóttir, E.; Schoos, A.-M.M.; Wolsk, H.M.; Pedersen, T.M.; Vinding, R.K.; Thorsteinsdóttir, S.; et al. Effect of Vitamin D3 Supplementation During Pregnancy on Risk of Persistent Wheeze in the Offspring: A Randomized Clinical Trial. JAMA 2016, 315, 353–361. [Google Scholar] [CrossRef]
  168. Hansen, S.; Maslova, E.; Strøm, M.; Linneberg, A.; Halldorsson, T.I.; Granström, C.; Dahl, R.; Hoffmann, H.J.; Olsen, S.F. The Long-Term Programming Effect of Maternal 25-Hydroxyvitamin D in Pregnancy on Allergic Airway Disease and Lung Function in Offspring after 20 to 25 Years of Follow-Up. J. Allergy Clin. Immunol. 2015, 136, 169–176.e2. [Google Scholar] [CrossRef] [PubMed]
  169. Morales, E.; Romieu, I.; Guerra, S.; Ballester, F.; Rebagliato, M.; Vioque, J.; Tardón, A.; Rodriguez Delhi, C.; Arranz, L.; Torrent, M.; et al. Maternal Vitamin D Status in Pregnancy and Risk of Lower Respiratory Tract Infections, Wheezing, and Asthma in Offspring. Epidemiology 2012, 23, 64–71. [Google Scholar] [CrossRef] [PubMed]
  170. Pike, K.C.; Inskip, H.M.; Robinson, S.; Lucas, J.S.; Cooper, C.; Harvey, N.C.; Godfrey, K.M.; Roberts, G.; the Southampton Women’s Survey Study Group. Maternal Late-Pregnancy Serum 25-Hydroxyvitamin D in Relation to Childhood Wheeze and Atopic Outcomes. Thorax 2012, 67, 950–956. [Google Scholar] [CrossRef] [PubMed]
  171. Rothers, J.; Wright, A.L.; Stern, D.A.; Halonen, M.; Camargo, C.A. Cord Blood 25-Hydroxyvitamin D Levels Are Associated with Aeroallergen Sensitization in Children from Tucson, Arizona. J. Allergy Clin. Immunol. 2011, 128, 1093–1099.e5. [Google Scholar] [CrossRef]
  172. Stone, C.A.; Cook-Mills, J.; Gebretsadik, T.; Rosas-Salazar, C.; Turi, K.; Brunwasser, S.M.; Connolly, A.; Russell, P.; Liu, Z.; Costello, K.; et al. Delineation of the Individual Effects of Vitamin E Isoforms on Early Life Incident Wheezing. J. Pediatr. 2019, 206, 156–163.e3. [Google Scholar] [CrossRef]
  173. Devereux, G.; Turner, S.W.; Craig, L.C.A.; McNeill, G.; Martindale, S.; Harbour, P.J.; Helms, P.J.; Seaton, A. Low Maternal Vitamin E Intake during Pregnancy Is Associated with Asthma in 5-Year-Old Children. Am. J. Respir. Crit. Care Med. 2006, 174, 499–507. [Google Scholar] [CrossRef]
  174. Devereux, G. Early Life Events in Asthma—Diet. Pediatr. Pulmonol. 2007, 42, 663–673. [Google Scholar] [CrossRef]
  175. Litonjua, A.A.; Rifas-Shiman, S.L.; Ly, N.P.; Tantisira, K.G.; Rich-Edwards, J.W.; Camargo, C.A.; Weiss, S.T.; Gillman, M.W.; Gold, D.R. Maternal Antioxidant Intake in Pregnancy and Wheezing Illnesses in Children at 2 y of Age. Am. J. Clin. Nutr. 2006, 84, 903–911. [Google Scholar] [CrossRef] [PubMed]
  176. Martindale, S.; McNeill, G.; Devereux, G.; Campbell, D.; Russell, G.; Seaton, A. Antioxidant Intake in Pregnancy in Relation to Wheeze and Eczema in the First Two Years of Life. Am. J. Respir. Crit. Care Med. 2005, 171, 121–128. [Google Scholar] [CrossRef] [PubMed]
  177. Greenough, A.; Shaheen, S.O.; Shennan, A.; Seed, P.T.; Poston, L. Respiratory Outcomes in Early Childhood Following Antenatal Vitamin C and E Supplementation. Thorax 2010, 65, 998–1003. [Google Scholar] [CrossRef] [PubMed]
  178. Abdala-Valencia, H.; Soveg, F.; Cook-Mills, J.M. γ-Tocopherol Supplementation of Allergic Female Mice Augments Development of CD11c + CD11b + Dendritic Cells in Utero and Allergic Inflammation in Neonates. Am. J. Physiol.-Lung Cell. Mol. Physiol. 2016, 310, L759–L771. [Google Scholar] [CrossRef] [PubMed]
  179. Abdala-Valencia, H.; Berdnikovs, S.; Soveg, F.W.; Cook-Mills, J.M. α-Tocopherol Supplementation of Allergic Female Mice Inhibits Development of CD11c+CD11b+ Dendritic Cells in Utero and Allergic Inflammation in Neonates. Am. J. Physiol. Lung Cell. Mol. Physiol. 2014, 307, L482–L496. [Google Scholar] [CrossRef]
  180. Gao, Y.; Nanan, R.; Macia, L.; Tan, J.; Sominsky, L.; Quinn, T.P.; O’Hely, M.; Ponsonby, A.-L.; Tang, M.L.K.; Collier, F.; et al. The Maternal Gut Microbiome during Pregnancy and Offspring Allergy and Asthma. J. Allergy Clin. Immunol. 2021, 148, 669–678. [Google Scholar] [CrossRef]
  181. Gray, L.E.K.; O’Hely, M.; Ranganathan, S.; Sly, P.D.; Vuillermin, P. The Maternal Diet, Gut Bacteria, and Bacterial Metabolites during Pregnancy Influence Offspring Asthma. Front. Immunol. 2017, 8, 365. [Google Scholar] [CrossRef]
  182. Alsharairi, N.A. The Infant Gut Microbiota and Risk of Asthma: The Effect of Maternal Nutrition during Pregnancy and Lactation. Microorganisms 2020, 8, 1119. [Google Scholar] [CrossRef]
  183. Arrieta, M.-C.; Stiemsma, L.T.; Dimitriu, P.A.; Thorson, L.; Russell, S.; Yurist-Doutsch, S.; Kuzeljevic, B.; Gold, M.J.; Britton, H.M.; Lefebvre, D.L.; et al. Early Infancy Microbial and Metabolic Alterations Affect Risk of Childhood Asthma. Sci. Transl. Med. 2015, 7, 307ra152. [Google Scholar] [CrossRef]
  184. Padilha, M.; Danneskiold-Samsøe, N.B.; Brejnrod, A.; Hoffmann, C.; Cabral, V.P.; Iaucci, J.D.M.; Sales, C.H.; Fisberg, R.M.; Cortez, R.V.; Brix, S.; et al. The Human Milk Microbiota Is Modulated by Maternal Diet. Microorganisms 2019, 7, 502. [Google Scholar] [CrossRef]
  185. Borak, J.; Lefkowitz, R.Y. Bronchial Hyperresponsiveness. Occup. Med. 2016, 66, 95–105. [Google Scholar] [CrossRef] [PubMed]
  186. Sears, M.R. Lung Function Decline in Asthma. Eur. Respir. J. 2007, 30, 411–413. [Google Scholar] [CrossRef]
  187. Manni, M.L.; Trudeau, J.B.; Scheller, E.V.; Mandalapu, S.; Elloso, M.M.; Kolls, J.K.; Wenzel, S.E.; Alcorn, J.F. The Complex Relationship between Inflammation and Lung Function in Severe Asthma. Mucosal Immunol. 2014, 7, 1186–1198. [Google Scholar] [CrossRef] [PubMed]
  188. Berend, N.; Salome, C.M.; King, G.G. Mechanisms of Airway Hyperresponsiveness in Asthma. Respirology 2008, 13, 624–631. [Google Scholar] [CrossRef] [PubMed]
  189. James, A.L.; Palmer, L.J.; Kicic, E.; Maxwell, P.S.; Lagan, S.E.; Ryan, G.F.; Musk, A.W. Decline in Lung Function in the Busselton Health Study: The Effects of Asthma and Cigarette Smoking. Am. J. Respir. Crit. Care Med. 2005, 171, 109–114. [Google Scholar] [CrossRef]
  190. Dijkstra, A. Lung Function Decline in Asthma: Association with Inhaled Corticosteroids, Smoking and Sex. Thorax 2006, 61, 105–110. [Google Scholar] [CrossRef]
  191. Psarras, S.; Caramori, G.; Contoli, M.; Papadopoulos, N.; Papi, A. Oxidants in Asthma and in Chronic Obstructive Pulmonary Disease (COPD). Curr. Pharm. Des. 2005, 11, 2053–2062. [Google Scholar] [CrossRef]
  192. King, M.R.; Ismail, A.S.; Davis, L.S.; Karp, D.R. Oxidative Stress Promotes Polarization of Human T Cell Differentiation toward a T Helper 2 Phenotype. J. Immunol. 2006, 176, 2765–2772. [Google Scholar] [CrossRef]
  193. Park, C.-S.; Kim, T.-B.; Lee, K.-Y.; Moon, K.-A.; Bae, Y.-J.; Jang, M.K.; Cho, Y.S.; Moon, H.-B. Increased Oxidative Stress in the Airway and Development of Allergic Inflammation in a Mouse Model of Asthma. Ann. Allergy Asthma Immunol. Off. Publ. Am. Coll. Allergy Asthma Immunol. 2009, 103, 238–247. [Google Scholar] [CrossRef]
  194. Riedl, M.A.; Nel, A.E. Importance of Oxidative Stress in the Pathogenesis and Treatment of Asthma. Curr. Opin. Allergy Clin. Immunol. 2008, 8, 49–56. [Google Scholar] [CrossRef]
  195. Peters, M.C.; Nguyen, M.-L.T.; Dunican, E.M. Biomarkers of Airway Type-2 Inflammation and Integrating Complex Phenotypes to Endotypes in Asthma. Curr. Allergy Asthma Rep. 2016, 16, 71. [Google Scholar] [CrossRef] [PubMed]
  196. Lambrecht, B.N.; Hammad, H.; Fahy, J.V. The Cytokines of Asthma. Immunity 2019, 50, 975–991. [Google Scholar] [CrossRef] [PubMed]
  197. Frey, A.; Lunding, L.P.; Ehlers, J.C.; Weckmann, M.; Zissler, U.M.; Wegmann, M. More Than Just a Barrier: The Immune Functions of the Airway Epithelium in Asthma Pathogenesis. Front. Immunol. 2020, 11, 761. [Google Scholar] [CrossRef] [PubMed]
  198. Morcillo, E.J.; Cortijo, J. Mucus and MUC in Asthma. Curr. Opin. Pulm. Med. 2006, 12, 1–6. [Google Scholar] [CrossRef]
  199. Shen, Y.; Huang, S.; Kang, J.; Lin, J.; Lai, K.; Sun, Y.; Xiao, W.; Yang, L.; Yao, W.; Cai, S.; et al. Management of Airway Mucus Hypersecretion in Chronic Airway Inflammatory Disease: Chinese Expert Consensus (English Edition). Int. J. Chron. Obstruct. Pulmon. Dis. 2018, 13, 399–407. [Google Scholar] [CrossRef]
  200. Camoretti-Mercado, B.; Lockey, R.F. Airway Smooth Muscle Pathophysiology in Asthma. J. Allergy Clin. Immunol. 2021, 147, 1983–1995. [Google Scholar] [CrossRef]
  201. Fang, L.; Sun, Q.; Roth, M. Immunologic and Non-Immunologic Mechanisms Leading to Airway Remodeling in Asthma. Int. J. Mol. Sci. 2020, 21, 757. [Google Scholar] [CrossRef]
  202. Sferrazza Papa, G.F.; Pellegrino, G.M.; Pellegrino, R. Asthma and Respiratory Physiology: Putting Lung Function into Perspective. Respirol. Carlton Vic 2014, 19, 960–969. [Google Scholar] [CrossRef]
  203. Boulet, L.-P. Airway Remodeling in Asthma: Update on Mechanisms and Therapeutic Approaches. Curr. Opin. Pulm. Med. 2018, 24, 56–62. [Google Scholar] [CrossRef]
  204. Luo, Z.-X.; Liu, E.-M.; Luo, J.; Li, F.-R.; Li, S.-B.; Zeng, F.-Q.; Qu, P.; Fu, Z.; Li, T.-Y. Vitamin A Deficiency and Wheezing. World J. Pediatr. 2010, 6, 81–84. [Google Scholar] [CrossRef]
  205. Al Senaidy, A.M. Serum Vitamin A and β-Carotene Levels in Children with Asthma. J. Asthma 2009, 46, 699–702. [Google Scholar] [CrossRef] [PubMed]
  206. Andino, D.; Moy, J.; Gaynes, B.I. Serum Vitamin A, Zinc and Visual Function in Children with Moderate to Severe Persistent Asthma. J. Asthma 2019, 56, 1198–1203. [Google Scholar] [CrossRef] [PubMed]
  207. Arora, P.; Kumar, V.; Batra, S. Vitamin A Status in Children with Asthma: Vitamin A Status in Asthmatic Children. Pediatr. Allergy Immunol. 2002, 13, 223–226. [Google Scholar] [CrossRef] [PubMed]
  208. Bai, Y.-J.; Dai, R.-J. Serum Levels of Vitamin A and 25-Hydroxyvitamin D3 (25OHD3) as Reflectors of Pulmonary Function and Quality of Life (QOL) in Children with Stable Asthma: A Case–Control Study. Medicine 2018, 97, e9830. [Google Scholar] [CrossRef]
  209. Fabian, E.; Pölöskey, P.; Kósa, L.; Elmadfa, I.; Réthy, L.A. Nutritional Supplements and Plasma Antioxidants in Childhood Asthma. Wien. Klin. Wochenschr. 2013, 125, 309–315. [Google Scholar] [CrossRef]
  210. Riccioni, G.; Bucciarelli, T.; Mancini, B.; Ilio, C.D.; Vecchia, R.D.; D’Orazio, N. Plasma Lycopene and Antioxidant Vitamins in Asthma: The PLAVA Study. J. Asthma 2007, 44, 429–432. [Google Scholar] [CrossRef]
  211. Sackesen, C.; Ercan, H.; Dizdar, E.; Soyer, O.; Gumus, P.; Tosun, B.N.; Büyüktuncer, Z.; Karabulut, E.; Besler, T.; Kalayci, O. A Comprehensive Evaluation of the Enzymatic and Nonenzymatic Antioxidant Systems in Childhood Asthma. J. Allergy Clin. Immunol. 2008, 122, 78–85. [Google Scholar] [CrossRef]
  212. Kassaye, T.; Becklake, M.R.; Receveur, O.; Hanley, J.A.; Johns, T. Association between Vitamin A Status and Lung Function Level in Children Aged 6–9 Years in Wukro Wereda, Northern Ethiopia. Int. J. Epidemiol. 2001, 30, 457–464. [Google Scholar] [CrossRef]
  213. Marquez, H.A.; Cardoso, W.V. Vitamin A-Retinoid Signaling in Pulmonary Development and Disease. Mol. Cell. Pediatr. 2016, 3, 28. [Google Scholar] [CrossRef]
  214. Ochs-Balcom, H.M.; Grant, B.J.B.; Muti, P.; Sempos, C.T.; Freudenheim, J.L.; Browne, R.W.; McCann, S.E.; Trevisan, M.; Cassano, P.A.; Iacoviello, L.; et al. Antioxidants, Oxidative Stress, and Pulmonary Function in Individuals Diagnosed with Asthma or COPD. Eur. J. Clin. Nutr. 2006, 60, 991–999. [Google Scholar] [CrossRef]
  215. Rodrigues, L.C.; Mota, J.F.; Corgosinho, F.C.; Masquio, D.C.L.; Dâmaso, A.R.; Tufik, S.; de Mello, M.T.; Cheik, N.C.; da Silva Agostinho, P.L. Nutrient Intake Is a Predictor of Lung Function in Obese Asthmatic Adolescents Undergoing Interdisciplinary Therapy. Br. J. Nutr. 2019, 122, 974–985. [Google Scholar] [CrossRef] [PubMed]
  216. Talaei, M.; Hughes, D.A.; Mahmoud, O.; Emmett, P.M.; Granell, R.; Guerra, S.; Shaheen, S.O. Dietary Intake of Vitamin A, Lung Function and Incident Asthma in Childhood. Eur. Respir. J. 2021, 58, 2004407. [Google Scholar] [CrossRef] [PubMed]
  217. Tobias, T.A.M.; Wood, L.G.; Rastogi, D. Carotenoids, Fatty Acids and Disease Burden in Obese Minority Adolescents with Asthma. Clin. Exp. Allergy 2019, 49, 838–846. [Google Scholar] [CrossRef] [PubMed]
  218. Ferreira, C.A.; de Souza, F.I.S.; Melges, A.P.B.; Fonseca, F.A.; Solé, D.; Sarni, R.O.S. Retinol, Beta-Carotene, Oxidative Stress, and Metabolic Syndrome Components in Obese Asthmatic Children. Pediatr. Allergy Immunol. 2014, 25, 292–294. [Google Scholar] [CrossRef]
  219. Bantulà, M.; Roca-Ferrer, J.; Arismendi, E.; Picado, C. Asthma and Obesity: Two Diseases on the Rise and Bridged by Inflammation. J. Clin. Med. 2021, 10, 169. [Google Scholar] [CrossRef] [PubMed]
  220. Schock, B.C.; Young, I.S.; Brown, V.; Fitch, P.S.; Shields, M.D.; Ennis, M. Antioxidants and Oxidative Stress in BAL Fluid of Atopic Asthmatic Children. Pediatr. Res. 2003, 53, 375–381. [Google Scholar] [CrossRef]
  221. Laerum, B.N.; Wentzel-Larsen, T.; Gulsvik, A.; Omenaas, E.; Gíslason, T.; Janson, C.; Svanes, C. Relationship of Fish and Cod Oil Intake with Adult Asthma. Clin. Exp. Allergy 2007, 37, 1616–1623. [Google Scholar] [CrossRef]
  222. Rerksuppaphol, S.; Rerksuppaphol, L. Carotenoids Intake and Asthma Prevalence in Thai Children. Pediatr. Rep. 2012, 4, e12. [Google Scholar] [CrossRef]
  223. Wood, L.G.; Garg, M.L.; Blake, R.J.; Garcia-Caraballo, S.; Gibson, P.G. Airway and Circulating Levels of Carotenoids in Asthma and Healthy Controls. J. Am. Coll. Nutr. 2005, 24, 448–455. [Google Scholar] [CrossRef]
  224. Babu, T.A.; Sharmila, V. Vitamin A Supplementation in Late Pregnancy Can Decrease the Incidence of Bronchopulmonary Dysplasia in Newborns. J. Matern. Fetal Neonatal Med. 2010, 23, 1468–1469. [Google Scholar] [CrossRef]
  225. Chen, F.; Marquez, H.; Kim, Y.-K.; Qian, J.; Shao, F.; Fine, A.; Cruikshank, W.W.; Quadro, L.; Cardoso, W.V. Prenatal Retinoid Deficiency Leads to Airway Hyperresponsiveness in Adult Mice. J. Clin. Investig. 2014, 124, 801–811. [Google Scholar] [CrossRef] [PubMed]
  226. Spears, K.; Cheney, C.; Zerzan, J. Low Plasma Retinol Concentrations Increase the Risk of Developing Bronchopulmonary Dysplasia and Long-Term Respiratory Disability in Very-Low-Birth-Weight Infants. Am. J. Clin. Nutr. 2004, 80, 1589–1594. [Google Scholar] [CrossRef] [PubMed]
  227. McGowan, S.E.; Smith, J.; Holmes, A.J.; Smith, L.A.; Businga, T.R.; Madsen, M.T.; Kopp, U.C.; Kline, J.N. Vitamin A Deficiency Promotes Bronchial Hyperreactivity in Rats by Altering Muscarinic M 2 Receptor Function. Am. J. Physiol.-Lung Cell. Mol. Physiol. 2002, 282, L1031–L1039. [Google Scholar] [CrossRef] [PubMed]
  228. Chen, F.; Shao, F.; Hinds, A.; Yao, S.; Ram-Mohan, S.; Norman, T.A.; Krishnan, R.; Fine, A. Retinoic Acid Signaling Is Essential for Airway Smooth Muscle Homeostasis. JCI Insight 2018, 3, e120398. [Google Scholar] [CrossRef]
  229. Cui, W.; Zhang, P.; Gu, J.; Tian, Y.; Gao, X.; Liu, Y.; Jin, Z.; Yan, D.; Zhu, X.; Li, D. Vitamin A Deficiency Promotes Inflammation by Induction of Type 2 Cytokines in Experimental Ovalbumin-Induced Asthma Murine Model. Inflammation 2016, 39, 1798–1804. [Google Scholar] [CrossRef]
  230. Fujii, U.; Miyahara, N.; Taniguchi, A.; Oda, N.; Morichika, D.; Murakami, E.; Nakayama, H.; Waseda, K.; Kataoka, M.; Kakuta, H.; et al. Effect of a Retinoid X Receptor Partial Agonist on Airway Inflammation and Hyperresponsiveness in a Murine Model of Asthma. Respir. Res. 2017, 18, 23. [Google Scholar] [CrossRef]
  231. Denburg, J.A.; Sehmi, R.; Upham, J. Regulation of IL-5 Receptor on Eosinophil Progenitors in Allergic Inflammation: Role of Retinoic Acid. Int. Arch. Allergy Immunol. 2001, 124, 246–248. [Google Scholar] [CrossRef]
  232. Spiegl, N.; Didichenko, S.; McCaffery, P.; Langen, H.; Dahinden, C.A. Human Basophils Activated by Mast Cell–Derived IL-3 Express Retinaldehyde Dehydrogenase-II and Produce the Immunoregulatory Mediator Retinoic Acid. Blood 2008, 112, 3762–3771. [Google Scholar] [CrossRef]
  233. Kanagaratham, C.; Kalivodová, A.; Najdekr, L.; Friedecký, D.; Adam, T.; Hajduch, M.; De Sanctis, J.B.; Radzioch, D. Fenretinide Prevents Inflammation and Airway Hyperresponsiveness in a Mouse Model of Allergic Asthma. Am. J. Respir. Cell Mol. Biol. 2014, 51, 783–792. [Google Scholar] [CrossRef]
  234. Sakamoto, H.; Koya, T.; Tsukioka, K.; Shima, K.; Watanabe, S.; Kagamu, H.; Kimura, Y.; Sakagami, T.; Hasegawa, T.; Suzuki, E.; et al. The Effects of All-Trans Retinoic Acid on the Induction of Oral Tolerance in a Murine Model of Bronchial Asthma. Int. Arch. Allergy Immunol. 2015, 167, 167–176. [Google Scholar] [CrossRef]
  235. Schuster, G.U.; Kenyon, N.J.; Stephensen, C.B. Vitamin A Deficiency Decreases and High Dietary Vitamin A Increases Disease Severity in the Mouse Model of Asthma. J. Immunol. 2008, 180, 1834–1842. [Google Scholar] [CrossRef] [PubMed]
  236. Schünemann, H.J.; Grant, B.J.B.; Freudenheim, J.L.; Muti, P.; Browne, R.W.; Drake, J.A.; Klocke, R.A.; Trevisan, M. The Relation of Serum Levels of Antioxidant Vitamins C and E, Retinol and Carotenoids with Pulmonary Function in the General Population. Am. J. Respir. Crit. Care Med. 2001, 163, 1246–1255. [Google Scholar] [CrossRef] [PubMed]
  237. Bishopp, A.; Sathyamurthy, R.; Manney, S.; Webbster, C.; Krishna, M.T.; Mansur, A.H. Biomarkers of Oxidative Stress and Antioxidants in Severe Asthma. Ann. Allergy. Asthma Immunol. 2017, 118, 445–451. [Google Scholar] [CrossRef] [PubMed]
  238. de Bittencourt Pasquali, M.A.; Schnorr, C.E.; Feistauer, L.B.H.; Gelain, D.P.; Moreira, J.C.F. Vitamin A Supplementation to Pregnant and Breastfeeding Female Rats Induces Oxidative Stress in the Neonatal Lung. Reprod. Toxicol. 2010, 30, 452–456. [Google Scholar] [CrossRef] [PubMed]
  239. Sommer, A.; Vyas, K.S. A Global Clinical View on Vitamin A and Carotenoids. Am. J. Clin. Nutr. 2012, 96, 1204S–1206S. [Google Scholar] [CrossRef]
  240. Neuman, I.; Nahum, H.; Ben-Amotz, A. Reduction of Exercise-Induced Asthma Oxidative Stress by Lycopene, a Natural Antioxidant. Allergy 2000, 55, 1184–1189. [Google Scholar] [CrossRef]
  241. Wood, L.G.; Gibson, P.G. Reduced Circulating Antioxidant Defences Are Associated with Airway Hyper-Responsiveness, Poor Control and Severe Disease Pattern in Asthma. Br. J. Nutr. 2010, 103, 735–741. [Google Scholar] [CrossRef]
  242. Heine, G.; Hollstein, T.; Treptow, S.; Radbruch, A.; Worm, M. 9-Cis Retinoic Acid Modulates the Type I Allergic Immune Response. J. Allergy Clin. Immunol. 2018, 141, 650–658.e5. [Google Scholar] [CrossRef]
  243. Son, H.-L.; Park, H.-R.; Park, Y.-J.; Kim, S.-W. Effect of Retinoic Acid in a Mouse Model of Allergic Rhinitis. Allergy Asthma Immunol. Res. 2015, 7, 590. [Google Scholar] [CrossRef]
  244. Wu, J.; Zhang, Y.; Liu, Q.; Zhong, W.; Xia, Z. All-Trans Retinoic Acid Attenuates Airway Inflammation by Inhibiting Th2 and Th17 Response in Experimental Allergic Asthma. BMC Immunol. 2013, 14, 28. [Google Scholar] [CrossRef]
  245. Maruya, M.; Suzuki, K.; Fujimoto, H.; Miyajima, M.; Kanagawa, O.; Wakayama, T.; Fagarasan, S. Vitamin A-Dependent Transcriptional Activation of the Nuclear Factor of Activated T Cells C1 (NFATc1) Is Critical for the Development and Survival of B1 Cells. Proc. Natl. Acad. Sci. USA 2011, 108, 722–727. [Google Scholar] [CrossRef] [PubMed]
  246. Tian, Y.; Tian, Q.; Wu, Y.; Peng, X.; Chen, Y.; Li, Q.; Zhang, G.; Tian, X.; Ren, L.; Luo, Z. Vitamin A Supplement after Neonatal Streptococcus Pneumoniae Pneumonia Inhibits the Progression of Experimental Asthma by Altering CD4+T Cell Subsets. Sci. Rep. 2020, 10, 4214. [Google Scholar] [CrossRef] [PubMed]
  247. Takamura, K.; Nasuhara, Y.; Kobayashi, M.; Betsuyaku, T.; Tanino, Y.; Kinoshita, I.; Yamaguchi, E.; Matsukura, S.; Schleimer, R.P.; Nishimura, M. Retinoic Acid Inhibits Interleukin-4-Induced Eotaxin Production in a Human Bronchial Epithelial Cell Line. Am. J. Physiol.-Lung Cell. Mol. Physiol. 2004, 286, L777–L785. [Google Scholar] [CrossRef]
  248. Fang, H.; Jin, H.; Wang, H. Effect of All-Trans Retinoic Acid on Airway Inflammation in Asthmatic Rats and Its Mechanism. J. Huazhong Univ. Sci. Technol. Med. Sci. 2004, 24, 229–232. [Google Scholar] [CrossRef]
  249. Goswami, S.; Angkasekwinai, P.; Shan, M.; Greenlee, K.J.; Barranco, W.T.; Polikepahad, S.; Seryshev, A.; Song, L.; Redding, D.; Singh, B.; et al. Divergent Functions for Airway Epithelial Matrix Metalloproteinase 7 and Retinoic Acid in Experimental Asthma. Nat. Immunol. 2009, 10, 496–503. [Google Scholar] [CrossRef] [PubMed]
  250. Niu, C.; Liu, N.; Liu, J.; Zhang, M.; Ying, L.; Wang, L.; Tian, D.; Dai, J.; Luo, Z.; Liu, E.; et al. Vitamin A Maintains the Airway Epithelium in a Murine Model of Asthma by Suppressing Glucocorticoid-Induced Leucine Zipper. Clin. Exp. Allergy 2016, 46, 848–860. [Google Scholar] [CrossRef]
  251. Hazlewood, L.C.; Wood, L.G.; Hansbro, P.M.; Foster, P.S. Dietary Lycopene Supplementation Suppresses Th2 Responses and Lung Eosinophilia in a Mouse Model of Allergic Asthma. J. Nutr. Biochem. 2011, 22, 95–100. [Google Scholar] [CrossRef]
  252. Lee, C.-M.; Chang, J.-H.; Moon, D.-O.; Choi, Y.H.; Choi, I.-W.; Park, Y.-M.; Kim, G.-Y. Lycopene Suppresses Ovalbumin-Induced Airway Inflammation in a Murine Model of Asthma. Biochem. Biophys. Res. Commun. 2008, 374, 248–252. [Google Scholar] [CrossRef]
  253. Aggarwal, S.; Kim, S.-W.; Cheon, K.; Tabassam, F.H.; Yoon, J.-H.; Koo, J.S. Nonclassical Action of Retinoic Acid on the Activation of the CAMP Response Element-Binding Protein in Normal Human Bronchial Epithelial Cells. Mol. Biol. Cell 2006, 17, 566–575. [Google Scholar] [CrossRef]
  254. Defnet, A.E.; Shah, S.D.; Huang, W.; Shapiro, P.; Deshpande, D.A.; Kane, M.A. Dysregulated Retinoic Acid Signaling in Airway Smooth Muscle Cells in Asthma. FASEB J. 2021, 35, e22016. [Google Scholar] [CrossRef]
  255. Day, R.M.; Lee, Y.H.; Park, A.-M.; Suzuki, Y.J. Retinoic Acid Inhibits Airway Smooth Muscle Cell Migration. Am. J. Respir. Cell Mol. Biol. 2006, 34, 695–703. [Google Scholar] [CrossRef] [PubMed]
  256. Husemoen, L.L.N.; Toft, U.; Fenger, M.; Jørgensen, T.; Johansen, N.; Linneberg, A. The Association between Atopy and Factors Influencing Folate Metabolism: Is Low Folate Status Causally Related to the Development of Atopy? Int. J. Epidemiol. 2006, 35, 954–961. [Google Scholar] [CrossRef] [PubMed]
  257. Heinrich, J.; Hölscher, B.; Bolte, G.; Winkler, G. Allergic Sensitization and Diet: Ecological Analysis in Selected European Cities. Eur. Respir. J. 2001, 17, 395–402. [Google Scholar] [CrossRef] [PubMed]
  258. Comhair, S.A.A.; McDunn, J.; Bennett, C.; Fettig, J.; Erzurum, S.C.; Kalhan, S.C. Metabolomic Endotype of Asthma. J. Immunol. 2015, 195, 643–650. [Google Scholar] [CrossRef]
  259. Liu, Y.; Zhang, X.; Zhang, L.; Oliver, B.G.; Wang, H.G.; Liu, Z.P.; Chen, Z.H.; Wood, L.; Hsu, A.C.-Y.; Xie, M.; et al. Sputum Metabolomic Profiling Reveals Metabolic Pathways and Signatures Associated With Inflammatory Phenotypes in Patients With Asthma. Allergy Asthma Immunol. Res. 2022, 14, 393–411. [Google Scholar] [CrossRef]
  260. Delport, R.; Ubbink, J.B.; Serfontein, W.J.; Becker, P.J.; Walters, L. Vitamin B6 Nutritional Status in Asthma: The Effect of Theophylline Therapy on Plasma Pyridoxal-5′-Phosphate and Pyridoxal Levels. Int. J. Vitam. Nutr. Res. Int. Z. Vitam.-Ernahrungsforschung J. Int. Vitaminol. Nutr. 1988, 58, 67–72. [Google Scholar]
  261. Shimizu, T.; Maeda, S.; Mochizuki, H.; Tokuyama, K.; Morikawa, A. Theophylline Attenuates Circulating Vitamin B6 Levels in Children with Asthma. Pharmacology 1994, 49, 392–397. [Google Scholar] [CrossRef]
  262. Nicholson, A.; Pollard, S.L.; Lima, J.J.; Romero, K.M.; Tarazona-Meza, C.; Malpartida-Guzmán, G.; Mougey, E.; Hansel, N.N.; Checkley, W. Serum Folate Concentrations, Asthma, Atopy, and Asthma Control in Peruvian Children. Respir. Med. 2017, 133, 29–35. [Google Scholar] [CrossRef]
  263. Papamichael, M.M.; Katsardis, C.; Tsoukalas, D.; Lambert, K.; Erbas, B.; Itsiopoulos, C. Potential Role of Folate Status on Pulmonary Function in Pediatric Asthma. Nutrition 2021, 90, 111267. [Google Scholar] [CrossRef]
  264. Farres, M.N.; Shahin, R.Y.; Melek, N.A.; El-Kabarity, R.H.; Arafa, N.A. Study of Folate Status Among Egyptian Asthmatics. Intern. Med. 2011, 50, 205–211. [Google Scholar] [CrossRef]
  265. Thuesen, B.H.; Husemoen, L.L.N.; Ovesen, L.; Jørgensen, T.; Fenger, M.; Gilderson, G.; Linneberg, A. Atopy, Asthma, and Lung Function in Relation to Folate and Vitamin B12 in Adults: Atopy and Asthma in Relation to Folate and B12. Allergy 2010, 65, 1446–1454. [Google Scholar] [CrossRef] [PubMed]
  266. Blatter, J.; Brehm, J.M.; Sordillo, J.; Forno, E.; Boutaoui, N.; Acosta-Pérez, E.; Alvarez, M.; Colón-Semidey, A.; Weiss, S.T.; Litonjua, A.A.; et al. Folate Deficiency, Atopy, and Severe Asthma Exacerbations in Puerto Rican Children. Ann. Am. Thorac. Soc. 2016, 13, 223–230. [Google Scholar] [CrossRef] [PubMed]
  267. Skaaby, T.; Taylor, A.E.; Jacobsen, R.K.; Møllehave, L.T.; Friedrich, N.; Thuesen, B.H.; Shabanzadeh, D.M.; Paternoster, L.; Völker, U.; Nauck, M.; et al. Associations of Genetic Determinants of Serum Vitamin B12 and Folate Concentrations with Hay Fever and Asthma: A Mendelian Randomization Meta-Analysis. Eur. J. Clin. Nutr. 2018, 72, 264–271. [Google Scholar] [CrossRef]
  268. Han, Y.-Y.; Forno, E.; Rosser, F.; Celedón, J.C. Serum Folate Metabolites, Asthma, and Lung Function in a Nationwide US Study. J. Allergy Clin. Immunol. 2020, 146, 220–222.e8. [Google Scholar] [CrossRef] [PubMed]
  269. Lin, J.H.; Matsui, W.; Aloe, C.; Peng, R.D.; Diette, G.B.; Breysse, P.N.; Matsui, E.C. Relationships between Folate and Inflammatory Features of Asthma. J. Allergy Clin. Immunol. 2013, 131, 918–920.e6. [Google Scholar] [CrossRef] [PubMed]
  270. Bekier, E.; Szyc, H.; Czerwińska, U.; Maśliński, C. The Influence of Nicotinamide on the Course of Experimental Bronchial Asthma in Guinea Pig. Agents Actions 1973, 3, 176. [Google Scholar] [CrossRef]
  271. Wu, C.-H.; Huang, T.-C.; Lin, B.-F. Folate Deficiency Affects Dendritic Cell Function and Subsequent T Helper Cell Differentiation. J. Nutr. Biochem. 2017, 41, 65–72. [Google Scholar] [CrossRef]
  272. Okupa, A.Y.; Lemanske, R.F.; Jackson, D.J.; Evans, M.D.; Wood, R.A.; Matsui, E.C. Early-Life Folate Levels Are Associated with Incident Allergic Sensitization. J. Allergy Clin. Immunol. 2013, 131, 226–228.e2. [Google Scholar] [CrossRef]
  273. İscan, B.; Tuzun, F.; Eroglu Filibeli, B.; Cilekar Micili, S.; Ergur, B.U.; Duman, N.; Ozkan, H.; Kumral, A. Effects of Maternal Folic Acid Supplementation on Airway Remodeling and Allergic Airway Disease Development. J. Matern. Fetal Neonatal Med. 2019, 32, 2970–2978. [Google Scholar] [CrossRef]
  274. Hollingsworth, J.W.; Maruoka, S.; Boon, K.; Garantziotis, S.; Li, Z.; Tomfohr, J.; Bailey, N.; Potts, E.N.; Whitehead, G.; Brass, D.M.; et al. In Utero Supplementation with Methyl Donors Enhances Allergic Airway Disease in Mice. J. Clin. Investig. 2008, 118, 3462–3469. [Google Scholar] [CrossRef]
  275. Siripornpanich, S.; Chongviriyaphan, N.; Manuyakorn, W.; Matangkasombut, P. Zinc and Vitamin C Deficiencies Associate with Poor Pulmonary Function in Children with Persistent Asthma. Asian Pac. J. Allergy Immunol. 2022, 40, 103–110. [Google Scholar] [CrossRef] [PubMed]
  276. Harik-Khan, R.I. Serum Vitamin Levels and the Risk of Asthma in Children. Am. J. Epidemiol. 2004, 159, 351–357. [Google Scholar] [CrossRef] [PubMed]
  277. Mudway, I.S.; Stenfors, N.; Blomberg, A.; Helleday, R.; Dunster, C.; Marklund, S.L.; Frew, A.J.; Sandström, T.; Kelly, F.J. Differences in Basal Airway Antioxidant Concentrations Are Not Predictive of Individual Responsiveness to Ozone: A Comparison of Healthy and Mild Asthmatic Subjects. Free Radic. Biol. Med. 2001, 31, 962–974. [Google Scholar] [CrossRef] [PubMed]
  278. Allan, K.; Devereux, G. Diet and Asthma: Nutrition Implications from Prevention to Treatment. J. Am. Diet. Assoc. 2011, 111, 258–268. [Google Scholar] [CrossRef]
  279. Picado, C.; Deulofeu, R.; Lleonart, R.; Agusti, M.; Mullol, J.; Torra, M.; Quinto, L. Dietary Micronutrients/Antioxidants and Their Relationship with Bronchial Asthma Severity. Allergy 2001, 56, 43–49. [Google Scholar] [CrossRef]
  280. Fogarty, A.; Lewis, S.A.; Scrivener, S.L.; Antoniak, M.; Pacey, S.; Pringle, M.; Britton, J. Corticosteroid Sparing Effects of Vitamin C and Magnesium in Asthma: A Randomised Trial. Respir. Med. 2006, 100, 174–179. [Google Scholar] [CrossRef]
  281. Fogarty, A.; Lewis, S.A.; Scrivener, S.L.; Antoniak, M.; Pacey, S.; Pringle, M.; Britton, J. Oral Magnesium and Vitamin C Supplements in Asthma: A Parallel Group Randomized Placebo-Controlled Trial: Oral Magnesium and Vitamin C Supplements in Asthma. Clin. Exp. Allergy 2003, 33, 1355–1359. [Google Scholar] [CrossRef]
  282. Tecklenburg, S.L.; Mickleborough, T.D.; Fly, A.D.; Bai, Y.; Stager, J.M. Ascorbic Acid Supplementation Attenuates Exercise-Induced Bronchoconstriction in Patients with Asthma. Respir. Med. 2007, 101, 1770–1778. [Google Scholar] [CrossRef]
  283. Jeong, Y.-J.; Kim, J.-H.; Kang, J.S.; Lee, W.J.; Hwang, Y. Mega-Dose Vitamin C Attenuated Lung Inflammation in Mouse Asthma Model. Anat. Cell Biol. 2010, 43, 294. [Google Scholar] [CrossRef]
  284. Nadi, E.; Tavakoli, F.; Zeraati, F.; Goodarzi, M.T.; Hashemi, S.H. Effect of Vitamin C Administration on Leukocyte Vitamin C Level and Severity of Bronchial Asthma. Acta Med. Iran. 2012, 50, 233–238. [Google Scholar]
  285. Hemilä, H. Vitamin C May Alleviate Exercise-Induced Bronchoconstriction: A Meta-Analysis. BMJ Open 2013, 3, e002416. [Google Scholar] [CrossRef] [PubMed]
  286. Hemilä, H. Vitamin C Should Be Tested against Exercise-Induced Bronchoconstriction. Am. J. Respir. Crit. Care Med. 2013, 188, 1370. [Google Scholar] [CrossRef] [PubMed]
  287. Davison, G.W.; Ashton, T.; Davies, B.; Bailey, D.M. In Vitro Electron Paramagnetic Resonance Characterization of Free Radicals: Relevance to Exercise-Induced Lipid Peroxidation and Implications of Ascorbate Prophylaxis. Free Radic. Res. 2008, 42, 379–386. [Google Scholar] [CrossRef] [PubMed]
  288. Block, G.; Jensen, C.D.; Dalvi, T.B.; Norkus, E.P.; Hudes, M.; Crawford, P.B.; Holland, N.; Fung, E.B.; Schumacher, L.; Harmatz, P. Vitamin C Treatment Reduces Elevated C-Reactive Protein. Free Radic. Biol. Med. 2009, 46, 70–77. [Google Scholar] [CrossRef]
  289. Hemilä, H.; Louhiala, P. Vitamin C for Preventing and Treating Pneumonia. Cochrane Database Syst. Rev. 2013, 2013, CD005532. [Google Scholar] [CrossRef]
  290. Noh, K.; Lim, H.; Moon, S.; Kang, J.S.; Lee, W.J.; Lee, D.; Hwang, Y. Mega-Dose Vitamin C Modulates T Cell Functions in Balb/c Mice Only When Administered during T Cell Activation. Immunol. Lett. 2005, 98, 63–72. [Google Scholar] [CrossRef]
  291. Kianian, F.; Karimian, S.M.; Kadkhodaee, M.; Takzaree, N.; Seifi, B.; Sadeghipour, H.R. Protective Effects of Ascorbic Acid and Calcitriol Combination on Airway Remodelling in Ovalbumin-Induced Chronic Asthma. Pharm. Biol. 2020, 58, 107–115. [Google Scholar] [CrossRef]
  292. Ali, A.M.; Selim, S.; Abbassi, M.M.; Sabry, N.A. Effect of Alfacalcidol on the Pulmonary Function of Adult Asthmatic Patients: A Randomized Trial. Ann. Allergy. Asthma Immunol. 2017, 118, 557–563. [Google Scholar] [CrossRef]
  293. Boonpiyathad, T.; Chantveerawong, T.; Pradubpongsa, P.; Sangasapaviliya, A. Serum Vitamin D Levels and Vitamin D Supplement in Adult Patients with Asthma Exacerbation. J. Allergy 2016, 2016, 4070635. [Google Scholar] [CrossRef]
  294. Li, F.; Peng, M.; Jiang, L.; Sun, Q.; Zhang, K.; Lian, F.; Litonjua, A.A.; Gao, J.; Gao, X. Vitamin D Deficiency Is Associated with Decreased Lung Function in Chinese Adults with Asthma. Respiration 2011, 81, 469–475. [Google Scholar] [CrossRef]
  295. Tolppanen, A.-M.; Williams, D.; Henderson, J.; Lawlor, D.A. Serum 25-Hydroxy-Vitamin D and Ionised Calcium in Relation to Lung Function and Allergen Skin Tests. Eur. J. Clin. Nutr. 2011, 65, 493–500. [Google Scholar] [CrossRef] [PubMed]
  296. Bener, A.; Ehlayel, M.; Bener, H.; Hamid, Q. The Impact of Vitamin D Deficiency on Asthma, Allergic Rhinitis and Wheezing in Children: An Emerging Public Health Problem. J. Fam. Community Med. 2014, 21, 154–161. [Google Scholar] [CrossRef] [PubMed]
  297. Bose, S.; Breysse, P.N.; McCormack, M.C.; Hansel, N.N.; Rusher, R.R.; Matsui, E.; Peng, R.; Curtin-Brosnan, J.; Diette, G.B.; for the Center for Childhood Asthma in the Urban Environment. Outdoor Exposure and Vitamin D Levels in Urban Children with Asthma. Nutr. J. 2013, 12, 81. [Google Scholar] [CrossRef]
  298. Brehm, J.M.; Acosta-Pérez, E.; Klei, L.; Roeder, K.; Barmada, M.; Boutaoui, N.; Forno, E.; Kelly, R.; Paul, K.; Sylvia, J.; et al. Vitamin D Insufficiency and Severe Asthma Exacerbations in Puerto Rican Children. Am. J. Respir. Crit. Care Med. 2012, 186, 140–146. [Google Scholar] [CrossRef] [PubMed]
  299. Han, Y.-Y.; Forno, E.; Celedón, J.C. Vitamin D Insufficiency and Asthma in a US Nationwide Study. J. Allergy Clin. Immunol. Pract. 2017, 5, 790–796.e1. [Google Scholar] [CrossRef] [PubMed]
  300. Hatami, G.; Ghasemi, K.; Motamed, N.; Firoozbakht, S.; Movahed, A.; Farrokhi, S. Relationship between Vitamin D and Childhood Asthma: A Case–Control Study. Iran J Pediatr 2014, 24, 710–714. [Google Scholar]
  301. Mirzakhani, H.; Al-Garawi, A.; Weiss, S.T.; Litonjua, A.A. Vitamin D and the Development of Allergic Disease: How Important Is It? Clin. Exp. Allergy 2015, 45, 114–125. [Google Scholar] [CrossRef]
  302. Samrah, S.; Khatib, I.; Omari, M.; Khassawneh, B.; Momany, S.; Daoud, A.; Malkawi, M.; Khader, Y. Vitamin D Deficiency and Level of Asthma Control in Women from North of Jordan: A Case–Control Study. J. Asthma 2014, 51, 832–838. [Google Scholar] [CrossRef]
  303. Wang, Q.; Ying, Q.; Zhu, W.; Chen, J. Vitamin D and Asthma Occurrence in Children: A Systematic Review and Meta-Analysis. J. Pediatr. Nurs. 2022, 62, e60–e68. [Google Scholar] [CrossRef]
  304. Gupta, A.; Sjoukes, A.; Richards, D.; Banya, W.; Hawrylowicz, C.; Bush, A.; Saglani, S. Relationship between Serum Vitamin D, Disease Severity, and Airway Remodeling in Children with Asthma. Am. J. Respir. Crit. Care Med. 2011, 184, 1342–1349. [Google Scholar] [CrossRef]
  305. Mann, E.H.; Chambers, E.S.; Pfeffer, P.E.; Hawrylowicz, C.M. Immunoregulatory Mechanisms of Vitamin D Relevant to Respiratory Health and Asthma: Immunoregulatory Mechanisms of Vitamin D in Asthma. Ann. N. Y. Acad. Sci. 2014, 1317, 57–69. [Google Scholar] [CrossRef] [PubMed]
  306. Brehm, J.M.; Schuemann, B.; Fuhlbrigge, A.L.; Hollis, B.W.; Strunk, R.C.; Zeiger, R.S.; Weiss, S.T.; Litonjua, A.A. Serum Vitamin D Levels and Severe Asthma Exacerbations in the Childhood Asthma Management Program Study. J. Allergy Clin. Immunol. 2010, 126, 52–58.e5. [Google Scholar] [CrossRef] [PubMed]
  307. Forno, E.; Lescher, R.; Strunk, R.; Weiss, S.; Fuhlbrigge, A.; Celedón, J.C. Decreased Response to Inhaled Steroids in Overweight and Obese Asthmatic Children. J. Allergy Clin. Immunol. 2011, 127, 741–749. [Google Scholar] [CrossRef] [PubMed]
  308. Searing, D.A.; Zhang, Y.; Murphy, J.R.; Hauk, P.J.; Goleva, E.; Leung, D.Y.M. Decreased Serum Vitamin D Levels in Children with Asthma Are Associated with Increased Corticosteroid Use. J. Allergy Clin. Immunol. 2010, 125, 995–1000. [Google Scholar] [CrossRef]
  309. Sutherland, E.R.; Goleva, E.; Jackson, L.P.; Stevens, A.D.; Leung, D.Y.M. Vitamin D Levels, Lung Function, and Steroid Response in Adult Asthma. Am. J. Respir. Crit. Care Med. 2010, 181, 699–704. [Google Scholar] [CrossRef]
  310. Wu, A.C.; Tantisira, K.; Li, L.; Fuhlbrigge, A.L.; Weiss, S.T.; Litonjua, A.; for the Childhood Asthma Management Program Research Group. Effect of Vitamin D and Inhaled Corticosteroid Treatment on Lung Function in Children. Am. J. Respir. Crit. Care Med. 2012, 186, 508–513. [Google Scholar] [CrossRef]
  311. Szentpetery, S.E.; Han, Y.-Y.; Brehm, J.M.; Acosta-Pérez, E.; Forno, E.; Boutaoui, N.; Canino, G.; Alcorn, J.F.; Celedón, J.C. Vitamin D Insufficiency, Plasma Cytokines, and Severe Asthma Exacerbations in School-Aged Children. J. Allergy Clin. Immunol. Pract. 2018, 6, 289–291.e2. [Google Scholar] [CrossRef]
  312. Turkeli, A.; Ayaz, O.; Uncu, A.; Ozhan, B.; Bas, V.N.; Tufan, A.K.; Yilmaz, O.; Yuksel, H. Effects of Vitamin D Levels on Asthma Control and Severity in Pre-School Children. Eur. Rev. Med. Pharmacol. Sci. 2016, 20, 26–36. [Google Scholar]
  313. Freishtat, R.J.; Iqbal, S.F.; Pillai, D.K.; Klein, C.J.; Ryan, L.M.; Benton, A.S.; Teach, S.J. High Prevalence of Vitamin D Deficiency among Inner-City African American Youth with Asthma in Washington, DC. J. Pediatr. 2010, 156, 948–952. [Google Scholar] [CrossRef]
  314. Gupta, A.; Bush, A.; Hawrylowicz, C.; Saglani, S. Vitamin D and Asthma in Children. Paediatr. Respir. Rev. 2012, 13, 236–243. [Google Scholar] [CrossRef]
  315. Majak, P.; Olszowiec-Chlebna, M.; Smejda, K.; Stelmach, I. Vitamin D Supplementation in Children May Prevent Asthma Exacerbation Triggered by Acute Respiratory Infection. J. Allergy Clin. Immunol. 2011, 127, 1294–1296. [Google Scholar] [CrossRef]
  316. Martineau, A.R.; Cates, C.J.; Urashima, M.; Jensen, M.; Griffiths, A.P.; Nurmatov, U.; Sheikh, A.; Griffiths, C.J. Vitamin D for the Management of Asthma. Cochrane Database Syst. Rev. 2016, 2019, CD011511. [Google Scholar] [CrossRef]
  317. Hibbs, A.M.; Ross, K.; Kerns, L.A.; Wagner, C.; Fuloria, M.; Groh-Wargo, S.; Zimmerman, T.; Minich, N.; Tatsuoka, C. Effect of Vitamin D Supplementation on Recurrent Wheezing in Black Infants Who Were Born Preterm: The D-Wheeze Randomized Clinical Trial. JAMA 2018, 319, 2086–2094. [Google Scholar] [CrossRef] [PubMed]
  318. Weiss, G.; Schaible, U.E. Macrophage Defense Mechanisms against Intracellular Bacteria. Immunol. Rev. 2015, 264, 182–203. [Google Scholar] [CrossRef]
  319. Devereux, G.; Wilson, A.; Avenell, A.; McNeill, G.; Fraser, W.D. A Case-Control Study of Vitamin D Status and Asthma in Adults. Allergy 2010, 65, 666–667. [Google Scholar] [CrossRef] [PubMed]
  320. Mai, X.-M.; Langhammer, A.; Camargo, C.A.; Chen, Y. Serum 25-Hydroxyvitamin D Levels and Incident Asthma in Adults: The HUNT Study. Am. J. Epidemiol. 2012, 176, 1169–1176. [Google Scholar] [CrossRef] [PubMed]
  321. Camargo, C.A.; Ingham, T.; Wickens, K.; Thadhani, R.; Silvers, K.M.; Epton, M.J.; Town, G.I.; Pattemore, P.K.; Espinola, J.A.; Crane, J.; et al. Cord-Blood 25-Hydroxyvitamin D Levels and Risk of Respiratory Infection, Wheezing, and Asthma. Pediatrics 2011, 127, e180–e187. [Google Scholar] [CrossRef]
  322. Cheng, H.M.; Kim, S.; Park, G.-H.; Chang, S.E.; Bang, S.; Won, C.H.; Lee, M.W.; Choi, J.H.; Moon, K.C. Low Vitamin D Levels Are Associated with Atopic Dermatitis, but Not Allergic Rhinitis, Asthma, or IgE Sensitization, in the Adult Korean Population. J. Allergy Clin. Immunol. 2014, 133, 1048–1055. [Google Scholar] [CrossRef]
  323. Thuesen, B.H.; Skaaby, T.; Husemoen, L.L.N.; Fenger, M.; Jørgensen, T.; Linneberg, A. The Association of Serum 25-OH Vitamin D with Atopy, Asthma, and Lung Function in a Prospective Study of Danish Adults. Clin. Exp. Allergy 2015, 45, 265–272. [Google Scholar] [CrossRef] [PubMed]
  324. Berry, D.J.; Hesketh, K.; Power, C.; Hyppönen, E. Vitamin D Status Has a Linear Association with Seasonal Infections and Lung Function in British Adults. Br. J. Nutr. 2011, 106, 1433–1440. [Google Scholar] [CrossRef]
  325. Rehan, V.K.; Torday, J.S.; Peleg, S.; Gennaro, L.; Vouros, P.; Padbury, J.; Rao, D.S.; Reddy, G.S. 1a,25-Dihydroxy-3-Epi-Vitamin D3, a Natural Metabolite of 1a,25-Dihydroxy Vitamin D3: Production and Biological Activity Studies in Pulmonary Alveolar Type II Cellsq. Mol. Genet. Metab. 2002, 76, 46–56. [Google Scholar] [CrossRef] [PubMed]
  326. Amrein, K.; Quraishi, S.A.; Litonjua, A.A.; Gibbons, F.K.; Pieber, T.R.; Camargo, C.A.; Giovannucci, E.; Christopher, K.B. Evidence for a U-Shaped Relationship Between Prehospital Vitamin D Status and Mortality: A Cohort Study. J. Clin. Endocrinol. Metab. 2014, 99, 1461–1469. [Google Scholar] [CrossRef] [PubMed]
  327. Quraishi, S.A.; Bittner, E.A.; Christopher, K.B.; Camargo, C.A. Vitamin D Status and Community-Acquired Pneumonia: Results from the Third National Health and Nutrition Examination Survey. PLoS ONE 2013, 8, e81120. [Google Scholar] [CrossRef] [PubMed]
  328. Ali, N.S.; Nanji, K. A Review on the Role of Vitamin D in Asthma. Cureus 2017, 9, e1288. [Google Scholar] [CrossRef] [PubMed]
  329. Papamichael, M.M.; Itsiopoulos, C.; Lambert, K.; Katsardis, C.; Tsoukalas, D.; Erbas, B. Sufficient Vitamin D Status Positively Modified Ventilatory Function in Asthmatic Children Following a Mediterranean Diet Enriched with Fatty Fish Intervention Study. Nutr. Res. 2020, 82, 99–109. [Google Scholar] [CrossRef]
  330. Hufnagl, K.; Jensen-Jarolim, E. Vitamin A and D in Allergy: From Experimental Animal Models and Cellular Studies to Human Disease. Allergo J. Int. 2018, 27, 72–78. [Google Scholar] [CrossRef]
  331. Jolliffe, D.A.; Greenberg, L.; Hooper, R.L.; Griffiths, C.J.; Camargo, C.A.; Kerley, C.P.; Jensen, M.E.; Mauger, D.; Stelmach, I.; Urashima, M.; et al. Vitamin D Supplementation to Prevent Asthma Exacerbations: A Systematic Review and Meta-Analysis of Individual Participant Data. Lancet Respir. Med. 2017, 5, 881–890. [Google Scholar] [CrossRef]
  332. Tachimoto, H.; Mezawa, H.; Segawa, T.; Akiyama, N.; Ida, H.; Urashima, M. Improved Control of Childhood Asthma with Low-Dose, Short-Term Vitamin D Supplementation: A Randomized, Double-Blind, Placebo-Controlled Trial. Allergy 2016, 71, 1001–1009. [Google Scholar] [CrossRef]
  333. Yadav, M.; Mittal, K. Effect of Vitamin D Supplementation on Moderate to Severe Bronchial Asthma. Indian J. Pediatr. 2014, 81, 650–654. [Google Scholar] [CrossRef]
  334. Baris, S.; Kiykim, A.; Ozen, A.; Tulunay, A.; Karakoc-Aydiner, E.; Barlan, I.B. Vitamin D as an Adjunct to Subcutaneous Allergen Immunotherapy in Asthmatic Children Sensitized to House Dust Mite. Allergy 2014, 69, 246–253. [Google Scholar] [CrossRef]
  335. Kerley, C.P.; Hutchinson, K.; Cormican, L.; Faul, J.; Greally, P.; Coghlan, D.; Elnazir, B. Vitamin D3 for Uncontrolled Childhood Asthma: A Pilot Study. Pediatr. Allergy Immunol. 2016, 27, 404–412. [Google Scholar] [CrossRef] [PubMed]
  336. Puranik, S.; Forno, E.; Bush, A.; Celedón, J.C. Predicting Severe Asthma Exacerbations in Children. Am. J. Respir. Crit. Care Med. 2017, 195, 854–859. [Google Scholar] [CrossRef] [PubMed]
  337. Agrawal, T.; Gupta, G.K.; Agrawal, D.K. Vitamin D Supplementation Reduces Airway Hyperresponsiveness and Allergic Airway Inflammation in a Murine Model. Clin. Exp. Allergy 2013, 43, 672–683. [Google Scholar] [CrossRef] [PubMed]
  338. Fischer, K.D.; Hall, S.C.; Agrawal, D.K. Vitamin D Supplementation Reduces Induction of Epithelial-Mesenchymal Transition in Allergen Sensitized and Challenged Mice. PLoS ONE 2016, 11, e0149180. [Google Scholar] [CrossRef]
  339. Heine, G.; Tabeling, C.; Hartmann, B.; González Calera, C.R.; Kühl, A.A.; Lindner, J.; Radbruch, A.; Witzenrath, M.; Worm, M. 25-Hydroxvitamin D 3 Promotes the Long-Term Effect of Specific Immunotherapy in a Murine Allergy Model. J. Immunol. 2014, 193, 1017–1023. [Google Scholar] [CrossRef]
  340. Schedel, M.; Jia, Y.; Michel, S.; Takeda, K.; Domenico, J.; Joetham, A.; Ning, F.; Strand, M.; Han, J.; Wang, M.; et al. 1,25D3 Prevents CD8+Tc2 Skewing and Asthma Development through VDR Binding Changes to the Cyp11a1 Promoter. Nat. Commun. 2016, 7, 10213. [Google Scholar] [CrossRef]
  341. Lan, N.; Luo, G.; Yang, X.; Cheng, Y.; Zhang, Y.; Wang, X.; Wang, X.; Xie, T.; Li, G.; Liu, Z.; et al. 25-Hydroxyvitamin D3-Deficiency Enhances Oxidative Stress and Corticosteroid Resistance in Severe Asthma Exacerbation. PLoS ONE 2014, 9, e111599. [Google Scholar] [CrossRef]
  342. Codoñer-Franch, P.; Tavárez-Alonso, S.; Simó-Jordá, R.; Laporta-Martín, P.; Carratalá-Calvo, A.; Alonso-Iglesias, E. Vitamin D Status Is Linked to Biomarkers of Oxidative Stress, Inflammation, and Endothelial Activation in Obese Children. J. Pediatr. 2012, 161, 848–854. [Google Scholar] [CrossRef]
  343. Wang, Z.; Zhang, H.; Sun, X.; Ren, L. The Protective Role of Vitamin D3 in a Murine Model of Asthma via the Suppression of TGF-β/Smad Signaling and Activation of the Nrf2/HO-1 Pathway. Mol. Med. Rep. 2016, 14, 2389–2396. [Google Scholar] [CrossRef]
  344. Adam-Bonci, T.-I.; Bonci, E.-A.; Pârvu, A.-E.; Herdean, A.-I.; Moț, A.; Taulescu, M.; Ungur, A.; Pop, R.-M.; Bocșan, C.; Irimie, A. Vitamin D Supplementation: Oxidative Stress Modulation in a Mouse Model of Ovalbumin-Induced Acute Asthmatic Airway Inflammation. Int. J. Mol. Sci. 2021, 22, 7089. [Google Scholar] [CrossRef]
  345. Adams, J.S.; Hewison, M. Unexpected Actions of Vitamin D: New Perspectives on the Regulation of Innate and Adaptive Immunity. Nat. Clin. Pract. Endocrinol. Metab. 2008, 4, 80–90. [Google Scholar] [CrossRef] [PubMed]
  346. Chambers, E.S.; Hawrylowicz, C.M. The Impact of Vitamin D on Regulatory T Cells. Curr. Allergy Asthma Rep. 2011, 11, 29–36. [Google Scholar] [CrossRef] [PubMed]
  347. Biggs, L.; Yu, C.; Fedoric, B.; Lopez, A.F.; Galli, S.J.; Grimbaldeston, M.A. Evidence That Vitamin D3 Promotes Mast Cell–Dependent Reduction of Chronic UVB-Induced Skin Pathology in Mice. J. Exp. Med. 2010, 207, 455–463. [Google Scholar] [CrossRef] [PubMed]
  348. Bscheider, M.; Butcher, E.C. Vitamin D Immunoregulation through Dendritic Cells. Immunology 2016, 148, 227–236. [Google Scholar] [CrossRef] [PubMed]
  349. Hartmann, B.; Heine, G.; Babina, M.; Steinmeyer, A.; Zügel, U.; Radbruch, A.; Worm, M. Targeting the Vitamin D Receptor Inhibits the B Cell-Dependent Allergic Immune Response: VDR Targeting Inhibits the Allergic Immune Response. Allergy 2011, 66, 540–548. [Google Scholar] [CrossRef]
  350. Heine, G.; Niesner, U.; Chang, H.-D.; Steinmeyer, A.; Zügel, U.; Zuberbier, T.; Radbruch, A.; Worm, M. 1,25-Dihydroxyvitamin D3 Promotes IL-10 Production in Human B Cells. Eur. J. Immunol. 2008, 38, 2210–2218. [Google Scholar] [CrossRef]
  351. Litonjua, A.A. Dietary Factors and the Development of Asthma. Immunol. Allergy Clin. North Am. 2008, 28, 603–629. [Google Scholar] [CrossRef]
  352. Keating, P.; Munim, A.; Hartmann, J.X. Effect of Vitamin D on T-Helper Type 9 Polarized Human Memory Cells in Chronic Persistent Asthma. Ann. Allergy. Asthma. Immunol. 2014, 112, 154–162. [Google Scholar] [CrossRef]
  353. Yip, K.-H.; Kolesnikoff, N.; Yu, C.; Hauschild, N.; Taing, H.; Biggs, L.; Goltzman, D.; Gregory, P.A.; Anderson, P.H.; Samuel, M.S.; et al. Mechanisms of Vitamin D3 Metabolite Repression of IgE-Dependent Mast Cell Activation. J. Allergy Clin. Immunol. 2014, 133, 1356–1364.e14. [Google Scholar] [CrossRef]
  354. Taher, Y.A.; van Esch, B.C.A.M.; Hofman, G.A.; Henricks, P.A.J.; van Oosterhout, A.J.M. 1α,25-Dihydroxyvitamin D3 Potentiates the Beneficial Effects of Allergen Immunotherapy in a Mouse Model of Allergic Asthma: Role for IL-10 and TGF-β. J. Immunol. 2008, 180, 5211–5221. [Google Scholar] [CrossRef]
  355. Belderbos, M.E.; Houben, M.L.; Wilbrink, B.; Lentjes, E.; Bloemen, E.M.; Kimpen, J.L.L.; Rovers, M.; Bont, L. Cord Blood Vitamin D Deficiency Is Associated with Respiratory Syncytial Virus Bronchiolitis. Pediatrics 2011, 127, e1513–e1520. [Google Scholar] [CrossRef] [PubMed]
  356. Camargo, C.A.; Ganmaa, D.; Frazier, A.L.; Kirchberg, F.F.; Stuart, J.J.; Kleinman, K.; Sumberzul, N.; Rich-Edwards, J.W. Randomized Trial of Vitamin D Supplementation and Risk of Acute Respiratory Infection in Mongolia. Pediatrics 2012, 130, e561–e567. [Google Scholar] [CrossRef] [PubMed]
  357. Greiller, C.; Martineau, A. Modulation of the Immune Response to Respiratory Viruses by Vitamin D. Nutrients 2015, 7, 4240–4270. [Google Scholar] [CrossRef] [PubMed]
  358. Jartti, T.; Ruuskanen, O.; Mansbach, J.M.; Vuorinen, T.; Camargo, C.A. Low Serum 25-Hydroxyvitamin D Levels Are Associated with Increased Risk of Viral Coinfections in Wheezing Children. J. Allergy Clin. Immunol. 2010, 126, 1074–1076.e4. [Google Scholar] [CrossRef] [PubMed]
  359. Urashima, M.; Segawa, T.; Okazaki, M.; Kurihara, M.; Wada, Y.; Ida, H. Randomized Trial of Vitamin D Supplementation to Prevent Seasonal Influenza A in Schoolchildren. Am. J. Clin. Nutr. 2010, 91, 1255–1260. [Google Scholar] [CrossRef]
  360. Goodall, E.C.; Granados, A.C.; Luinstra, K.; Pullenayegum, E.; Coleman, B.L.; Loeb, M.; Smieja, M. Vitamin D3 and Gargling for the Prevention of Upper Respiratory Tract Infections: A Randomized Controlled Trial. BMC Infect. Dis. 2014, 14, 273. [Google Scholar] [CrossRef]
  361. Vasiliou, J.E.; Lui, S.; Walker, S.A.; Chohan, V.; Xystrakis, E.; Bush, A.; Hawrylowicz, C.M.; Saglani, S.; Lloyd, C.M. Vitamin D Deficiency Induces T H2 Skewing and Eosinophilia in Neonatal Allergic Airways Disease. Allergy 2014, 69, 1380–1389. [Google Scholar] [CrossRef]
  362. Lai, G.; Wu, C.; Hong, J.; Song, Y. 1,25-Dihydroxyvitamin D3 (1,25-(OH) 2 D3) Attenuates Airway Remodeling in a Murine Model of Chronic Asthma. J. Asthma 2013, 50, 133–140. [Google Scholar] [CrossRef]
  363. Matheu, V.; Bäck, O.; Mondoc, E.; Issazadeh-Navikas, S. Dual Effects of Vitamin D-Induced Alteration of TH1/TH2 Cytokine Expression: Enhancing IgE Production and Decreasing Airway Eosinophilia in Murine Allergic Airway Disease. J. Allergy Clin. Immunol. 2003, 112, 585–592. [Google Scholar] [CrossRef]
  364. Bose, S.; Diette, G.B.; Woo, H.; Koehler, K.; Romero, K.; Rule, A.M.; Detrick, B.; Brigham, E.; McCormack, M.C.; Hansel, N.N. Vitamin D Status Modifies the Response to Indoor Particulate Matter in Obese Urban Children with Asthma. J. Allergy Clin. Immunol. Pract. 2019, 7, 1815–1822.e2. [Google Scholar] [CrossRef]
  365. Szymczak-Pajor, I.; Kleniewska, P.; Wieczfinska, J.; Pawliczak, R. Wide-Range Effects of 1,25(OH)2D3 on Group 4A Phospholipases Is Related to Nuclear Factor κ-B and Phospholipase-A2 Activating Protein Activity in Mast Cells. Int. Arch. Allergy Immunol. 2020, 181, 56–70. [Google Scholar] [CrossRef] [PubMed]
  366. Yin, K.; Agrawal, D.K. Vitamin D and Inflammatory Diseases. J. Inflamm. Res. 2014, 7, 69–87. [Google Scholar] [CrossRef] [PubMed]
  367. Feng, L.; Meng, T.; Qi, Y.; Athari, S.S.; Chen, X. Study Effect of Vitamin D on the Immunopathology Responses of the Bronchi in Murine Model of Asthma. Iran. J. Allergy Asthma Immunol. 2021, 20, 509–519. [Google Scholar] [CrossRef]
  368. Banerjee, A.; Panettieri, R. Vitamin D Modulates Airway Smooth Muscle Function in COPD. Curr. Opin. Pharmacol. 2012, 12, 266–274. [Google Scholar] [CrossRef] [PubMed]
  369. Damera, G.; Fogle, H.; Lim, P.; Goncharova, E.; Zhao, H.; Banerjee, A.; Tliba, O.; Krymskaya, V.; Panettieri, R., Jr. Vitamin D Inhibits Growth of Human Airway Smooth Muscle Cells through Growth Factor-Induced Phosphorylation of Retinoblastoma Protein and Checkpoint Kinase 1: Airway Smooth Muscle Growth and Vitamin D. Br. J. Pharmacol. 2009, 158, 1429–1441. [Google Scholar] [CrossRef] [PubMed]
  370. Foley, S.C.; Mogas, A.K.; Olivenstein, R.; Fiset, P.O.; Chakir, J.; Bourbeau, J.; Ernst, P.; Lemière, C.; Martin, J.G.; Hamid, Q. Increased Expression of ADAM33 and ADAM8 with Disease Progression in Asthma. J. Allergy Clin. Immunol. 2007, 119, 863–871. [Google Scholar] [CrossRef]
  371. Johnson, L.A.; Sauder, K.L.; Rodansky, E.S.; Simpson, R.U.; Higgins, P.D.R. CARD-024, a Vitamin D Analog, Attenuates the pro-Fibrotic Response to Substrate Stiffness in Colonic Myofibroblasts. Exp. Mol. Pathol. 2012, 93, 91–98. [Google Scholar] [CrossRef]
  372. Slominski, A.T.; Li, W.; Bhattacharya, S.K.; Smith, R.A.; Johnson, P.L.; Chen, J.; Nelson, K.E.; Tuckey, R.C.; Miller, D.; Jiao, Y.; et al. Vitamin D Analogs 17,20S(OH)2pD and 17,20R(OH)2pD Are Noncalcemic and Exhibit Antifibrotic Activity. J. Investig. Dermatol. 2011, 131, 1167–1169. [Google Scholar] [CrossRef]
  373. Song, Y.; Qi, H.; Wu, C. Effect of 1,25-(OH) 2 D 3 (a Vitamin D Analogue) on Passively Sensitized Human Airway Smooth Muscle Cells. Respirology 2007, 12, 486–494. [Google Scholar] [CrossRef]
  374. Sundar, I.K.; Hwang, J.-W.; Wu, S.; Sun, J.; Rahman, I. Deletion of Vitamin D Receptor Leads to Premature Emphysema/COPD by Increased Matrix Metalloproteinases and Lymphoid Aggregates Formation. Biochem. Biophys. Res. Commun. 2011, 406, 127–133. [Google Scholar] [CrossRef]
  375. Al-Afaleg, N.O.; Al-Senaidy, A.; El-Ansary, A. Oxidative Stress and Antioxidant Status in Saudi Asthmatic Patients. Clin. Biochem. 2011, 44, 612–617. [Google Scholar] [CrossRef] [PubMed]
  376. Hijazi, N.; Abalkhail, B.; Seaton, A. Diet and Childhood Asthma in a Society in Transition: A Study in Urban and Rural Saudi Arabia. Thorax 2000, 55, 775–779. [Google Scholar] [CrossRef] [PubMed]
  377. Wood, L.G.; Garg, M.L.; Blake, R.J.; Simpson, J.L.; Gibson, P.G. Oxidized Vitamin E and Glutathione as Markers of Clinical Status in Asthma. Clin. Nutr. 2008, 27, 579–586. [Google Scholar] [CrossRef] [PubMed]
  378. Mizuno, Y.; Furusho, T.; Yoshida, A.; Nakamura, H.; Matsuura, T.; Eto, Y. Serum Vitamin A Concentrations in Asthmatic Children in Japan. Pediatr. Int. 2006, 48, 261–264. [Google Scholar] [CrossRef] [PubMed]
  379. Nwaru, B.I.; Virtanen, S.M.; Alfthan, G.; Karvonen, A.M.; Genuneit, J.; Lauener, R.P.; Dalphin, J.-C.; Hyvärinen, A.; Pfefferle, P.; Riedler, J.; et al. Serum Vitamin E Concentrations at 1 Year and Risk of Atopy, Atopic Dermatitis, Wheezing, and Asthma in Childhood: The PASTURE Study. Allergy 2014, 69, 87–94. [Google Scholar] [CrossRef]
  380. Butland, B.K. Diet, Lung Function, and Lung Function Decline in a Cohort of 2512 Middle Aged Men. Thorax 2000, 55, 102–108. [Google Scholar] [CrossRef]
  381. Hu, G.; Cassano, P.A. Antioxidant Nutrients and Pulmonary Function: The Third National Health and Nutrition Examination Survey (NHANES III). Am. J. Epidemiol. 2000, 151, 975–981. [Google Scholar] [CrossRef]
  382. Cui, H.; Huang, J.; Lu, M.; Zhang, Q.; Qin, W.; Zhao, Y.; Lu, X.; Zhang, J.; Xi, Z.; Li, R. Antagonistic Effect of Vitamin E on NAl2O3-Induced Exacerbation of Th2 and Th17-Mediated Allergic Asthma via Oxidative Stress. Environ. Pollut. 2019, 252, 1519–1531. [Google Scholar] [CrossRef]
  383. Li, J.; Li, L.; Chen, H.; Chang, Q.; Liu, X.; Wu, Y.; Wei, C.; Li, R.; Kwan, J.K.C.; Yeung, K.L.; et al. Application of Vitamin E to Antagonize SWCNTs-Induced Exacerbation of Allergic Asthma. Sci. Rep. 2014, 4, 4275. [Google Scholar] [CrossRef]
  384. Okamoto, N.; Murata, T.; Tamai, H.; Tanaka, H.; Nagai, H. Effects of Alpha Tocopherol and Probucol Supplements on Allergen-Induced Airway Inflammation and Hyperresponsiveness in a Mouse Model of Allergic Asthma. Int. Arch. Allergy Immunol. 2006, 141, 172–180. [Google Scholar] [CrossRef]
  385. Wagner, J.G.; Jiang, Q.; Harkema, J.R.; Illek, B.; Patel, D.D.; Ames, B.N.; Peden, D.B. Ozone Enhancement of Lower Airway Allergic Inflammation Is Prevented by γ-Tocopherol. Free Radic. Biol. Med. 2007, 43, 1176–1188. [Google Scholar] [CrossRef] [PubMed]
  386. Talati, M.; Meyrick, B.; Peebles, R.S.; Davies, S.S.; Dworski, R.; Mernaugh, R.; Mitchell, D.; Boothby, M.; Roberts, L.J.; Sheller, J.R. Oxidant Stress Modulates Murine Allergic Airway Responses. Free Radic. Biol. Med. 2006, 40, 1210–1219. [Google Scholar] [CrossRef] [PubMed]
  387. Nishio, K.; Horie, M.; Akazawa, Y.; Shichiri, M.; Iwahashi, H.; Hagihara, Y.; Yoshida, Y.; Niki, E. Attenuation of Lipopolysaccharide (LPS)-Induced Cytotoxicity by Tocopherols and Tocotrienols. Redox Biol. 2013, 1, 97–103. [Google Scholar] [CrossRef] [PubMed]
  388. Yoshida, Y.; Saito, Y.; Jones, L.S.; Shigeri, Y. Chemical Reactivities and Physical Effects in Comparison between Tocopherols and Tocotrienols: Physiological Significance and Prospects as Antioxidants. J. Biosci. Bioeng. 2007, 104, 439–445. [Google Scholar] [CrossRef] [PubMed]
  389. Patel, A.; Liebner, F.; Netscher, T.; Mereiter, K.; Rosenau, T. Vitamin E Chemistry. Nitration of Non-Alpha-Tocopherols: Products and Mechanistic Considerations. J. Org. Chem. 2007, 72, 6504–6512. [Google Scholar] [CrossRef]
  390. Cook-Mills, J.; Gebretsadik, T.; Abdala-Valencia, H.; Green, J.; Larkin, E.K.; Dupont, W.D.; Shu, X.O.; Gross, M.; Bai, C.; Gao, Y.-T.; et al. Interaction of Vitamin E Isoforms on Asthma and Allergic Airway Disease. Thorax 2016, 71, 954–956. [Google Scholar] [CrossRef]
  391. Zhu, Y.; Li, J.; Wu, Z.; Lu, Y.; You, H.; Li, R.; Li, B.; Yang, X.; Duan, L. Acute Exposure of Ozone Induced Pulmonary Injury and the Protective Role of Vitamin E through the Nrf2 Pathway in Balb/c Mice. Toxicol. Res. 2016, 5, 268–277. [Google Scholar] [CrossRef]
  392. Dworski, R.; Han, W.; Blackwell, T.S.; Hoskins, A.; Freeman, M.L. Vitamin E Prevents NRF2 Suppression by Allergens in Asthmatic Alveolar Macrophages in Vivo. Free Radic. Biol. Med. 2011, 51, 516–521. [Google Scholar] [CrossRef]
  393. Quoc, Q.L.; Bich, T.C.T.; Kim, S.; Park, H.; Shin, Y.S. Administration of Vitamin E Attenuates Airway Inflammation through Restoration of Nrf2 in a Mouse Model of Asthma. J. Cell. Mol. Med. 2021, 25, 6721–6732. [Google Scholar] [CrossRef]
  394. Muti, A.D.; Pârvu, A.E.; Muti, L.A.; Moldovan, R.; Mureșan, A. Vitamin E effect in a rat model of toluene diisocyanate-induced asthma. Med. Pharm. Rep. 2016, 89, 499–505. [Google Scholar] [CrossRef]
  395. Shang, S.; Li, J.; Zhao, Y.; Xi, Z.; Lu, Z.; Li, B.; Yang, X.; Li, R. Oxidized Graphene-Aggravated Allergic Asthma Is Antagonized by Antioxidant Vitamin E in Balb/c Mice. Environ. Sci. Pollut. Res. 2017, 24, 1784–1793. [Google Scholar] [CrossRef] [PubMed]
  396. Pearson, P.; Lewis, S.A.; Britton, J.; Young, I.S.; Fogarty, A. The Pro-Oxidant Activity of High-Dose Vitamin E Supplements In Vivo. BioDrugs 2006, 20, 271–273. [Google Scholar] [CrossRef] [PubMed]
  397. Marchese, M.E.; Kumar, R.; Colangelo, L.A.; Avila, P.C.; Jacobs, D.R.; Gross, M.; Sood, A.; Liu, K.; Cook-Mills, J.M. The Vitamin E Isoforms α-Tocopherol and γ-Tocopherol Have Opposite Associations with Spirometric Parameters: The CARDIA Study. Respir. Res. 2014, 15, 31. [Google Scholar] [CrossRef]
  398. McCary, C.A.; Yoon, Y.; Panagabko, C.; Cho, W.; Atkinson, J.; Cook-Mills, J.M. Vitamin E Isoforms Directly Bind PKCα and Differentially Regulate Activation of PKCα. Biochem. J. 2012, 441, 189–198. [Google Scholar] [CrossRef] [PubMed]
  399. Schock, B.C.; Van der Vliet, A.; Corbacho, A.M.; Leonard, S.W.; Finkelstein, E.; Valacchi, G.; Obermueller-Jevic, U.; Cross, C.E.; Traber, M.G. Enhanced Inflammatory Responses in α-Tocopherol Transfer Protein Null Mice. Arch. Biochem. Biophys. 2004, 423, 162–169. [Google Scholar] [CrossRef] [PubMed]
  400. Singh, U.; Devaraj, S.; Jialal, I. Vitamin E, Oxidative Stress, and Inflammation. Annu. Rev. Nutr. 2005, 25, 151–174. [Google Scholar] [CrossRef] [PubMed]
  401. Duan, L.; Li, J.; Ma, P.; Yang, X.; Xu, S. Vitamin E Antagonizes Ozone-Induced Asthma Exacerbation in Balb/c Mice through the Nrf2 Pathway. Food Chem. Toxicol. 2017, 107, 47–56. [Google Scholar] [CrossRef]
  402. Jiang, J.; Mehrabi Nasab, E.; Athari, S.M.; Athari, S.S. Effects of Vitamin E and Selenium on Allergic Rhinitis and Asthma Pathophysiology. Respir. Physiol. Neurobiol. 2021, 286, 103614. [Google Scholar] [CrossRef]
  403. Mabalirajan, U.; Aich, J.; Leishangthem, G.D.; Sharma, S.K.; Dinda, A.K.; Ghosh, B. Effects of Vitamin E on Mitochondrial Dysfunction and Asthma Features in an Experimental Allergic Murine Model. J. Appl. Physiol. 2009, 107, 1285–1292. [Google Scholar] [CrossRef]
  404. Nounou, H.A.; Deif, M.M.; Arafah, M. The Influence of Dexamethasone and the Role of Some Antioxidant Vitamins in the Pathogenesis of Experimental Bronchial Asthma. J. Exp. Pharmacol. 2010, 2, 93–103. [Google Scholar] [CrossRef]
  405. Salinthone, S.; Kerns, A.R.; Tsang, V.; Carr, D.W. α-Tocopherol (Vitamin E) Stimulates Cyclic AMP Production in Human Peripheral Mononuclear Cells and Alters Immune Function. Mol. Immunol. 2013, 53, 173–178. [Google Scholar] [CrossRef] [PubMed]
  406. Pein, H.; Ville, A.; Pace, S.; Temml, V.; Garscha, U.; Raasch, M.; Alsabil, K.; Viault, G.; Dinh, C.-P.; Guilet, D.; et al. Endogenous Metabolites of Vitamin E Limit Inflammation by Targeting 5-Lipoxygenase. Nat. Commun. 2018, 9, 3834. [Google Scholar] [CrossRef] [PubMed]
  407. Centanni, S.; Santus, P.; Dimarco, F.; Fumagalli, F.; Zarini, S.; Sala, A. The Potential Role of Tocopherol in Asthma and Allergies: Modification of the Leukotriene Pathway. BioDrugs 2001, 15, 81–86. [Google Scholar] [CrossRef] [PubMed]
  408. Burbank, A.J.; Duran, C.G.; Almond, M.; Wells, H.; Jenkins, S.; Jiang, Q.; Yang, C.; Wang, T.; Zhou, H.; Hernandez, M.L.; et al. A Short Course of Gamma-Tocopherol Mitigates LPS-Induced Inflammatory Responses in Humans Ex Vivo. J. Allergy Clin. Immunol. 2017, 140, 1179–1181.e4. [Google Scholar] [CrossRef] [PubMed]
  409. Hernandez, M.L.; Wagner, J.G.; Kala, A.; Mills, K.; Wells, H.B.; Alexis, N.E.; Lay, J.C.; Jiang, Q.; Zhang, H.; Zhou, H.; et al. Vitamin E, γ-Tocopherol, Reduces Airway Neutrophil Recruitment after Inhaled Endotoxin Challenge in Rats and in Healthy Volunteers. Free Radic. Biol. Med. 2013, 60, 56–62. [Google Scholar] [CrossRef] [PubMed]
  410. Wiser, J.; Alexis, N.E.; Jiang, Q.; Wu, W.; Robinette, C.; Roubey, R.; Peden, D.B. In Vivo γ-Tocopherol Supplementation Decreases Systemic Oxidative Stress and Cytokine Responses of Human Monocytes in Normal and Asthmatic Subjects. Free Radic. Biol. Med. 2008, 45, 40–49. [Google Scholar] [CrossRef] [PubMed]
  411. Suchankova, J.; Voprsalova, M.; Kottova, M.; Semecky, V.; Visnovsky, P. Effects of Oral Alpha-Tocopherol on Lung Response in Rat Model of Allergic Asthma. Respirology 2006, 11, 414–421. [Google Scholar] [CrossRef]
  412. Kuhad, A.; Chopra, K. Tocotrienol Attenuates Oxidative–Nitrosative Stress and Inflammatory Cascade in Experimental Model of Diabetic Neuropathy. Neuropharmacology 2009, 57, 456–462. [Google Scholar] [CrossRef]
  413. Matsunaga, T.; Shoji, A.; Gu, N.; Joo, E.; Li, S.; Adachi, T.; Yamazaki, H.; Yasuda, K.; Kondoh, T.; Tsuda, K. γ-Tocotrienol Attenuates TNF-α-Induced Changes in Secretion and Gene Expression of MCP-1, IL-6 and Adiponectin in 3T3-L1 Adipocytes. Mol. Med. Rep. 2012, 5, 905–909. [Google Scholar] [CrossRef]
  414. Morante, M.; Sandoval, J.; Gómez-Cabrera, M.-C.; Rodríguez, J.L.; Pallardó, F.V.; Viña, J.R.; Torres, L.; Barber, T. Vitamin E Deficiency Induces Liver Nuclear Factor-KappaB DNA-Binding Activity and Changes in Related Genes. Free Radic. Res. 2005, 39, 1127–1138. [Google Scholar] [CrossRef]
  415. Wu, G.; Zhu, H.; Wu, X.; Liu, L.; Ma, X.; Yuan, Y.; Fu, X.; Zhang, L.; Lv, Y.; Li, D.; et al. Anti-Allergic Function of α-Tocopherol Is Mediated by Suppression of PI3K-PKB Activity in Mast Cells in Mouse Model of Allergic Rhinitis. Allergol. Immunopathol. 2020, 48, 395–400. [Google Scholar] [CrossRef] [PubMed]
  416. Ramsahai, J.M.; Hansbro, P.M.; Wark, P.A.B. Mechanisms and Management of Asthma Exacerbations. Am. J. Respir. Crit. Care Med. 2019, 199, 423–432. [Google Scholar] [CrossRef] [PubMed]
  417. Anitua, E.; Tierno, R.; Alkhraisat, M.H. Current Opinion on the Role of Vitamin D Supplementation in Respiratory Infections and Asthma/COPD Exacerbations: A Need to Establish Publication Guidelines for Overcoming the Unpublished Data. Clin. Nutr. 2022, 41, 755–777. [Google Scholar] [CrossRef] [PubMed]
  418. Jartti, T.; Bønnelykke, K.; Elenius, V.; Feleszko, W. Role of Viruses in Asthma. Semin. Immunopathol. 2020, 42, 61–74. [Google Scholar] [CrossRef] [PubMed]
  419. Hansbro, N.G.; Horvat, J.C.; Wark, P.A.; Hansbro, P.M. Understanding the Mechanisms of Viral Induced Asthma: New Therapeutic Directions. Pharmacol. Ther. 2008, 117, 313–353. [Google Scholar] [CrossRef] [PubMed]
  420. Hershenson, M.B. Rhinovirus-Induced Exacerbations of Asthma and COPD. Scientifica 2013, 2013, 405876. [Google Scholar] [CrossRef] [PubMed]
  421. Coverstone, A.M.; Wang, L.; Sumino, K. Beyond Respiratory Syncytial Virus and Rhinovirus in the Pathogenesis and Exacerbation of Asthma. Immunol. Allergy Clin. North Am. 2019, 39, 391–401. [Google Scholar] [CrossRef] [PubMed]
  422. Adir, Y.; Saliba, W.; Beurnier, A.; Humbert, M. Asthma and COVID-19: An Update. Eur. Respir. Rev. 2021, 30, 210152. [Google Scholar] [CrossRef]
  423. Skevaki, C.; Karsonova, A.; Karaulov, A.; Fomina, D.; Xie, M.; Chinthrajah, S.; Nadeau, K.C.; Renz, H. SARS-CoV-2 Infection and COVID-19 in Asthmatics: A Complex Relationship. Nat. Rev. Immunol. 2021, 21, 202–203. [Google Scholar] [CrossRef]
  424. Palmon, P.A.; Jackson, D.J.; Denlinger, L.C. COVID-19 Infections and Asthma. J. Allergy Clin. Immunol. Pract. 2022, 10, 658–663. [Google Scholar] [CrossRef]
  425. Salciccioli, J.D.; She, L.; Tulchinsky, A.; Rockhold, F.; Cardet, J.C.; Israel, E. Effect of COVID-19 on Asthma Exacerbation. J. Allergy Clin. Immunol. Pract. 2021, 9, 2896–2899.e1. [Google Scholar] [CrossRef] [PubMed]
  426. Stoodley, I.; Williams, L.; Thompson, C.; Scott, H.; Wood, L. Evidence for Lifestyle Interventions in Asthma. Breathe 2019, 15, e50–e61. [Google Scholar] [CrossRef] [PubMed]
  427. Sinopoli, A.; Caminada, S.; Isonne, C.; Santoro, M.M.; Baccolini, V. What Are the Effects of Vitamin A Oral Supplementation in the Prevention and Management of Viral Infections? A Systematic Review of Randomized Clinical Trials. Nutrients 2022, 14, 4081. [Google Scholar] [CrossRef] [PubMed]
  428. Vlieg-Boerstra, B.; de Jong, N.; Meyer, R.; Agostoni, C.; De Cosmi, V.; Grimshaw, K.; Milani, G.P.; Muraro, A.; Oude Elberink, H.; Pali- Schöll, I.; et al. Nutrient Supplementation for Prevention of Viral Respiratory Tract Infections in Healthy Subjects: A Systematic Review and Meta-analysis. Allergy 2022, 77, 1373–1388. [Google Scholar] [CrossRef] [PubMed]
  429. Cerullo, G.; Negro, M.; Parimbelli, M.; Pecoraro, M.; Perna, S.; Liguori, G.; Rondanelli, M.; Cena, H.; D’Antona, G. The Long History of Vitamin C: From Prevention of the Common Cold to Potential Aid in the Treatment of COVID-19. Front. Immunol. 2020, 11, 574029. [Google Scholar] [CrossRef]
  430. Hemilä, H.; Chalker, E. Vitamin C for Preventing and Treating the Common Cold. Cochrane Database Syst. Rev. 2013, 2013, CD000980. [Google Scholar] [CrossRef]
  431. Keya, T.A.; Leela, A.; Fernandez, K.; Habib, N.; Rashid, M. Effect of Vitamin C Supplements on Respiratory Tract Infections: A SystematicReview and Meta-Analysis. Curr. Rev. Clin. Exp. Pharmacol. 2022, 17, 205–215. [Google Scholar] [CrossRef]
  432. Abioye, A.I.; Bromage, S.; Fawzi, W. Effect of Micronutrient Supplements on Influenza and Other Respiratory Tract Infections among Adults: A Systematic Review and Meta-Analysis. BMJ Glob. Health 2021, 6, e003176. [Google Scholar] [CrossRef]
  433. BourBour, F.; Mirzaei Dahka, S.; Gholamalizadeh, M.; Akbari, M.E.; Shadnoush, M.; Haghighi, M.; Taghvaye-Masoumi, H.; Ashoori, N.; Doaei, S. Nutrients in Prevention, Treatment, and Management of Viral Infections; Special Focus on Coronavirus. Arch. Physiol. Biochem. 2023, 129, 16–25. [Google Scholar] [CrossRef]
  434. Calder, P.; Carr, A.; Gombart, A.; Eggersdorfer, M. Optimal Nutritional Status for a Well-Functioning Immune System Is an Important Factor to Protect against Viral Infections. Nutrients 2020, 12, 1181. [Google Scholar] [CrossRef]
  435. Jolliffe, D.A.; Camargo, C.A.; Sluyter, J.D.; Aglipay, M.; Aloia, J.F.; Ganmaa, D.; Bergman, P.; Bischoff-Ferrari, H.A.; Borzutzky, A.; Damsgaard, C.T.; et al. Vitamin D Supplementation to Prevent Acute Respiratory Infections: A Systematic Review and Meta-Analysis of Aggregate Data from Randomised Controlled Trials. Lancet Diabetes Endocrinol. 2021, 9, 276–292. [Google Scholar] [CrossRef] [PubMed]
  436. Martineau, A.R.; Jolliffe, D.A.; Hooper, R.L.; Greenberg, L.; Aloia, J.F.; Bergman, P.; Dubnov-Raz, G.; Esposito, S.; Ganmaa, D.; Ginde, A.A.; et al. Vitamin D Supplementation to Prevent Acute Respiratory Tract Infections: Systematic Review and Meta-Analysis of Individual Participant Data. BMJ 2017, 356, i6583. [Google Scholar] [CrossRef] [PubMed]
  437. Trivillin, A.; Zanella, S.; Castaldo, R.J.; Prati, F.; Zanconato, S.; Carraro, S.; Ferraro, V.A. Early Oral Nutritional Supplements in the Prevention of Wheezing, Asthma, and Respiratory Infections. Front. Pediatr. 2022, 10, 866868. [Google Scholar] [CrossRef] [PubMed]
  438. Ferolla, F.M.; Yfran, E.W.; Ballerini, M.G.; Caratozzolo, A.; Toledano, A.; Giordano, A.C.; Acosta, P.L.; Cassinelli, H.; Bergada, I.; Ropelato, M.G.; et al. Serum Vitamin D Levels and Life-Threatening Respiratory Syncytial Virus Infection in Previously Healthy Infants. J. Infect. Dis. 2022, 226, 958–966. [Google Scholar] [CrossRef]
  439. Saraf, R.; Jensen, B.P.; Camargo, C.A.; Morton, S.M.B.; Jing, M.; Sies, C.W.; Grant, C.C. Vitamin D Status at Birth and Acute Respiratory Infection Hospitalisation during Infancy. Paediatr. Perinat. Epidemiol. 2021, 35, 540–548. [Google Scholar] [CrossRef]
  440. Charoenngam, N.; Holick, M.F. Immunologic Effects of Vitamin D on Human Health and Disease. Nutrients 2020, 12, 2097. [Google Scholar] [CrossRef]
  441. Hong, M.; Xiong, T.; Huang, J.; Wu, Y.; Lin, L.; Zhang, Z.; Huang, L.; Gao, D.; Wang, H.; Kang, C.; et al. Association of Vitamin D Supplementation with Respiratory Tract Infection in Infants. Matern. Child. Nutr. 2020, 16, e12987. [Google Scholar] [CrossRef]
  442. Ramos-Martínez, E.; López-Vancell, M.R.; Fernández de Córdova-Aguirre, J.C.; Rojas-Serrano, J.; Chavarría, A.; Velasco-Medina, A.; Velázquez-Sámano, G. Reduction of Respiratory Infections in Asthma Patients Supplemented with Vitamin D Is Related to Increased Serum IL-10 and IFNγ Levels and Cathelicidin Expression. Cytokine 2018, 108, 239–246. [Google Scholar] [CrossRef]
  443. Sharma, S.; Yang, I.V.; Schwartz, D.A. Epigenetic Regulation of Immune Function in Asthma. J. Allergy Clin. Immunol. 2022, 150, 259–265. [Google Scholar] [CrossRef]
Figure 1. Relationship between vitamins and factors leading to asthma induction (for details, see text). ↓ low; ↑ high/excess; [ox] oxidative stress. Created with BioRender.com.
Figure 1. Relationship between vitamins and factors leading to asthma induction (for details, see text). ↓ low; ↑ high/excess; [ox] oxidative stress. Created with BioRender.com.
Ijms 24 08574 g001
Figure 2. Factors contributing to asthma control (for details, see text). In green are factors improving asthma control, in red those worsening it. ↓ low/decrease; ↑ high/increase; RTI respiratory tract infections, ICS inhaled corticosteroids, [ox] oxidative stress.
Figure 2. Factors contributing to asthma control (for details, see text). In green are factors improving asthma control, in red those worsening it. ↓ low/decrease; ↑ high/increase; RTI respiratory tract infections, ICS inhaled corticosteroids, [ox] oxidative stress.
Ijms 24 08574 g002
Figure 3. Effects of low vitamin level in asthma and outcomes of the vitamin supplementation (for details, see text). In green are factors improving asthma outcomes, in red those worsening it. ↓ low/decrease; ↑ high/increase; Created with BioRender.com.
Figure 3. Effects of low vitamin level in asthma and outcomes of the vitamin supplementation (for details, see text). In green are factors improving asthma outcomes, in red those worsening it. ↓ low/decrease; ↑ high/increase; Created with BioRender.com.
Ijms 24 08574 g003
Table 1. Vitamins, their levels in asthma, and the impact of maternal intake on asthma development in a child. (Data from animal and human studies, for details, see text).
Table 1. Vitamins, their levels in asthma, and the impact of maternal intake on asthma development in a child. (Data from animal and human studies, for details, see text).
VitaminLevels in AsthmaIncreased Maternal Vitamin Intake and the Risk of Developing Asthma by the Child
A
B1, B2, B6, B7, B12??
B3?
B9
C
D
E
↓—decrease; ↑—increase; ?—not known.
Table 2. Influence of vitamins on main asthma features. (Data combined from animal and human studies, for details, see text).
Table 2. Influence of vitamins on main asthma features. (Data combined from animal and human studies, for details, see text).
VitaminLung FunctionAHROxidative StressInflammationAirway
Remodeling
A?
B?????
C?
D
E↓↑ *↓↑ *↓↑ *
K????
* depending on the isoform. ↓—decrease; ↑—increase; ? not known.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Zajac, D.; Wojciechowski, P. The Role of Vitamins in the Pathogenesis of Asthma. Int. J. Mol. Sci. 2023, 24, 8574. https://doi.org/10.3390/ijms24108574

AMA Style

Zajac D, Wojciechowski P. The Role of Vitamins in the Pathogenesis of Asthma. International Journal of Molecular Sciences. 2023; 24(10):8574. https://doi.org/10.3390/ijms24108574

Chicago/Turabian Style

Zajac, Dominika, and Piotr Wojciechowski. 2023. "The Role of Vitamins in the Pathogenesis of Asthma" International Journal of Molecular Sciences 24, no. 10: 8574. https://doi.org/10.3390/ijms24108574

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop